{
    "0HC.F": {
        "short_name": "MOJAVE BRANDS INC.",
        "long_name": "Mojave Brands Inc.",
        "summary": "Mojave Brands Inc. does not have significant operations. Previously, it was engaged in the manufacturing, processing, and sale of cannabis extracts. The company was formerly known as Mojave Jane Brands Inc. and changed its name to Mojave Brands Inc. in March 2020. Mojave Brands Inc. is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "0IL.F": {
        "short_name": "INTELGENX TECHN.DL-,00001",
        "long_name": "IntelGenx Technologies Corp.",
        "summary": "IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "0NN.F": {
        "short_name": "AVICANNA INC.",
        "long_name": "Avicanna Inc.",
        "summary": "Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally. The company provides pharmaceutical grade cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other rare cannabinoids; active pharmaceutical ingredients (APIs); feminized seeds; and bulk formulations under the Aureus Santa Marta brand. It also offers CBD based derma-cosmetic consumer products, such as beauty treatment, moisture and protection, and specialized care products under the Pura Earth brand; and medical cannabis/phyto-therapeutic products for the medical or homeopathic use under the Rho Phyto brand. In addition, the company provides pharmaceutical products focusing on skin disorders, including epidermolysis bullosa, eczema, and general skin problems comprising acne, erythema, and dryness; and neurological disorders, such as neuropathic pain, epilepsy, Parkinson's disease and multiple sclerosis, and nociceptive pain resulting from inflammatory and joint disorders, as well as a topical cream for rare genetic skin disorders. Avicanna has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation. Avicanna Inc.was founded in 2016 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "0OG.F": {
        "short_name": "ORGANIGRAM HLDGS INC.",
        "long_name": "OrganiGram Holdings Inc.",
        "summary": "Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Moncton"
    },
    "0OX.F": {
        "short_name": "ZYMEWORKS INC.",
        "long_name": "Zymeworks Inc.",
        "summary": "Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "0VH.F": {
        "short_name": "OVATION SCIENCE I",
        "long_name": "Ovation Science Inc.",
        "summary": "Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "10E.F": {
        "short_name": "APHRIA INC.",
        "long_name": "Tilray, Inc.",
        "summary": "Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Leamington"
    },
    "11L1.F": {
        "short_name": "CANOPY GROWTH",
        "long_name": "Canopy Growth Corporation",
        "summary": "Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Smiths Falls"
    },
    "14K.F": {
        "short_name": "SUNDIAL GROWERS INC.",
        "long_name": "Sundial Growers Inc.",
        "summary": "Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "18H.F": {
        "short_name": "PREVECEUTICAL MED.",
        "long_name": "PreveCeutical Medical Inc.",
        "summary": "PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products in the United States and Canada. It has research and development programs, including dual gene therapy for curative and prevention therapies for type 2 diabetes and obesity; a soluble gel drug delivery program, which provide relief from pain, inflammation, seizures, and neurological disorders; Nature Identical peptide therapeutic applications; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. It also provides medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "1AZ.F": {
        "short_name": "ICANIC BRANDS CO. INC.",
        "long_name": "Icanic Brands Company Inc.",
        "summary": "Icanic Brands Company Inc. provides life enhancement products in Canada. The company owns license for X-Sprays, a brand of life enhancement products administered through an oral spray delivery system. It markets and sells dietary supplements for nonmedical use primarily cannabinoid and cannabis-infused sprays, as well as non-cannabis infused sprays. The company was formerly known as Integrated Cannabis Company, Inc. and changed its name to Icanic Brands Company Inc. in February 2020. Icanic Brands Company Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "1BUP.F": {
        "short_name": "GTEC HLDGS LTD",
        "long_name": "GTEC Holdings Ltd.",
        "summary": "GTEC Holdings Ltd., doing business as GTEC Cannabis Co, cultivates, markets, and distributes cannabis products in Canada. The company brand portfolio includes BLK MKT, Tenzo, Pristine, GreenTec, Cognoscente, and Treehugger. It sells its products through medical and recreational sales channels, as well as through its GreenTec medical website and various licensed partners. The company was founded in 2017 and is headquartered in Kelowna, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "1JV1.F": {
        "short_name": "GNOMESTAR CRAFT INC.",
        "long_name": "Gnomestar Craft Inc.",
        "summary": "Gnomestar Craft Inc. operates as a licensed stage company for producing medical marijuana in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Delta"
    },
    "1N9.F": {
        "short_name": "NEUTRISCI INTL",
        "long_name": "NeutriSci International Inc.",
        "summary": "NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "1R3.F": {
        "short_name": "IZOTROPIC CORP.",
        "long_name": "Izotropic Corporation",
        "summary": "Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Surrey"
    },
    "1UB.F": {
        "short_name": "COGNETIVITY NEUROC. LTD",
        "long_name": "Cognetivity Neurosciences Ltd.",
        "summary": "Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical and commercial environments for potentially allowing early diagnosis of dementia. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "1V70.F": {
        "short_name": "VINERGY CAPITAL INC.",
        "long_name": "Vinergy Capital Inc.",
        "summary": "Vinergy Capital Inc. does not have significant operations. Previously, it was engaged in the development of cannabis products. The company was formerly known as Vinergy Cannabis Capital Inc. and changed its name to Vinergy Capital Inc. in March 2021. Vinergy Capital Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "1WZA.F": {
        "short_name": "THOUGHTFUL BRANDS INC.",
        "long_name": "Thoughtful Brands Inc.",
        "summary": "Mota Ventures Corp., together with its subsidiaries, operates in the cannabidiol (CBD) e-commerce business. It provides CBD hemp-oil formulations and cosmetics. The company offers its products under the Nature's Exclusive, First Class, and Sativida brands in the United States and Europe. Mota Ventures Corp. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "1XU1.F": {
        "short_name": "ENTHEON BIOMEDICAL CORP.",
        "long_name": "Entheon Biomedical Corp.",
        "summary": "Entheon Biomedical Corp., a biotechnology research and drug development company, engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "20B.F": {
        "short_name": "BIOMARK DIAGNOSTICS INC.",
        "long_name": "Biomark Diagnostics Inc",
        "summary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. It also has a collaborative research and development agreement with Phytronix Technologies Inc. to advance the development of early lung cancer screening applications using Phytronix-proprietary Laser Diode Thermal Desorption technology. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "23J.F": {
        "short_name": "PROMIS NEUROSCIENCES",
        "long_name": "ProMIS Neurosciences, Inc.",
        "summary": "ProMIS Neurosciences, Inc., a development stage biotech company, discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform\u00c2\u0097ProMIS and Collective Coordinates to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb); PMN350, a mAb targeting on toxic amyloid beta oligomers (A\u00c3\u009fO); and PMN330, a monoclonal antibody targeting toxic prion-like forms of A\u00c3\u009fO for AD. The company is also developing therapeutics targeting the neurotoxic form of the tau protein in AD; and superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in PD and Lewy body dementia. The company has a collaboration with BC Neuroimmunology to develop and commercialize proprietary diagnostic assays; and BC Neuroimmunology to develop and offer blood-based diagnostic tests for Alzheimer's diseases. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "23N.F": {
        "short_name": "NUVO PHARMACEUTICALS INC.",
        "long_name": "Nuvo Pharmaceuticals Inc.",
        "summary": "Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "29C1.F": {
        "short_name": "CARERX CORP.",
        "long_name": "CareRx Corporation",
        "summary": "CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "2CG2.F": {
        "short_name": "NANOSPHERE HEA.SCIENCES",
        "long_name": "NanoSphere Health Sciences Inc.",
        "summary": "Nanosphere Health Sciences Inc., a nano-biotechnology company, focuses on providing next generation delivery of biologically active compounds in the United States. Its nanoencapsulation technology delivers nutritive elements and medicants through licensing arrangements. The company was incorporated in 2005 is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "2FA.F": {
        "short_name": "GLOBAL CANNABIS APPL.",
        "long_name": "Global Cannabis Applications Corp.",
        "summary": "Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies and applications for the medical cannabis industry. The company offers Citizen Green platform, a medical cannabis data solution. It uses various technologies, such as mobile applications, artificial intelligence, regulatory, smart databases, blockchain, and digital reward tokens to qualify candidates for clinical studies. The company was formerly known as Fundamental Applications Corp. Global Cannabis Applications Corp. was founded in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "2HQ.DE": {
        "short_name": "TILRAY INC. CL.2 DL-,0001",
        "long_name": "Tilray, Inc.",
        "summary": "As of May 3, 2021, Tilray, Inc. was acquired by Aphria Inc., in a reverse merger transaction. Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, clinics, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, Germany, Israel, New Zealand, Portugal, Spain, Africa, Switzerland, the United States, Malta, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Canada",
        "city": "Nanaimo"
    },
    "2J6.F": {
        "short_name": "MPX INTERNATIONAL CORP.",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "2J6.MU": {
        "short_name": "MPX INTERNATIONAL CORP.",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "2J6.SG": {
        "short_name": "MPX International Corp. Registe",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "2M4.F": {
        "short_name": "MICROBIX BIOSYSTEMS",
        "long_name": "Microbix Biosystems Inc.",
        "summary": "Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry. Its infectious disease antigens also used in controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, or for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. The company also offers viral transport media that stabilize the organisms in patient samples. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "2VF0.F": {
        "short_name": "HEMOSTEMIX INC.",
        "long_name": "Hemostemix Inc.",
        "summary": "Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions. It develops cell therapy products from the patient's own blood, a relatively non-invasive source of therapeutic cells. The company's lead product is ACP-01, an autologous cell therapy for the treatment of critical limb ischemia, peripheral arterial disease, angina, ischemic cardiomyopathy, dilated cardiomyopathy, and other conditions of ischemia that is in Phase II clinical trial in Canada and the United States. It also offers various types of synergetic cell populations, such as angiogenic cell precursors, myocardial cell precursors, neural cell precursors, and bone cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "2VV.F": {
        "short_name": "ZENABIS GLOBAL INC.",
        "long_name": "Zenabis Global Inc.",
        "summary": "Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-\u00c3\u00bcp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "2VX.F": {
        "short_name": "THE FLOWR CORP.",
        "long_name": "The Flowr Corporation",
        "summary": "The Flowr Corporation cultivates, produces, and sells cannabis in Canada. It also has operations in Canada, Europe, and Australia. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "31F.F": {
        "short_name": "MEDICAL FACILITIES NEW",
        "long_name": "Medical Facilities Corporation",
        "summary": "Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and an ambulatory surgery center in the United States. The company's specialty surgical hospitals provide surgical, imaging, diagnostic, and other pain management procedures; and other ancillary services, such as urgent care and occupational health. It also offers ambulatory surgery center, which performs scheduled outpatient surgical procedures. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "31R.F": {
        "short_name": "REVIVE THERAPEUTICS LTD",
        "long_name": "Revive Therapeutics Ltd.",
        "summary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform, as well as a research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "385.F": {
        "short_name": "CEAPRO INC.",
        "long_name": "Ceapro Inc.",
        "summary": "Ceapro Inc., a biotechnology company, engages in the development and commercialization of active ingredients in the United States, Germany, China, Canada, and internationally. It operates in two segments, The Active Ingredient Product Technology Industry and The Cosmeceutical Industry. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, such as Pressurized Gas eXpanded drying technology; and technologies to enhance the content of avenanthramides. The company has a collaboration with the McMaster University to develop inhalable therapeutic for COVID-19; and a research project with the University of Alberta to expand the utilization of the PGX technology and generate ingredients targeting applications in functional food, dietary supplement, personal care, and pharmaceuticals. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "38G.F": {
        "short_name": "SPROUTLY CDA INC.",
        "long_name": "Sproutly Canada Inc.",
        "summary": "Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumable markets in Canada. It offers its products under the Caliber brand name. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "38H0.F": {
        "short_name": "HEALTHSPACE DATA SYS LTD",
        "long_name": "HealthSpace Data Systems Ltd.",
        "summary": "HealthSpace Data Systems Ltd. develops and sells information and communication management systems for health inspection departments of federal, provincial, state, and municipal governments in Canada and the United States. Its products include HSCloud product, a no-code data management platform for managing applications, licenses, permits, inspections, and virtually other data for operating state and local government agencies; and HSTouch for data collection, such as calendars, past inspections, regulatory codes, and violations, which works either connected to or disconnected from the internet to record observations is the field, as well as captures electronic signature, and insert photos and email inspection reports. The company also offers HealthSpace EnviroIntel EHS Manager, an internet-based client/server application used to fill out forms, request information, and view data, including real-time reports. HealthSpace Data Systems Ltd. was founded in 1998 and is headquartered in Chilliwack, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Chilliwack"
    },
    "39H.F": {
        "short_name": "SPEAKEASY CANNAB.CLUB",
        "long_name": "Speakeasy Cannabis Club Ltd.",
        "summary": "Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Rock Creek"
    },
    "39N.F": {
        "short_name": "MATICA ENTERPRISES INC.",
        "long_name": "Matica Enterprises Inc.",
        "summary": "Matica Enterprises Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odours. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "3CT0.F": {
        "short_name": "LYNX GLOBAL DIGITAL FINL.",
        "long_name": "Lynx Global Digital Finance Corporation",
        "summary": "CannaOne Technologies Inc., a software development and technology company, develops and markets online e-commerce marketplace solution for the cannabis industry in Canada. It provides BloomKit, a software suite that delivers an online toolkit for various applications for companies in the cannabis sector; and BWell, which uses BloomKit to facilitate the sale of premium CBD products on its online marketplace. The company also operates Primo, a review driven marketplace that show a dispensary directory, brand pages, visual product attributes, and multi-varied cannabis centric reviews. CannaOne Technologies Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "3D0A.F": {
        "short_name": "TELO GENOMICS CORP. O.N.",
        "long_name": "Telo Genomics Corp.",
        "summary": "Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "3D7.F": {
        "short_name": "WILLOW BIOSCIENCES",
        "long_name": "Willow Biosciences Inc.",
        "summary": "Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "3KF.F": {
        "short_name": "AUXLY CANNABIS GRP",
        "long_name": "Auxly Cannabis Group Inc.",
        "summary": "Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "3TP.F": {
        "short_name": "ACERUS PHARMACEUTICALS",
        "long_name": "Acerus Pharmaceuticals Corporation",
        "summary": "Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "47M.F": {
        "short_name": "MEDMIRA INC.",
        "long_name": "MedMira Inc.",
        "summary": "MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America, the Caribbean, Europe, and the Asia Pacific. The company's research is focused on specific areas of the diagnostics market, such as rapid, point-of-care, and in vitro sectors. It offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. The company also provides Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis; and REVEALCOVID-19, an antibody test. In addition, it offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "484.F": {
        "short_name": "SATIVA WELLNESS GROUP INC",
        "long_name": "Sativa Wellness Group Inc.",
        "summary": "Sativa Wellness Group Inc. operates as a CBD wellness company. The company engages in the cultivation and extraction of cannabinoids. It also sells CBD products to wholesale and online retail markets, as well as white label CBD products for third party brands. The company is based in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "4B70.F": {
        "short_name": "ANTIBE THERAPEUTICS INC.",
        "long_name": "Antibe Therapeutics Inc.",
        "summary": "Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. The company's lead compound is ATB-346, a hydrogen sulfide-releasing derivative of naproxen for treating rheumatoid arthritis, ankylosing spondylitis, and general pain reduction that has completed Phase 2B gastrointestinal safety study. Its products also comprise ATB-352, which is in preclinical stage for the treatment of gout, dental pain, post-surgical pain, etc.; and ATB-340 that is in preclinical development stage for the treatment of stroke and cancer. In addition, it offers bone graft substitutes, barrier membranes, and other products for the dental and orthopedic markets under the C-Graft Putty, C-Blast Putty, Eclipse, NeoGuarde, Neomem, Neomem FlexPlus, PentOS OI, and Raptos trademarks. The company was incorporated in 2009 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "4K9.F": {
        "short_name": "CANAFARMA HEMP PROD.CORP.",
        "long_name": "CanaFarma Hemp Products Corp.",
        "summary": "CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "4KH.F": {
        "short_name": "KHIRON LIFE SCIENCES",
        "long_name": "Khiron Life Sciences Corp.",
        "summary": "Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "4PC.F": {
        "short_name": "PERIMETER MED.IMAG.AI",
        "long_name": "Perimeter Medical Imaging AI, Inc.",
        "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "4VV.F": {
        "short_name": "JUVA LIFE INC.",
        "long_name": "Juva Life Inc.",
        "summary": "Juva Life Inc. engages in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "4WE.F": {
        "short_name": "WEEDMD INC.",
        "long_name": "WeedMD Inc.",
        "summary": "WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Aylmer"
    },
    "4XM.F": {
        "short_name": "PAC ROOTS CANNABIS CORP.",
        "long_name": "Pac Roots Cannabis Corp.",
        "summary": "Pac Roots Cannabis Corp. cultivates and sells marijuana for medicinal purposes. The company was incorporated in 2012 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "4XT.DE": {
        "short_name": "XPHYTO THERAPEUTICS",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "4XT.F": {
        "short_name": "XPHYTO THERAPEUTICS",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "4YX.F": {
        "short_name": "RED LIGHT HOLLAND CORP.",
        "long_name": "Red Light Holland Corp.",
        "summary": "Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the legal recreational market in the Netherlands. It sells its products under the iMicrodose brand name through smart shops operators and an advanced e-commerce platform, iMicrodose.nl. The company was incorporated in 1982 and is based in Toronto, Ontario.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "50N.F": {
        "short_name": "NATURALLY SPLEND.ENTERPR.",
        "long_name": "Naturally Splendid Enterprises Ltd.",
        "summary": "Naturally Splendid Enterprises Ltd., a biotechnology and consumer products company, develops, produces, commercializes, sells, and licenses plant-derived, bio-active ingredients, nutrient dense foods, and related products in Canada, Japan, South Korea, Thailand, and Western Europe. The company offers nutrition for athletes under the Natera Sport brand; food energy bars under the WOODS WILD BAR; healthy snack bars under the ELEVATE ME brand; hemp for health under the CHII brand; products for dogs under the PawsitiveFX brand; and hemp and plant-based natural health products under the Natera FX brand. It also provides hemp processing, manufacturing, private label, and CBD extraction services; and distributes lifestyle and healthy meal replacement products. The company sells food and ingredients to commercial processors and consumers through grocery stores, health and nutrition stores, and online. Naturally Splendid Enterprises Ltd. was incorporated in 2010 and is headquartered in Pitt Meadows, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Pitt Meadows"
    },
    "5GZ.F": {
        "short_name": "WAVERLEY PHARMA INC.",
        "long_name": "Waverley Pharma Inc.",
        "summary": "Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom, European Union, and North America. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as WAV-101 for the treatment of non-small cell lung cancer and pleural mesothelioma; and WAV-102 to treat multiple myeloma and mantle cell lymphoma. The company has a collaboration with the University of Manitoba for the development of a synthetic library of chloroquine analogs to treat COVID-19. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "5IV1.F": {
        "short_name": "IMV INC.",
        "long_name": "IMV Inc.",
        "summary": "IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Dartmouth"
    },
    "5LB.F": {
        "short_name": "BIOVAXYS TECHNOLOGY CORP.",
        "long_name": "BioVaxys Technology Corp.",
        "summary": "BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor antigen vaccine for ovarian cancer, as well as and Covid-T, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and Covid-T; research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320; and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its Covid-T immunodiagnostic. The company is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "5NP.F": {
        "short_name": "HAVN LIFE SCIENCES INC.",
        "long_name": "HAVN Life Sciences Inc.",
        "summary": "HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was founded in 2020 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "5OP.F": {
        "short_name": "OPSENS INC.",
        "long_name": "Opsens Inc.",
        "summary": "Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a direct sales force to distributors in the United States, Japan, Canada, and internationally. The company is headquartered in Qu\u00c3\u00a9bec, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Qu\u00c3\u00a9bec"
    },
    "5V51.F": {
        "short_name": "AVIVAGEN INC.",
        "long_name": "Avivagen Inc.",
        "summary": "Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "5V7.F": {
        "short_name": "VENTRIPOINT DIAGNOSTICS",
        "long_name": "VentriPoint Diagnostics Ltd.",
        "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "5XE.F": {
        "short_name": "EXTENDICARE INC.",
        "long_name": "Extendicare Inc.",
        "summary": "Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a net of 121 LTC homes and retirement communities, including 69 owned and 52 contract services, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was founded in 1968 and is based in Markham, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Markham"
    },
    "61N1.F": {
        "short_name": "STAGEZERO LIFE SCIENC.",
        "long_name": "StageZero Life Sciences Ltd.",
        "summary": "StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Richmond Hill"
    },
    "636.F": {
        "short_name": "SIENNA SENIOR LIV.",
        "long_name": "Sienna Senior Living Inc.",
        "summary": "Sienna Senior Living Inc., through its subsidiaries, provides senior living and long-term care (LTC) services in Canada. It operates through Retirement and LTC segments. The company offers a range of seniors' living options, including independent supportive and assisted living, memory care, long-term care, and specialized programs and services, as well as provides management services. As of December 31, 2020, it owned and operated a total of 70 seniors' living residences comprising 27 retirement residences, 35 LTC residences, and eight seniors' living residences. The company was formerly known as Leisureworld Senior Care Corporation and changed its name to Sienna Senior Living Inc. in May 2015. Sienna Senior Living Inc. was founded in 1972 and is headquartered in Markham, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Markham"
    },
    "6BX.F": {
        "short_name": "RELEVIUM TECHN. INC.",
        "long_name": "Relevium Technologies Inc.",
        "summary": "Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "6OVA.F": {
        "short_name": "VITALHUB CORP..",
        "long_name": "Vitalhub Corp.",
        "summary": "Vitalhub Corp., together with its subsidiaries, develops technology solutions for health and human service providers in the hospital, regional health authority, mental health, long term care, home health, and community and social service sectors in Canada, the United Kingdom, and the United States. Its solutions include electronic healthcare record, case management, care coordination, patient flow and operational visibility, and DOCit mobile apps. Vitalhub Corp. is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "6PB.F": {
        "short_name": "PASCAL BIOSCIENCES INC.",
        "long_name": "Pascal Biosciences Inc.",
        "summary": "Pascal Biosciences Inc., a biotechnology company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy for cancer treatment. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "6PH.F": {
        "short_name": "CLOUDMD SOFTWARE+SERVICES",
        "long_name": "CloudMD Software & Services Inc.",
        "summary": "CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services. The company also retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies, as well as provides clinical services, such as medical reviews and compounding; and provides cloud-based electronic medical records (EMR) software, medical billing and practice management software, and various telemedicine platforms to medical professionals, as well as digital platforms to serve individuals for their eyecare and specialty drug needs. In addition, it offers JunoEMR, a cloud-based EMR solution; MyHealthAccess, an online patient portal for online appointment booking and telemedicine visits; Benchmark, a suite of cloud-based medical practice solutions; and ClinicAid, a medical billing software. Further, the company provides Livecare Connect, a telemedicine platform; IDYA4, a health data integration and security technology platform; VisionPros, an online eyecare platform that offers contact lenses and eyeglasses under the KIND brand; Rxi, a specialty drug wholesaler, pharmacy, and technology/patient support program administrator. Additionally, it provides enterprise health solutions, including mental health support; employee and student assistance programs; healthcare navigation and specialist; rehabilitation and assessments; education; and absence management. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Victoria, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "6UF.F": {
        "short_name": "NEONMIND BIOSCIENCES INC.",
        "long_name": "NeonMind Biosciences Inc.",
        "summary": "NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin based products comprising mushroom-infused beverages and other mushroom-infused products to treat weight loss and management, depression, cardiovascular, obesity, diabetes, and heart diseases. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "73M0.F": {
        "short_name": "MEDAVAIL HOLDINGS DL-,001",
        "long_name": "MedAvail Holdings, Inc",
        "summary": "MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "74HA.F": {
        "short_name": "HEXO CORP.",
        "long_name": "HEXO Corp.",
        "summary": "HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Kanata"
    },
    "75J.F": {
        "short_name": "LEVELJUMP HEALTHCARE CORP",
        "long_name": "Leveljump Healthcare Corp.",
        "summary": "Leveljump Healthcare Corp. operates as a medical diagnostic imaging company. It provides teleradiology services to its client hospitals and imaging centers. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "7CI.F": {
        "short_name": "CRONOS GRP INC.",
        "long_name": "Cronos Group Inc.",
        "summary": "Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "7LV.F": {
        "short_name": "THE VALENS CO.",
        "long_name": "The Valens Company Inc.",
        "summary": "The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "7RB.F": {
        "short_name": "TEVANO SYSTEMS HLDGS INC.",
        "long_name": "Tevano Systems Holdings Inc.",
        "summary": "Tevano Systems Holdings Inc. develops and sells electronics products to businesses and consumers. It offers Health Shield, an AI-driven electronic device that provides instant body temperature scanning and notifies users if they need to wear a face mask. The company was formerly known as RBI Ventures Ltd. and changed its name to Tevano System Holdings Inc. in March 2021. Tevano System Holdings Inc. was incorporated in 2000 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "84S.F": {
        "short_name": "SLANG WORLDWIDE I",
        "long_name": "SLANG Worldwide Inc.",
        "summary": "SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. It owns, licenses, and/or markets 11 brands which serve flower, inhalable concentrates, and ingestibles, including edibles and pressed pills. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "8BTA.F": {
        "short_name": "BRIACELL THERAPEUTICS",
        "long_name": "BriaCell Therapeutics Corp.",
        "summary": "BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "West Vancouver"
    },
    "8CB.F": {
        "short_name": "CANNARA BIOTECH INC.",
        "long_name": "Cannara Biotech Inc.",
        "summary": "Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "8CT.F": {
        "short_name": "CANNABIX TECHS INC.",
        "long_name": "Cannabix Technologies Inc.",
        "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Burnaby"
    },
    "8EC.F": {
        "short_name": "EMPOWER CLINICS INC",
        "long_name": "Empower Clinics Inc.",
        "summary": "Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through its clinics, with digital and telemedicine care, and medical diagnostics laboratories in North America. It offers preventative, diagnostic, and treatment services that focuses on patient experience. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "8FW.F": {
        "short_name": "TRYP THERAPEUTICS INC.",
        "long_name": "Tryp Therapeutics Inc.",
        "summary": "Tryp Therapeutics Inc., a clinical stage pharmaceutical company, focuses on developing compounds with known activity and/or safety profiles for the treatment of rare or orphan diseases and other diseases. The company's lead development program is psilocybin-for-neuropsychiatry (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 for fibromyalgia, hyperphagia in prader-willi syndrome, and other therapies; and TRP-1001, an oral formulation of razoxane evaluating for the treatment of soft tissue sarcoma. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was founded in 2019 and is headquartered in Kelowna, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "8MV.F": {
        "short_name": "BIOHARVEST SCIENCES INC",
        "long_name": "BioHarvest Sciences Inc.",
        "summary": "BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "8QQ.F": {
        "short_name": "ABCELLERA BIOLOGICS",
        "long_name": "AbCellera Biologics Inc.",
        "summary": "AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "8SV1.F": {
        "short_name": "WPD PHARMACEUTICALS",
        "long_name": "WPD Pharmaceuticals Inc.",
        "summary": "WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "8VP1.F": {
        "short_name": "AVRICORE HEALTH INC.",
        "long_name": "Avricore Health Inc.",
        "summary": "Avricore Health Inc. operates as a healthcare technology company in Canada. The company provides HealthTab, a lab-accurate point of care testing platform. In addition, it offers Corozon Platform, which consists of Corozon Academy that provides practical professional education to community pharmacists; and Corozon Hardware, an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "9DF.F": {
        "short_name": "MINDSET PHARMA INC.",
        "long_name": "Mindset Pharma Inc.",
        "summary": "Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "9DO.F": {
        "short_name": "GLOW LIFETECH CORP.",
        "long_name": "Glow Lifetech Corp.",
        "summary": "Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company was founded in 2018 and is based in Toronto, Canada. Glow LifeTech Ltd. operates as a subsidiary of Relay Medical Corp.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "9MH.F": {
        "short_name": "MEDX HEALTH CORP.",
        "long_name": "MedX Health Corp",
        "summary": "MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "A1PA.F": {
        "short_name": "ACASTI PHARMA INC.",
        "long_name": "Acasti Pharma Inc.",
        "summary": "Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Laval"
    },
    "A491.F": {
        "short_name": "ISRACANN BIOSCIENCES INC.",
        "long_name": "Isracann Biosciences Inc.",
        "summary": "Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "A9K.F": {
        "short_name": "HALO COLLECTIVE INC.",
        "long_name": "Halo Collective Inc.",
        "summary": "Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. The company also offers edible products, including single piece chews and a syrup-based drink in California and, Oregon. In addition, it markets branded and private label products. The company sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. It serves licensed retailers and wholesalers. Halo Collective Inc. has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ABCL": {
        "short_name": "AbCellera Biologics Inc.",
        "long_name": "AbCellera Biologics Inc.",
        "summary": "AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ACB": {
        "short_name": "Aurora Cannabis Inc.",
        "long_name": "Aurora Cannabis Inc.",
        "summary": "Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "ACB.TO": {
        "short_name": "AURORA CANNABIS INC",
        "long_name": "Aurora Cannabis Inc.",
        "summary": "Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "ACHFF": {
        "short_name": "ARCH BIOPARTNERS INC",
        "long_name": "Arch Biopartners Inc.",
        "summary": "Arch Biopartners Inc., a biotechnology company, develops technologies for improving the health of patients. It focuses on developing its lead drug candidate MetaBlok, which is in Phase II for the treatment or prevention of dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver, or kidneys. The company also develops AB569, a drug candidate for the treatment of antibiotic resistant bacterial infections, primarily in the lungs and wounds, as well as to treat pseudomonas aeruginosa infections in the respiratory tracts of patients with cystic fibrosis. In addition, the company develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. Arch Biopartners Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ACHV": {
        "short_name": "Achieve Life Sciences, Inc.",
        "long_name": "Achieve Life Sciences, Inc.",
        "summary": "Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ACOG.V": {
        "short_name": "ALPHA COGNITION INC",
        "long_name": "Alpha Cognition Inc.",
        "summary": "Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's Disease and Amyotrophic Lateral Sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type; and ALPHA-0602, a gene therapy program for the treatment of ALS. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. The company was founded in 2000 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ACST": {
        "short_name": "Acasti Pharma, Inc.",
        "long_name": "Acasti Pharma Inc.",
        "summary": "Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Laval"
    },
    "ACST.V": {
        "short_name": "ACASTI PHARMA INC",
        "long_name": "Acasti Pharma Inc.",
        "summary": "Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Laval"
    },
    "ADK.V": {
        "short_name": "DIAGNOS INC.",
        "long_name": "DIAGNOS Inc.",
        "summary": "DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Kenya, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy. The company was founded in 1998 and is headquartered in Brossard, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Brossard"
    },
    "AEQ.F": {
        "short_name": "AEQUUS PHARMACEUTICALS",
        "long_name": "Aequus Pharmaceuticals Inc.",
        "summary": "Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AGFAF": {
        "short_name": "AGRAFLORA ORGANICS INTERNATIONA",
        "long_name": "AgraFlora Organics International Inc.",
        "summary": "AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AGN.CN": {
        "short_name": "AlgernonPharma",
        "long_name": "Algernon Pharmaceuticals Inc.",
        "summary": "Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non\u00c2\u0096alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188 (N,N-Dimethyltryptamine), a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AGNPF": {
        "short_name": "ALGERNON PHARMACEUTICALS INC",
        "long_name": "Algernon Pharmaceuticals Inc.",
        "summary": "Algernon Pharmaceuticals Inc., a clinical stage pharmaceutical development company, focuses in the areas of non\u00c2\u0096alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188 (N,N-Dimethyltryptamine), a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AGRA.CN": {
        "short_name": "AgraFlora",
        "long_name": "AgraFlora Organics International Inc.",
        "summary": "AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AH.TO": {
        "short_name": "ALEAFIA HEALTH INC",
        "long_name": "Aleafia Health Inc.",
        "summary": "Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Concord"
    },
    "AHGIF": {
        "short_name": "ALTERNATE HEALTH CORP",
        "long_name": "Alternate Health Corp.",
        "summary": "Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "AION.CN": {
        "short_name": "AionTherapeutic",
        "long_name": "Aion Therapeutic Inc.",
        "summary": "Aion Therapeutic Inc. researches, grows, harvests, and markets medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was founded in 2011 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ALEAF": {
        "short_name": "ALEAFIA HEALTH INC",
        "long_name": "Aleafia Health Inc.",
        "summary": "Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Concord"
    },
    "ALID": {
        "short_name": "ALLIED CORP",
        "long_name": "Allied Corp.",
        "summary": "Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp derived natural health products, including Liberty, a hemp derived cannabidiol (CBD) tincture; and Tactical Hydration, a CBD infused electrolyte replacement drink under the Tactical Relief brand. The company also provides Hydro Sport, a CBD-infused rehydration drink under the Equilibrium Bio brand; anti-aging cosmetics and topicals infused with CBD under the MaXXa brand; and anti-aging, anti-pain, and anti-inflammation skin care products under the Buds Pure Naturals brand. In addition, it is developing ALID 12, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder in Colombia. The company is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "ALST": {
        "short_name": "ALLSTAR HEALTH BRANDS INC",
        "long_name": "Allstar Health Brands, Inc.",
        "summary": "Allstar Health Brands, Inc., a specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas. The company holds the Tapout license to sell globally branded nutraceutical products, including pain relief sprays and wipes. It has partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products. Allstar Health Brands, Inc. was formerly known as Axxess Pharma, Inc. and changed its name to Allstar Health Brands, Inc. in June 2017. The company was founded in 1997 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "AND.TO": {
        "short_name": "ANDLAUER HEALTHCARE GROUP INC",
        "long_name": "Andlauer Healthcare Group Inc.",
        "summary": "Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada. It operates in two segments, Specialized Transportation and Healthcare Logistics. The company provides specialized temperature controlled services; and ground transportation services, including less-than-truckload and courier services; and air freight forwarding, and dedicated and last mile delivery services. It also offers logistics and distribution services, including warehousing and inventory management, order fulfillment, reverse logistics, and transportation management; and packaging services, such as reusable thermal packaging solutions and trade customization services. The company provides services to healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. Andlauer Healthcare Group Inc. was founded in 1991 and is headquartered in Vaughan, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Distribution",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vaughan"
    },
    "ANTCF": {
        "short_name": "AION THERAPEUTIC INC",
        "long_name": "Aion Therapeutic Inc.",
        "summary": "Aion Therapeutic Inc. researches, grows, harvests, and markets medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was founded in 2011 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ANU1.F": {
        "short_name": "XORTX THERAPEUTICS",
        "long_name": "XORTX Therapeutics Inc.",
        "summary": "XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "APC.V": {
        "short_name": "ADVANCED PROTEOME THERAPEUTICS ",
        "long_name": "Advanced Proteome Therapeutics Corporation",
        "summary": "Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics, primarily antibody-drug conjugates. Its proprietary technology targets delivery of anti-cancer drugs to cancerous tumors. The company is headquartered in Burnaby, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Burnaby"
    },
    "APHA": {
        "short_name": "Aphria Inc.",
        "long_name": "Tilray, Inc.",
        "summary": "Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc. and changed its name to Tilray, Inc. Tilray Inc. is based in Leamington, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Leamington"
    },
    "APHA.TO": {
        "short_name": "APHRIA INC",
        "long_name": "Aphria Inc.",
        "summary": "Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Leamington"
    },
    "APLI.TO": {
        "short_name": "APPILI THERAPEUTICS INC",
        "long_name": "Appili Therapeutics Inc.",
        "summary": "Appili Therapeutics Inc., a biopharmaceutical company, acquires, develops, and commercializes novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1501, a taste-masked oral liquid suspension formulation of an antibiotic, metronidazole; ATI-1503 that develops a class of gram-negative targeting antibiotics; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. Appili Therapeutics Inc. was founded in 2015 and is headquartered in Halifax, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "APLIF": {
        "short_name": "APPILI THERAPEUTICS INC",
        "long_name": "Appili Therapeutics Inc.",
        "summary": "Appili Therapeutics Inc., a biopharmaceutical company, acquires, develops, and commercializes novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1501, a taste-masked oral liquid suspension formulation of an antibiotic, metronidazole; ATI-1503 that develops a class of gram-negative targeting antibiotics; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. Appili Therapeutics Inc. was founded in 2015 and is headquartered in Halifax, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "APP.CN": {
        "short_name": "Global CannaApp",
        "long_name": "Global Cannabis Applications Corp.",
        "summary": "Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies and applications for the medical cannabis industry. The company offers Citizen Green platform, a medical cannabis data solution. It uses various technologies, such as mobile applications, artificial intelligence, regulatory, smart databases, blockchain, and digital reward tokens to qualify candidates for clinical studies. The company was formerly known as Fundamental Applications Corp. Global Cannabis Applications Corp. was founded in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "APS.TO": {
        "short_name": "APTOSE BIOSCIENCES INC",
        "long_name": "Aptose Biosciences Inc.",
        "summary": "Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806 and CG-806, which are in Phase 1a/b clinical trial for the treatment of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, and certain non-Hodgkin's lymphomas, as well as relapsed/refractory acute myeloid leukemia. The company also has an agreement with OHM Oncology for the development, manufacture, and commercialization of APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "APTO": {
        "short_name": "Aptose Biosciences, Inc.",
        "long_name": "Aptose Biosciences Inc.",
        "summary": "Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806 and CG-806, which are in Phase 1a/b clinical trial for the treatment of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, and certain non-Hodgkin's lymphomas, as well as relapsed/refractory acute myeloid leukemia. The company also has an agreement with OHM Oncology for the development, manufacture, and commercialization of APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "AQS.V": {
        "short_name": "AEQUUS PHARMACEUTICALS INC",
        "long_name": "Aequus Pharmaceuticals Inc.",
        "summary": "Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AQSZF": {
        "short_name": "AEQUUS PHARMACEUTICALS INC",
        "long_name": "Aequus Pharmaceuticals Inc.",
        "summary": "Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ARAH.F": {
        "short_name": "ALEAFIA HEALTH INC.",
        "long_name": "Aleafia Health Inc.",
        "summary": "Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Concord"
    },
    "ARCH.V": {
        "short_name": "ARCH BIOPARTNERS INC",
        "long_name": "Arch Biopartners Inc.",
        "summary": "Arch Biopartners Inc., a biotechnology company, develops technologies for improving the health of patients. It focuses on developing its lead drug candidate MetaBlok, which is in Phase II for the treatment or prevention of dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver, or kidneys. The company also develops AB569, a drug candidate for the treatment of antibiotic resistant bacterial infections, primarily in the lungs and wounds, as well as to treat pseudomonas aeruginosa infections in the respiratory tracts of patients with cystic fibrosis. In addition, the company develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. Arch Biopartners Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "AREV.CN": {
        "short_name": "AREVNanoTec",
        "long_name": "AREV NanoTec Brands Inc.",
        "summary": "AREV NanoTec Brands Inc., an integrated cannabis company, produces and delivers functional compounds and ingredients in Canada. The company's ingredients and formulations are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. Its products addresses the areas of health, which include anxiety, pain management, insomnia, central nervous system, and disorders and libido. The company was formerly known as AREV Brands International Ltd. and changed its name to AREV NanoTec Brands Inc. in March 2020. AREV NanoTec Brands Inc. was incorporated in 2005 and is based in Coquitlam, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Coquitlam"
    },
    "AREVF": {
        "short_name": "AREV NANOTEC BRANDS INC",
        "long_name": "AREV NanoTec Brands Inc.",
        "summary": "AREV NanoTec Brands Inc., an integrated cannabis company, produces and delivers functional compounds and ingredients in Canada. The company's ingredients and formulations are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. Its products addresses the areas of health, which include anxiety, pain management, insomnia, central nervous system, and disorders and libido. The company was formerly known as AREV Brands International Ltd. and changed its name to AREV NanoTec Brands Inc. in March 2020. AREV NanoTec Brands Inc. was incorporated in 2005 and is based in Coquitlam, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Coquitlam"
    },
    "ARFXF": {
        "short_name": "PROMIS NEUROSCIENCES INC",
        "long_name": "ProMIS Neurosciences, Inc.",
        "summary": "ProMIS Neurosciences, Inc., a development stage biotech company, discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform\u00c2\u0097ProMIS and Collective Coordinates to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb); PMN350, a mAb targeting on toxic amyloid beta oligomers (A\u00c3\u009fO); and PMN330, a monoclonal antibody targeting toxic prion-like forms of A\u00c3\u009fO for AD. The company is also developing therapeutics targeting the neurotoxic form of the tau protein in AD; and superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in PD and Lewy body dementia. The company has a collaboration with BC Neuroimmunology to develop and commercialize proprietary diagnostic assays; and BC Neuroimmunology to develop and offer blood-based diagnostic tests for Alzheimer's diseases. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ASAPF": {
        "short_name": "AURORA SPINE CORPORATION",
        "long_name": "Aurora Spine Corporation",
        "summary": "Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. It also provides pain care services. The company was incorporated in 2013 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ASG.V": {
        "short_name": "AURORA SPINE CORPORATION",
        "long_name": "Aurora Spine Corporation",
        "summary": "Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. It also provides pain care services. The company was incorporated in 2013 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ASIA.CN": {
        "short_name": "AsiaGrBiotech",
        "long_name": "Asia Green Biotechnology Corp.",
        "summary": "Asia Green Biotechnology Corp., an early stage international agri-technology company, focuses on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology in Asia. It focuses on planting, growing, and harvesting new and valuable strains of hemp and related crops. Asia Green Biotechnology Corp. has an agreement with Pathway Rx Inc. and PNW Biosciences Inc. for the clinical development and commercialization of the cannabis sativa varieties for prevention and treatment of COVID-19 and other infectious diseases. The company was formerly known as Asia Cannabis Corp. and changed its name to Asia Green Biotechnology Corp. in April 2020. The company was incorporated in 2017 and is based in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "ASP.TO": {
        "short_name": "ACERUS PHARMACEUTICALS CORP",
        "long_name": "Acerus Pharmaceuticals Corporation",
        "summary": "Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "ASPCF": {
        "short_name": "ACERUS PHARMACEUTICALS CORP",
        "long_name": "Acerus Pharmaceuticals Corporation",
        "summary": "Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "ASTI.CN": {
        "short_name": "AquariusSurgTe",
        "long_name": "Aquarius Surgical Technologies Inc.",
        "summary": "Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., manufactures, distributes, services, supports, and trains laser systems and consumables in various medical disciplines in Canada and the United States. Its products include Pathfinder laser for the treatment of benign prostate hyperplasia; HYPHO laser to treat urinary stone; Versafine FRx laser to address vaginal health related conditions associated with menopause; and ASTI's surgical lasers for supporting wavelengths and medical procedures. The company also offers clinical education, service, support, and maintenance services. The company was formerly known as Aquarius Coatings Inc. Aquarius Surgical Technologies Inc. was incorporated in 1986 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ATBPF": {
        "short_name": "ANTIBE THERAPEUTICS INC",
        "long_name": "Antibe Therapeutics Inc.",
        "summary": "Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. The company's lead compound is ATB-346, a hydrogen sulfide-releasing derivative of naproxen for treating rheumatoid arthritis, ankylosing spondylitis, and general pain reduction that has completed Phase 2B gastrointestinal safety study. Its products also comprise ATB-352, which is in preclinical stage for the treatment of gout, dental pain, post-surgical pain, etc.; and ATB-340 that is in preclinical development stage for the treatment of stroke and cancer. In addition, it offers bone graft substitutes, barrier membranes, and other products for the dental and orthopedic markets under the C-Graft Putty, C-Blast Putty, Eclipse, NeoGuarde, Neomem, Neomem FlexPlus, PentOS OI, and Raptos trademarks. The company was incorporated in 2009 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ATE.TO": {
        "short_name": "ANTIBE THERAPEUTICS INC",
        "long_name": "Antibe Therapeutics Inc.",
        "summary": "Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. The company's lead compound is ATB-346, a hydrogen sulfide-releasing derivative of naproxen for treating rheumatoid arthritis, ankylosing spondylitis, and general pain reduction that has completed Phase 2B gastrointestinal safety study. Its products also comprise ATB-352, which is in preclinical stage for the treatment of gout, dental pain, post-surgical pain, etc.; and ATB-340 that is in preclinical development stage for the treatment of stroke and cancer. In addition, it offers bone graft substitutes, barrier membranes, and other products for the dental and orthopedic markets under the C-Graft Putty, C-Blast Putty, Eclipse, NeoGuarde, Neomem, Neomem FlexPlus, PentOS OI, and Raptos trademarks. The company was incorporated in 2009 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ATTBF": {
        "short_name": "ABATTIS BIOCEUTICALS CORP",
        "long_name": "Abattis Bioceuticals Corp.",
        "summary": "Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AUHP.F": {
        "short_name": "EGF THERAMED HEALTH CORP.",
        "long_name": "EGF Theramed Health Corp.",
        "summary": "EGF Theramed Health Corp., a consumer technology company, develops technologies, products, and diagnostic tools for personalized medical care. It engages in the provision of biomedical online services for monitoring and treating common health problems; and extraction and purification of botanical extracts and creation of extract formulations, as well as development of medical monitoring device technologies. The company also provides TULIP medical health system device. It offers services in the medical areas of mental health problems, weight loss, skin care, and heart diseases. The company was formerly known as Theramed Health Corporation and changed its name to EGF Theramed Health Corp. in October 2019. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AUP.TO": {
        "short_name": "AURINIA PHARMACEUTICALS INC",
        "long_name": "Aurinia Pharmaceuticals Inc.",
        "summary": "Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "AUPH": {
        "short_name": "Aurinia Pharmaceuticals Inc",
        "long_name": "Aurinia Pharmaceuticals Inc.",
        "summary": "Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "AVCN.TO": {
        "short_name": "AVICANNA INC",
        "long_name": "Avicanna Inc.",
        "summary": "Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally. The company provides pharmaceutical grade cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other rare cannabinoids; active pharmaceutical ingredients (APIs); feminized seeds; and bulk formulations under the Aureus Santa Marta brand. It also offers CBD based derma-cosmetic consumer products, such as beauty treatment, moisture and protection, and specialized care products under the Pura Earth brand; and medical cannabis/phyto-therapeutic products for the medical or homeopathic use under the Rho Phyto brand. In addition, the company provides pharmaceutical products focusing on skin disorders, including epidermolysis bullosa, eczema, and general skin problems comprising acne, erythema, and dryness; and neurological disorders, such as neuropathic pain, epilepsy, Parkinson's disease and multiple sclerosis, and nociceptive pain resulting from inflammatory and joint disorders, as well as a topical cream for rare genetic skin disorders. Avicanna has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation. Avicanna Inc.was founded in 2016 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "AVCNF": {
        "short_name": "AVICANNA INC",
        "long_name": "Avicanna Inc.",
        "summary": "Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally. The company provides pharmaceutical grade cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other rare cannabinoids; active pharmaceutical ingredients (APIs); feminized seeds; and bulk formulations under the Aureus Santa Marta brand. It also offers CBD based derma-cosmetic consumer products, such as beauty treatment, moisture and protection, and specialized care products under the Pura Earth brand; and medical cannabis/phyto-therapeutic products for the medical or homeopathic use under the Rho Phyto brand. In addition, the company provides pharmaceutical products focusing on skin disorders, including epidermolysis bullosa, eczema, and general skin problems comprising acne, erythema, and dryness; and neurological disorders, such as neuropathic pain, epilepsy, Parkinson's disease and multiple sclerosis, and nociceptive pain resulting from inflammatory and joint disorders, as well as a topical cream for rare genetic skin disorders. Avicanna has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation. Avicanna Inc.was founded in 2016 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "AVCR.V": {
        "short_name": "AVRICORE HEALTH INC",
        "long_name": "Avricore Health Inc.",
        "summary": "Avricore Health Inc. operates as a healthcare technology company in Canada. The company provides HealthTab, a lab-accurate point of care testing platform. In addition, it offers Corozon Platform, which consists of Corozon Academy that provides practical professional education to community pharmacists; and Corozon Hardware, an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AVCRF": {
        "short_name": "AVRICORE HEALTH INC",
        "long_name": "Avricore Health Inc.",
        "summary": "Avricore Health Inc. operates as a healthcare technology company in Canada. The company provides HealthTab, a lab-accurate point of care testing platform. In addition, it offers Corozon Platform, which consists of Corozon Academy that provides practical professional education to community pharmacists; and Corozon Hardware, an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "AYUR.CN": {
        "short_name": "AyurcannHolding",
        "long_name": "Ayurcann Holdings Corp.",
        "summary": "Ayurcann Inc. offers customized post-harvest outsourcing solutions to licensed cannabis producers. It offers end-to-end full outsourcing solutions, including extraction, refinement, formulation, packaging, fulfillment, and distribution. The company was founded in 2018 and is based in Thornhill, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Thornhill"
    },
    "B3BN.F": {
        "short_name": "CVR MEDICAL CORP.",
        "long_name": "CVR Medical Corp.",
        "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "B3BN.MU": {
        "short_name": "CVR MEDICAL CORP.",
        "long_name": "CVR Medical Corp.",
        "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "BAMM.CN": {
        "short_name": "BodyandMindInc",
        "long_name": "Body and Mind Inc.",
        "summary": "Body and Mind Inc. cultivates, produces, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, and Ohio. The company offers packaged and grinded flower buds; concentrates; disposable pen vaporizers; distillate oil cartridges; and distillate infused edible products. It produces and sells cannabis flowers, oil extracts, and edibles under the Body and Mind brand name. The company also operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. In addition, it is involved in the production of marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was founded in 1998 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BBT.CN": {
        "short_name": "Benchmark Botan",
        "long_name": "Benchmark Botanics Inc.",
        "summary": "Benchmark Botanics Inc. cultivates and produces pharmaceutical grade medical and recreational cannabis. It serves the medical, pharmaceutical, and recreational markets in Canada. The company is headquartered in Richmond, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "BBW.F": {
        "short_name": "BENCHMARK BOTANICS INC.",
        "long_name": "Benchmark Botanics Inc.",
        "summary": "Benchmark Botanics Inc. cultivates and produces pharmaceutical grade medical and recreational cannabis. It serves the medical, pharmaceutical, and recreational markets in Canada. The company is headquartered in Richmond, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "BCT.V": {
        "short_name": "BRIACELL THERAPEUTICS CORP",
        "long_name": "BriaCell Therapeutics Corp.",
        "summary": "BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "West Vancouver"
    },
    "BCTX": {
        "short_name": "BriaCell Therapeutics Corp.",
        "long_name": "BriaCell Therapeutics Corp.",
        "summary": "BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "West Vancouver"
    },
    "BETR.CN": {
        "short_name": "BetterLifePhar",
        "long_name": "BetterLife Pharma Inc.",
        "summary": "BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumours to treat various types of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was founded in 2002 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BETRF": {
        "short_name": "BETTERLIFE PHARMA INC",
        "long_name": "BetterLife Pharma Inc.",
        "summary": "BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumours to treat various types of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was founded in 2002 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BHC": {
        "short_name": "Bausch Health Companies Inc.",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BHC.TO": {
        "short_name": "BAUSCH HEALTH COMPANIES INC",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BHCN.MX": {
        "short_name": "BAUSCH HEALTH COMPANIES INC",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "MXN",
        "sector": "Healthcare",
        "industry": "Drugs - Generic",
        "exchange": "MEX",
        "market": "mx_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BHHKF": {
        "short_name": "BENCHMARK BOTANICS INC",
        "long_name": "Benchmark Botanics Inc.",
        "summary": "Benchmark Botanics Inc. cultivates and produces pharmaceutical grade medical and recreational cannabis. It serves the medical, pharmaceutical, and recreational markets in Canada. The company is headquartered in Richmond, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "BHN0.F": {
        "short_name": "BELLUS HEALTH INC.",
        "long_name": "BELLUS Health Inc.",
        "summary": "BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BHNG.CN": {
        "short_name": "BhangInc",
        "long_name": "Bhang Inc.",
        "summary": "Bhang Inc. operates as a cannabis consumer packaged goods brand company in the United States. Its portfolio of products include cannabis; hempderived cannabidiol; and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, and gummies. The company was founded in 2010 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BHNGF": {
        "short_name": "BHANG INC",
        "long_name": "Bhang Inc.",
        "summary": "Bhang Inc. operates as a cannabis consumer packaged goods brand company in the United States. Its portfolio of products include cannabis; hempderived cannabidiol; and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, and gummies. The company was founded in 2010 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BHSC.CN": {
        "short_name": "BioHarvestSci",
        "long_name": "BioHarvest Sciences Inc.",
        "summary": "BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BICTF": {
        "short_name": "BIOCURE TECHNOLOGY INC",
        "long_name": "Biocure Technology Inc.",
        "summary": "Biocure Technology Inc. develops and commercializes biopharmaceutical technologies for uses in recombinant and ranibizumab. The company is developing Interferons- \u00c3\u009f for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It is also developing CAR T Cell Therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and a hair growth production product. Biocure Technology Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BILZ.CN": {
        "short_name": "IgniteIntlBr",
        "long_name": "Ignite International Brands, Ltd.",
        "summary": "Ignite International Brands, Ltd. operates in cannabis industry in the United States and Canada. It offers joints, beverages, drops, oil tinctures, topicals, pet products, and vape products under the IGNITE brand name. The company is headquartered in Vaughan, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BILZF": {
        "short_name": "IGNITE INTERNATIONAL BRANDS LTD",
        "long_name": "Ignite International Brands, Ltd.",
        "summary": "Ignite International Brands, Ltd. operates in cannabis industry in the United States and Canada. It offers joints, beverages, drops, oil tinctures, topicals, pet products, and vape products under the IGNITE brand name. The company is headquartered in Vaughan, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BIMUF": {
        "short_name": "PASCAL BIOSCIENCES INC",
        "long_name": "Pascal Biosciences Inc.",
        "summary": "Pascal Biosciences Inc., a biotechnology company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy for cancer treatment. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BIO.CN": {
        "short_name": "BiomeGrowInc",
        "long_name": "Biome Grow Inc.",
        "summary": "Biome Grow Inc., through its subsidiaries, cultivates, produces, and distributes cannabis at Antigonish, Nova Scotia. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BIOIF": {
        "short_name": "BIOME GROW INC",
        "long_name": "Biome Grow Inc.",
        "summary": "Biome Grow Inc., through its subsidiaries, cultivates, produces, and distributes cannabis at Antigonish, Nova Scotia. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BIOV.CN": {
        "short_name": "BioVaxysTech",
        "long_name": "BioVaxys Technology Corp.",
        "summary": "BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor antigen vaccine for ovarian cancer, as well as and Covid-T, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and Covid-T; research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320; and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its Covid-T immunodiagnostic. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BIOYF": {
        "short_name": "BIOSYENT INC",
        "long_name": "BioSyent Inc.",
        "summary": "BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis;  ; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository for the healing of the anus and rectum; and Cysview, an adjunct to white-light cystoscopy for the detection and management of non-muscle invasive papillary bladder cancer. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "BLEVF": {
        "short_name": "BELEAVE INC",
        "long_name": "Beleave Inc.",
        "summary": "Beleave Inc. operates as a medical cannabis company in Canada. The company cultivates and sells medical and recreational cannabis products. It also operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner. The company sells its products through operating stores and online. Beleave Inc. is headquartered in Oakville, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "BLFE": {
        "short_name": "BIOLIFE SCIENCES INC",
        "long_name": "BioLife Sciences Inc.",
        "summary": "Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "BLLXF": {
        "short_name": "PLANTFUEL LIFE INC",
        "long_name": "PlantFuel Life Inc.",
        "summary": "Sire Bioscience Inc., together with its subsidiaries, invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC,FUSIONS, PURPLEK, INFUSIONS, Voila, Karma, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "BLO.CN": {
        "short_name": "CannabixTech",
        "long_name": "Cannabix Technologies Inc.",
        "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Burnaby"
    },
    "BLOZF": {
        "short_name": "CANNABIX TECHNOLOGIES INC",
        "long_name": "Cannabix Technologies Inc.",
        "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Burnaby"
    },
    "BLU": {
        "short_name": "BELLUS Health Inc.",
        "long_name": "BELLUS Health Inc.",
        "summary": "BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BLU.TO": {
        "short_name": "BELLUS HEALTH INC.",
        "long_name": "BELLUS Health Inc.",
        "summary": "BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BMBIF": {
        "short_name": "BRIGHT MINDS BIOSCIENCES INC",
        "long_name": "Bright Minds Biosciences Inc.",
        "summary": "Bright Minds Biosciences Inc., a biotechnology company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprise 5-HT2C, 5-HT2A, and 5-HT2C/A for central nervous system -pediatric pharmacoresistant epilepsy, pain- cluster headache, migraine, fibromyalgia, chemotherapy induced neuropathy, neuropsychiatry-major depressive disorder, and impulse control disorder therapeutic areas. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BMKDF": {
        "short_name": "BIOMARK DIAGNOSTICS INC",
        "long_name": "Biomark Diagnostics Inc",
        "summary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. It also has a collaborative research and development agreement with Phytronix Technologies Inc. to advance the development of early lung cancer screening applications using Phytronix-proprietary Laser Diode Thermal Desorption technology. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "BMMJ": {
        "short_name": "BODY AND MIND INC",
        "long_name": "Body and Mind Inc.",
        "summary": "Body and Mind Inc. cultivates, produces, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, and Ohio. The company offers packaged and grinded flower buds; concentrates; disposable pen vaporizers; distillate oil cartridges; and distillate infused edible products. It produces and sells cannabis flowers, oil extracts, and edibles under the Body and Mind brand name. The company also operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. In addition, it is involved in the production of marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was founded in 1998 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BNKL": {
        "short_name": "BIONIK LABORATORIES CORP",
        "long_name": "Bionik Laboratories Corp.",
        "summary": "Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM/HAND for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion WRIST, a rehabilitation device that enables clinicians to deliver optimum intensive sensor motor wrist and forearm therapy to patients with neurological conditions. The company also engages in developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, strokes, and other mobility disabilities; and InMotion Connect, a solution to meet the data connectivity and analytics needs of hospitals and healthcare facilities. Bionik Laboratories Corp. was founded in 2010 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BNVIF": {
        "short_name": "BINOVI TECHNOLOGIES CORP",
        "long_name": "Binovi Technologies Corp.",
        "summary": "Binovi Technologies Corp. develops and commercializes visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. Its products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BOAA": {
        "short_name": "BIO AMERICA INC",
        "long_name": "Bio-America Inc.",
        "summary": "Bio-America Inc. operates as a biotechnology company that researches and develops drug- screening technologies for manufacturing anti-obesity, anti-infective, and oncology products. The company was founded in 1999 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BR1C.F": {
        "short_name": "SIRE BIOSCIENCE INC.",
        "long_name": "PlantFuel Life Inc.",
        "summary": "Sire Bioscience Inc., together with its subsidiaries, invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC,FUSIONS, PURPLEK, INFUSIONS, Voila, Karma, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "BRAXF": {
        "short_name": "BRAXIA SCIENTIFIC CORP",
        "long_name": "Braxia Scientific Corp.",
        "summary": "AltMed Capital Corp. operates as an alternative medicine business incubator, IP aggregator, and solutions provider. The company was founded in 2019 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BSYI": {
        "short_name": "BIOSYNTECH INC",
        "long_name": "BioSyntech, Inc.",
        "summary": "BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company's products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials. In addition, it manufactures ultra pure chitosans under the Ultrasan name; and offers manufacturing and analytical services. The company was incorporated in 1994 and is based in Laval, Canada. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. Biosyntech Inc. is in reorganization.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Laval"
    },
    "BUGVF": {
        "short_name": "PRIMO NUTRACEUTICALS INC",
        "long_name": "Primo Nutraceuticals Inc.",
        "summary": "Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BUX.CN": {
        "short_name": "BioMarkDiagnos",
        "long_name": "Biomark Diagnostics Inc",
        "summary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. It also has a collaborative research and development agreement with Phytronix Technologies Inc. to advance the development of early lung cancer screening applications using Phytronix-proprietary Laser Diode Thermal Desorption technology. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "BUZZ.CN": {
        "short_name": "Pharmadrug",
        "long_name": "Pharmadrug Inc.",
        "summary": "Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "BVAXF": {
        "short_name": "BIOVAXYS TECHNOLOGY CORP",
        "long_name": "BioVaxys Technology Corp.",
        "summary": "BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor antigen vaccine for ovarian cancer, as well as and Covid-T, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and Covid-T; research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320; and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its Covid-T immunodiagnostic. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "BVF.F": {
        "short_name": "BAUSCH HEALTH COS.",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Laval"
    },
    "C4TA.F": {
        "short_name": "AMP ALTERNATIVE MED.PROD.",
        "long_name": "AMP Alternative Medical Products Inc.",
        "summary": "AMP Alternative Medical Products Inc., through its subsidiaries, operates in the medical cannabis industry. It imports and sells EU-GMP medical cannabis for patients in Germany. The company was formerly known as AMP German Cannabis Group Inc. and changed its name to AMP Alternative Medical Products Inc. in February 2021. AMP Alternative Medical Products Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CADMF": {
        "short_name": "CHEMESIS INTERNATIONAL INC",
        "long_name": "Chemesis International Inc.",
        "summary": "Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CANA.CN": {
        "short_name": "CannAmBr",
        "long_name": "CannAmerica Brands Corp.",
        "summary": "CannAmerica Brands Corp. owns a portfolio of brands in the medical cannabis and recreational cannabis space with licensees in the states of Colorado, Nevada, Oklahoma, Maryland, and Massachusetts. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors. It offers sweet, sour, and sweet and sour fruit juice gummies under the CannAmerica brand. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CANB.V": {
        "short_name": "CANADABIS CAPITAL INC",
        "long_name": "CanadaBis Capital Inc.",
        "summary": "CanadaBis Capital Inc. cultivates, produces, distributes, and sells cannabis and cannabis products in Canada. The company operates through three segments: wholesale, retail, and extraction and tolling. It also engages in the sale of cannabis and cannabis related products to end consumers, as well as provides cannabinoid extraction services to other licensed producers. The company is headquartered in Red Deer County, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Red Deer County"
    },
    "CANN.CN": {
        "short_name": "HeritageCanna",
        "long_name": "Heritage Cannabis Holdings Corp.",
        "summary": "Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States. It offers extraction services; and focuses on processing, manufacturing, and distributing medical cannabis products and cannabis oils. It provides integrative approach to cannabinoid therapy for healthcare consumers and healthcare practitioners. The company was formerly known as Umbral Energy Corp. and changed its name to Heritage Cannabis Holdings Corp. in January 2018. Heritage Cannabis Holdings Corp. was incorporated in 2007 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CANQF": {
        "short_name": "CANAQUEST MEDICAL CORPORATION",
        "long_name": "CanaQuest Medical Corp.",
        "summary": "CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "CANSF": {
        "short_name": "WILLOW BIOSCIENCES INC",
        "long_name": "Willow Biosciences Inc.",
        "summary": "Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "CARE.TO": {
        "short_name": "DIALOGUE HEALTH TECHNOLOGIES IN",
        "long_name": "Dialogue Health Technologies Inc.",
        "summary": "Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada. Its Integrated Health Platform is a healthcare hub that provides access to virtual healthcare, stress management, mental wellbeing, and other orientation and counselling services. The company's platform also enables its members and their dependents to access an employee assistance program and an occupational health and safety program for customers in Germany. It serves employers and organizations. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "CBDHF": {
        "short_name": "HEMPFUSION WELLNESS INC",
        "long_name": "Hempfusion Wellness Inc.",
        "summary": "Hempfusion Wellness Inc., a health and wellness supplement company, formulates, markets, and distributes hemp-based natural supplements and probiotic products in the United States. Its products include tinctures, capsules, and topical creams and gel products under the HempFusion brand; and digestive enzymes and probiotics, and skin care products under the Probulin brand; and HF Labs and Biome Research branded products. The company sells its products through its e-commerce websites and doctor practitioners, as well as through a various food, drug, mass, and convenience market retailers. Hempfusion Wellness Inc. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CBDT.CN": {
        "short_name": "EmpowerClinInc",
        "long_name": "Empower Clinics Inc.",
        "summary": "Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through its clinics, with digital and telemedicine care, and medical diagnostics laboratories in North America. It offers preventative, diagnostic, and treatment services that focuses on patient experience. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CBDX.CN": {
        "short_name": "CanbudDistri",
        "long_name": "Canbud Distribution Corporation",
        "summary": "Canbud Distribution Corporation produces clones of cannabis and hemp cannabinoids. It offers its products under the brands My SeeBD, My SeeBN, and My SeeBG. The company was formerly known as Cannabis Clonal Corporation. Canbud Distribution Corporation was founded in 2018 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CBDY": {
        "short_name": "TARGET GROUP INC",
        "long_name": "Target Group Inc.",
        "summary": "Target Group Inc. cultivates, processes, and distributes curated cannabis products for the adult-use medical and recreational cannabis market in Canada. Its products include cannabis flower and extract pods for vaporizer use, cannabis pre-rolls, k-cup infused coffee and tea pods, infused cannabis beverages and edibles, infused topical products, and CBD wellness products. The company also offers Wisp, a single-use pre-measured pod and vaporizer system for consumers involved in vaporizing natural herbs, including cannabis. It has a collaboration agreement with cGreen, Inc for manufacturing and distributing the patent-pending THC antidote True Focus in the United States, Europe, and the Caribbean; and distribution, collaboration, and licensing agreement with Serious Seeds B.V. The company was formerly known as Chess Supersite Corporation and changed its name to Target Group Inc. in July 2018. Target Group Inc. was incorporated in 2013 and is based in Hamilton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Hamilton"
    },
    "CBWTF": {
        "short_name": "AUXLY CANNABIS GROUP INC",
        "long_name": "Auxly Cannabis Group Inc.",
        "summary": "Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CD0.F": {
        "short_name": "CANBUD DISTRIBUTION CORP.",
        "long_name": "Canbud Distribution Corporation",
        "summary": "Canbud Distribution Corporation produces clones of cannabis and hemp cannabinoids. It offers its products under the brands My SeeBD, My SeeBN, and My SeeBG. The company was formerly known as Cannabis Clonal Corporation. Canbud Distribution Corporation was founded in 2018 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CDVA.CN": {
        "short_name": "CordovaCann",
        "long_name": "CordovaCann Corp.",
        "summary": "CordovaCann Corp., a cannabis-focused consumer products company, primarily provides services and investment capital to the processing, production, and retail vertical markets of the cannabis industry. As of March 8, 2021, it operated six stores under the Star Buds cannabis retail store in Alberta, Ontario, and Manitoba. The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CDX.V": {
        "short_name": "CLOUD DX INC",
        "long_name": "Cloud DX Inc.",
        "summary": "Cloud DX Inc. provides remote patient monitoring hardware and software solutions. The company offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including COPD and CHF, as well as patients recovering from surgery to large hospitals and provincial health authorities in Canada, and physician practices and hospitals in the United States. Its Cloud DX Connected Health Kits includes its proprietary Pulsewave wrist cuff blood pressure monitor; Cloud DX Bluetooth pulse oximeter; and Cloud DX wireless weight scale and optionally, a digital thermometer and digital wireless glucose meter from 3rd party suppliers. The company also offers CPT Codes for Remote Patient Monitoring; and VITALITI, a vital sign monitor for measuring ECG, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Kitchener, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kitchener"
    },
    "CEOS": {
        "short_name": "CECORS INC",
        "long_name": "CeCors, Inc.",
        "summary": "CeCors, Inc. provides high density public metro Ethernet switching, including Layer 2/3 switching platforms. It serves metro services providers, telecom companies, cable operators, and wireless suppliers. The company, formerly known as Foldera, Inc., was founded in 2001 and is based in Santa Ana, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Sarnia"
    },
    "CGC": {
        "short_name": "Canopy Growth Corporation",
        "long_name": "Canopy Growth Corporation",
        "summary": "Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Smiths Falls"
    },
    "CGN.CN": {
        "short_name": "CognetivityNeu",
        "long_name": "Cognetivity Neurosciences Ltd.",
        "summary": "Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical and commercial environments for potentially allowing early diagnosis of dementia. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CGNH": {
        "short_name": "CARDIOGENICS HOLDINGS INC",
        "long_name": "CardioGenics Holdings Inc",
        "summary": "CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "CGNSF": {
        "short_name": "COGNETIVITY NEUROSCIENCES LTD",
        "long_name": "Cognetivity Neurosciences Ltd.",
        "summary": "Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical and commercial environments for potentially allowing early diagnosis of dementia. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CHHHF": {
        "short_name": "CARERX CORPORATION",
        "long_name": "CareRx Corporation",
        "summary": "CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CHM.CN": {
        "short_name": "ChemistreeTech",
        "long_name": "Chemistree Technology Inc.",
        "summary": "Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "CHMJF": {
        "short_name": "CHEMISTREE TECHNOLOGY INC",
        "long_name": "Chemistree Technology Inc.",
        "summary": "Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "CHOO.CN": {
        "short_name": "ChoomHldgsInc",
        "long_name": "Choom Holdings Inc.",
        "summary": "Choom Holdings Inc., through its subsidiaries, engages in the retail of cannabis. As of June 30, 2020, the company operates two medical and two coaching clinics under the name Concord Medical Centre; and 13 retail stores. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CHOOF": {
        "short_name": "CHOOM HOLDINGS INC",
        "long_name": "Choom Holdings Inc.",
        "summary": "Choom Holdings Inc., through its subsidiaries, engages in the retail of cannabis. As of June 30, 2020, the company operates two medical and two coaching clinics under the name Concord Medical Centre; and 13 retail stores. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CHV.CN": {
        "short_name": "Canada House",
        "long_name": "Canada House Wellness Group Inc.",
        "summary": "Canada House Wellness Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics; and a licensed dispensary. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company is headquartered in Pickering, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Pickering"
    },
    "CLABF": {
        "short_name": "CORE ONE LABS INC",
        "long_name": "Core One Labs Inc.",
        "summary": "Core One Labs Inc. operates as a biotechnology research and technology life sciences company in the United States and Canada. It focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. The company manufactures CannaStrips, which are cannabis-infused strips, as well as produces oils, distillates, and resins. It also offers consulting services for cultivation, extraction, and manufacturing, as well as financing, nursery, and cultivation services; and holds real estate properties and equipment. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CLB.F": {
        "short_name": "CHRISTINA LAKE CANNABIS",
        "long_name": "Christina Lake Cannabis Corp.",
        "summary": "Christina Lake Cannabis Corp. engages in the growing, harvesting, processing, and sale of cannabis products in the British Columbia, Canada. It primarily offers cannabis oil, hemp oil, and other hemp and cannabis derived products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 21, 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CLC.CN": {
        "short_name": "ChristinaCanna",
        "long_name": "Christina Lake Cannabis Corp.",
        "summary": "Christina Lake Cannabis Corp. engages in the growing, harvesting, processing, and sale of cannabis products in the British Columbia, Canada. It primarily offers cannabis oil, hemp oil, and other hemp and cannabis derived products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 21, 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CLCFF": {
        "short_name": "CHRISTINA LAKE CANNABIS CORP",
        "long_name": "Christina Lake Cannabis Corp.",
        "summary": "Christina Lake Cannabis Corp. engages in the growing, harvesting, processing, and sale of cannabis products in the British Columbia, Canada. It primarily offers cannabis oil, hemp oil, and other hemp and cannabis derived products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 21, 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CLXPF": {
        "short_name": "CYBIN INC",
        "long_name": "Cybin Inc.",
        "summary": "Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CM1.F": {
        "short_name": "CHEMISTREE TECHNOLOGY",
        "long_name": "Chemistree Technology Inc.",
        "summary": "Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "CNFA.CN": {
        "short_name": "CanaFarma",
        "long_name": "CanaFarma Hemp Products Corp.",
        "summary": "CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CNFHF": {
        "short_name": "CANAFARMA HEMP PRODUCTS CORP",
        "long_name": "CanaFarma Hemp Products Corp.",
        "summary": "CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CNNXF": {
        "short_name": "CANNAMERICA BRANDS CORP",
        "long_name": "CannAmerica Brands Corp.",
        "summary": "CannAmerica Brands Corp. owns a portfolio of brands in the medical cannabis and recreational cannabis space with licensees in the states of Colorado, Nevada, Oklahoma, Maryland, and Massachusetts. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors. It offers sweet, sour, and sweet and sour fruit juice gummies under the CannAmerica brand. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CNONF": {
        "short_name": "LYNX GLOBAL DIGITAL FIN CORP",
        "long_name": "Lynx Global Digital Finance Corporation",
        "summary": "CannaOne Technologies Inc., a software development and technology company, develops and markets online e-commerce marketplace solution for the cannabis industry in Canada. It provides BloomKit, a software suite that delivers an online toolkit for various applications for companies in the cannabis sector; and BWell, which uses BloomKit to facilitate the sale of premium CBD products on its online marketplace. The company also operates Primo, a review driven marketplace that show a dispensary directory, brand pages, visual product attributes, and multi-varied cannabis centric reviews. CannaOne Technologies Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CNPOF": {
        "short_name": "RIV CAPITAL INC",
        "long_name": "RIV Capital Inc.",
        "summary": "RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CNTR.CN": {
        "short_name": "CENTRBrands",
        "long_name": "CENTR Brands Corp.",
        "summary": "CENTR Brands Corp. engages in the development and marketing of beverages infused with hemp-derived extracts and derivatives. The company primarily offers cannabidiol beverages. It offers CENTR, a CBD beverage product. CENTR Brands Corp. was founded in 2012 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CNTRF": {
        "short_name": "CENTR BRANDS CORP",
        "long_name": "CENTR Brands Corp.",
        "summary": "CENTR Brands Corp. engages in the development and marketing of beverages infused with hemp-derived extracts and derivatives. The company primarily offers cannabidiol beverages. It offers CENTR, a CBD beverage product. CENTR Brands Corp. was founded in 2012 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CNTTQ": {
        "short_name": "CANNTRUST HOLDINGS INC",
        "long_name": "CannTrust Holdings Inc.",
        "summary": "CannTrust Holdings Inc. produces and distributes medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is based in Vaughan, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vaughan"
    },
    "CNVCF": {
        "short_name": "BIOHARVEST SCIENCES INC",
        "long_name": "BioHarvest Sciences Inc.",
        "summary": "BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "COOL.CN": {
        "short_name": "CoreOneLabs",
        "long_name": "Core One Labs Inc.",
        "summary": "Core One Labs Inc. operates as a biotechnology research and technology life sciences company in the United States and Canada. It focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. The company manufactures CannaStrips, which are cannabis-infused strips, as well as produces oils, distillates, and resins. It also offers consulting services for cultivation, extraction, and manufacturing, as well as financing, nursery, and cultivation services; and holds real estate properties and equipment. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "COTQF": {
        "short_name": "COTINGA PHARMACEUTICALS INC",
        "long_name": "Cotinga Pharmaceuticals Inc.",
        "summary": "Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "COV.V": {
        "short_name": "COVALON TECHNOLOGIES LTD",
        "long_name": "Covalon Technologies Ltd.",
        "summary": "Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. The company has five proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device; aquaguard moisture barrier technology, an impermeable moisture barrier that allows the clinician or patient to cover wounds, dressings, and intravenous sites to keep them dry; and covaguard antimicrobial sanitizing technology that incorporates Benzalkonium Chloride into a lipid delivery system to surfaces and skin to kill viruses and bacteria. Its products include wound care dressings; surgical and peri-operative products; infection management products; moisture barriers; and antimicrobial sanitizers under the Covalon brand name. The company sells its products through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "CPH.TO": {
        "short_name": "CIPHER PHARMACEUTICALS INC",
        "long_name": "Cipher Pharmaceuticals Inc.",
        "summary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "CPHRF": {
        "short_name": "CIPHER PHARMACEUTICALS INC",
        "long_name": "Cipher Pharmaceuticals Inc.",
        "summary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "CPIVF": {
        "short_name": "CAPTIVA VERDE WELLNESS CORP",
        "long_name": "Captiva Verde Wellness Corp.",
        "summary": "Captiva Verde Wellness Corp. operates as a health and wellness company. The company's assets include sustainable real estate communities in California; outdoor organic cannabis cultivation in Canada; premium infused products and consumer retail partnerships across North America; and medical cannabis license product distribution in Mexico. It primarily invests in assets that contain green residential communities, disruptive manufacturing facilities, organic food production, and pharmaceutical products. The company was formerly known as Captiva Verde Land Corp. and changed its name to Captiva Verde Wellness Corp. in May 2021. Captiva Verde Wellness Corp. was incorporated in 2015 and is based in Coquitlam, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Coquitlam"
    },
    "CPMD": {
        "short_name": "CANNAPHARMARX INC",
        "long_name": "CannaPharmaRX, Inc.",
        "summary": "CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects in Canada. The company is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "CPTR.CN": {
        "short_name": "Captor Capital",
        "long_name": "Captor Capital Corp.",
        "summary": "Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CRBK.V": {
        "short_name": "CAREBOOK TECHNOLGIES INC",
        "long_name": "Carebook Technologies Inc.",
        "summary": "Carebook Technologies Inc., digital health company, develops digital health solutions. The company provides COVID-19 application and pharmacy engagement platform. It also offers virtual care and COVID-19 vital signs screening for pharmacies, insurance providers, individuals, governments, and businesses. The company is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "CRBKF": {
        "short_name": "CAREBOOK TECHNOLOGIES INC",
        "long_name": "Carebook Technologies Inc.",
        "summary": "Carebook Technologies Inc., digital health company, develops digital health solutions. The company provides COVID-19 application and pharmacy engagement platform. It also offers virtual care and COVID-19 vital signs screening for pharmacies, insurance providers, individuals, governments, and businesses. The company is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "CRDL.TO": {
        "short_name": "CARDIOL THERAPEUTICS INC",
        "long_name": "Cardiol Therapeutics Inc.",
        "summary": "Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "CRFT.CN": {
        "short_name": "BCCraftSupplyCo",
        "long_name": "BC Craft Supply Co. Ltd.",
        "summary": "BC Craft Supply Co. Ltd., together with its subsidiaries, engages in the production and distribution of licensed craft cannabis and craft cannabis related products for recreational and medical purposes. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CRFTF": {
        "short_name": "BC CRAFT SUPPLY CO LTD",
        "long_name": "BC Craft Supply Co. Ltd.",
        "summary": "BC Craft Supply Co. Ltd., together with its subsidiaries, engages in the production and distribution of licensed craft cannabis and craft cannabis related products for recreational and medical purposes. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CRH.TO": {
        "short_name": "CRH MEDICAL CORPORATION",
        "long_name": "CRH Medical Corporation",
        "summary": "CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada. As of April 22, 2021, CRH Medical Corporation operates as a subsidiary of WELL Health Technologies Corp.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CRON": {
        "short_name": "Cronos Group Inc. Common Share",
        "long_name": "Cronos Group Inc.",
        "summary": "Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CRON.TO": {
        "short_name": "CRONOS GROUP INC",
        "long_name": "Cronos Group Inc.",
        "summary": "Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CRPOF": {
        "short_name": "CEAPRO INC",
        "long_name": "Ceapro Inc.",
        "summary": "Ceapro Inc., a biotechnology company, engages in the development and commercialization of active ingredients in the United States, Germany, China, Canada, and internationally. It operates in two segments, The Active Ingredient Product Technology Industry and The Cosmeceutical Industry. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, such as Pressurized Gas eXpanded drying technology; and technologies to enhance the content of avenanthramides. The company has a collaboration with the McMaster University to develop inhalable therapeutic for COVID-19; and a research project with the University of Alberta to expand the utilization of the PGX technology and generate ingredients targeting applications in functional food, dietary supplement, personal care, and pharmaceuticals. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "CRRVF": {
        "short_name": "CVR MEDICAL CORP",
        "long_name": "CVR Medical Corp.",
        "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "CRRX.TO": {
        "short_name": "CARERX CORPORATION",
        "long_name": "CareRx Corporation",
        "summary": "CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CRTPF": {
        "short_name": "CARDIOL THERAPEUTICS INC",
        "long_name": "Cardiol Therapeutics Inc.",
        "summary": "Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "CSI.CN": {
        "short_name": "ChemesisIntl",
        "long_name": "Chemesis International Inc.",
        "summary": "Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CT9.F": {
        "short_name": "CARDIOL THERAPEUTICS CL.A",
        "long_name": "Cardiol Therapeutics Inc.",
        "summary": "Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "CTABF": {
        "short_name": "CANNTAB THERAPEUTICS LIMITED",
        "long_name": "Canntab Therapeutics Limited",
        "summary": "Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Markham"
    },
    "CTTH": {
        "short_name": "CTT PHARMACEUTICAL HLDGS INC",
        "long_name": "CTT Pharmaceutical Holdings, Inc.",
        "summary": "CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "CTX.TO": {
        "short_name": "CRESCITA THERAPEUTICS INC",
        "long_name": "Crescita Therapeutics Inc.",
        "summary": "Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns various proprietary drug delivery platforms, including Peel, DuraPeel, and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; and CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition. Its non-prescription skincare products comprise skincare products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of dermocosmetic products for anti-aging medical procedures under the Pro-Derm brand; skincare products primarily for the Asian consumers under Dermazulene brand; and a line of products to target and treat various skincare concerns under the Alyria brand. The company has a development and licensing agreement with Sundial Growers Inc. to develop cannabis and hemp topicals; a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Laval"
    },
    "CURE.CN": {
        "short_name": "BiocureTechInc",
        "long_name": "Biocure Technology Inc.",
        "summary": "Biocure Technology Inc. develops and commercializes biopharmaceutical technologies for uses in recombinant and ranibizumab. The company is developing Interferons- \u00c3\u009f for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It is also developing CAR T Cell Therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and a hair growth production product. Biocure Technology Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CVALF": {
        "short_name": "COVALON TECHNOLOGIES LTD",
        "long_name": "Covalon Technologies Ltd.",
        "summary": "Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. The company has five proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device; aquaguard moisture barrier technology, an impermeable moisture barrier that allows the clinician or patient to cover wounds, dressings, and intravenous sites to keep them dry; and covaguard antimicrobial sanitizing technology that incorporates Benzalkonium Chloride into a lipid delivery system to surfaces and skin to kill viruses and bacteria. Its products include wound care dressings; surgical and peri-operative products; infection management products; moisture barriers; and antimicrobial sanitizers under the Covalon brand name. The company sells its products through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "CVGR.CN": {
        "short_name": "CityViewGreen",
        "long_name": "City View Green Holdings Inc.",
        "summary": "City View Green Holdings Inc. intends to produce cannabis-infused food, oils, distillates, and water-soluble products for the food and beverage markets. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CVGRF": {
        "short_name": "CITY VIEW GREEN HOLDINGS INC",
        "long_name": "City View Green Holdings Inc.",
        "summary": "City View Green Holdings Inc. intends to produce cannabis-infused food, oils, distillates, and water-soluble products for the food and beverage markets. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CVM.V": {
        "short_name": "CVR MEDICAL CORP",
        "long_name": "CVR Medical Corp.",
        "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "CVY.F": {
        "short_name": "CITY VIEW GREEN HOLDINGS",
        "long_name": "City View Green Holdings Inc.",
        "summary": "City View Green Holdings Inc. intends to produce cannabis-infused food, oils, distillates, and water-soluble products for the food and beverage markets. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CWAB.F": {
        "short_name": "CHEMESIS INTL INC.  O.N.",
        "long_name": "Chemesis International Inc.",
        "summary": "Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CWWBF": {
        "short_name": "PLANT BASED INVESTMENT CORP",
        "long_name": "Plant-Based Investment Corp.",
        "summary": "Plant-Based Investment Corp. is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CXXI.CN": {
        "short_name": "C21 InvInc",
        "long_name": "C21 Investments Inc.",
        "summary": "C21 Investments Inc., an integrated cannabis company, cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CXXIF": {
        "short_name": "C21 INVESTMENTS INC",
        "long_name": "C21 Investments Inc.",
        "summary": "C21 Investments Inc., an integrated cannabis company, cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "CYBN.NE": {
        "short_name": "CYBIN INC.",
        "long_name": "Cybin Inc.",
        "summary": "Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "CZO.V": {
        "short_name": "Ceapro Inc",
        "long_name": "Ceapro Inc.",
        "summary": "Ceapro Inc., a biotechnology company, engages in the development and commercialization of active ingredients in the United States, Germany, China, Canada, and internationally. It operates in two segments, The Active Ingredient Product Technology Industry and The Cosmeceutical Industry. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, such as Pressurized Gas eXpanded drying technology; and technologies to enhance the content of avenanthramides. The company has a collaboration with the McMaster University to develop inhalable therapeutic for COVID-19; and a research project with the University of Alberta to expand the utilization of the PGX technology and generate ingredients targeting applications in functional food, dietary supplement, personal care, and pharmaceuticals. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "D2EA.F": {
        "short_name": "PHYTO EXTRACTIONS INC.",
        "long_name": "Phyto Extractions Inc.",
        "summary": "Adastra Labs Holdings Ltd. operates as a cannabis extraction and processing solutions company. It also offers third party analytical testing services, such as white labelling, contract processing, and cannabis testing. The company is based in Langley, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Langley"
    },
    "D84.F": {
        "short_name": "MAITRI HEALTH TECHN.CORP.",
        "long_name": "Maitri Health Technologies Corp.",
        "summary": "Maitri Health Technologies Corp. operates as a healthcare supply platform in Canada and internationally. The company offers personal protective equipment, and testing and technology solutions. Its products include face masks, face shields, anti-viral cleaning solutions, sanitizers, disinfectants, and PCR test kits. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "DB.V": {
        "short_name": "DECIBEL CANNABIS COMPANY INC",
        "long_name": "Decibel Cannabis Company Inc.",
        "summary": "Decibel Cannabis Company Inc. engages the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower under the Qwest and Qwest Reserve brands; and cannabis pre-rolls under the Blendcraft by Qwest brand. The company is also involved in the extraction, processing, and manufacturing of various cannabis derivative products. It also sells bulk amounts of cannabis biomass to licensed producers in Canada. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "DBCCF": {
        "short_name": "DECIBEL CANNABIS COMPANY INC",
        "long_name": "Decibel Cannabis Company Inc.",
        "summary": "Decibel Cannabis Company Inc. engages the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower under the Qwest and Qwest Reserve brands; and cannabis pre-rolls under the Blendcraft by Qwest brand. The company is also involved in the extraction, processing, and manufacturing of various cannabis derivative products. It also sells bulk amounts of cannabis biomass to licensed producers in Canada. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "DFMA.F": {
        "short_name": "IKAENIK FARMS INC.",
        "long_name": "Ik\u00e4nik Farms, Inc.",
        "summary": "Ikanik Farms Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator. The company is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "DLTNF": {
        "short_name": "DELTA 9 CANNABIS INC",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "DN.TO": {
        "short_name": "DELTA 9 CANNABIS INC",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "DOC.V": {
        "short_name": "CLOUDMD SOFTWARE AND SERVICES I",
        "long_name": "CloudMD Software & Services Inc.",
        "summary": "CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services. The company also retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies, as well as provides clinical services, such as medical reviews and compounding; and provides cloud-based electronic medical records (EMR) software, medical billing and practice management software, and various telemedicine platforms to medical professionals, as well as digital platforms to serve individuals for their eyecare and specialty drug needs. In addition, it offers JunoEMR, a cloud-based EMR solution; MyHealthAccess, an online patient portal for online appointment booking and telemedicine visits; Benchmark, a suite of cloud-based medical practice solutions; and ClinicAid, a medical billing software. Further, the company provides Livecare Connect, a telemedicine platform; IDYA4, a health data integration and security technology platform; VisionPros, an online eyecare platform that offers contact lenses and eyeglasses under the KIND brand; Rxi, a specialty drug wholesaler, pharmacy, and technology/patient support program administrator. Additionally, it provides enterprise health solutions, including mental health support; employee and student assistance programs; healthcare navigation and specialist; rehabilitation and assessments; education; and absence management. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Victoria, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "DOCRF": {
        "short_name": "CLOUDMD SOFTWARE & SERVICES INC",
        "long_name": "CloudMD Software & Services Inc.",
        "summary": "CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services. The company also retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies, as well as provides clinical services, such as medical reviews and compounding; and provides cloud-based electronic medical records (EMR) software, medical billing and practice management software, and various telemedicine platforms to medical professionals, as well as digital platforms to serve individuals for their eyecare and specialty drug needs. In addition, it offers JunoEMR, a cloud-based EMR solution; MyHealthAccess, an online patient portal for online appointment booking and telemedicine visits; Benchmark, a suite of cloud-based medical practice solutions; and ClinicAid, a medical billing software. Further, the company provides Livecare Connect, a telemedicine platform; IDYA4, a health data integration and security technology platform; VisionPros, an online eyecare platform that offers contact lenses and eyeglasses under the KIND brand; Rxi, a specialty drug wholesaler, pharmacy, and technology/patient support program administrator. Additionally, it provides enterprise health solutions, including mental health support; employee and student assistance programs; healthcare navigation and specialist; rehabilitation and assessments; education; and absence management. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Victoria, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "DOSE.CN": {
        "short_name": "RapidDose",
        "long_name": "Rapid Dose Therapeutics Corp.",
        "summary": "Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. It also offers PharmaStrip delivery system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Burlington"
    },
    "DPD3.F": {
        "short_name": "IMAGIN MEDICAL INC.",
        "long_name": "Imagin Medical Inc.",
        "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "DR.TO": {
        "short_name": "MEDICAL FACILITIES CORP",
        "long_name": "Medical Facilities Corporation",
        "summary": "Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and an ambulatory surgery center in the United States. The company's specialty surgical hospitals provide surgical, imaging, diagnostic, and other pain management procedures; and other ancillary services, such as urgent care and occupational health. It also offers ambulatory surgery center, which performs scheduled outpatient surgical procedures. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "DRDR.TO": {
        "short_name": "MCI ONEHEALTH TECHNOLOGIES INC",
        "long_name": "MCI Onehealth Technologies Inc.",
        "summary": "MCI Onehealth Technologies Inc., through its subsidiaries, provides healthcare and healthcare related services to patients and the employees of corporate customers in Canada. The company provides its services through a network of 25 brick and mortar clinics, as well as through telehealth/virtual care platform. The company was formerly known as MCI Brighthealth Technologies Inc. and changed its name to MCI Onehealth Technologies Inc. in December 2020. MCI Onehealth Technologies Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "DRUG.CN": {
        "short_name": "BrightMindsBio",
        "long_name": "Bright Minds Biosciences Inc.",
        "summary": "Bright Minds Biosciences Inc., a biotechnology company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprise 5-HT2C, 5-HT2A, and 5-HT2C/A for central nervous system -pediatric pharmacoresistant epilepsy, pain- cluster headache, migraine, fibromyalgia, chemotherapy induced neuropathy, neuropsychiatry-major depressive disorder, and impulse control disorder therapeutic areas. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "E031.F": {
        "short_name": "ESSA PHARMA INC.",
        "long_name": "ESSA Pharma Inc.",
        "summary": "ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EAPH": {
        "short_name": "EASTON PHARMACEUTICALS INC",
        "long_name": "Easton Pharmaceuticals Inc.",
        "summary": "Easton Pharmaceuticals Inc., a specialty pharmaceutical company, develops and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; and Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EAST.V": {
        "short_name": "EASTWEST BIOSCIENCE INC",
        "long_name": "EastWest Bioscience Inc.",
        "summary": "EastWest Bioscience Inc., a vertically-integrated wellness company, manufactures and sells hemp nutritional products in Canada and the United States. It offers bulk CBD and CBD consumer products, such as pet, beauty and skin care, food, and CBD supplement products, as well as tinctures, nutraceuticals, and chocolate infused CBD products to wholesalers and independent resellers. The company also operates Sangster's Health Center stores that sells supplements and wellness products through its franchise locations and online ecommerce platform. In addition, it is involved in the property management business. EastWest Bioscience Inc. was founded in 2016 and is headquartered in Penticton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EASY.CN": {
        "short_name": "SpeakEasyCanna",
        "long_name": "Speakeasy Cannabis Club Ltd.",
        "summary": "Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Rock Creek"
    },
    "EAT.CN": {
        "short_name": "NutritionalHi",
        "long_name": "Nutritional High International Inc.",
        "summary": "Nutritional High International Inc. manufactures and processes hemp and marijuana-infused cannabis oils, extracts, and edible products for medical and adult recreation use in the United States and Canada. It offers cannabis-based vaping, concentrate, and infused edible products, such as oil vape cartridges, syringes, dab jars, and mints, as well as cannabis infused chocolates under the FL\u00c3\u008f brand name. The company also distributes other branded cannabis products. Nutritional High International Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EBM.V": {
        "short_name": "EASTWOOD BIO MEDICAL CANADA INC",
        "long_name": "Eastwood Bio-Medical Canada Inc.",
        "summary": "Eastwood Bio-Medical Canada Inc. distributes natural health supplements under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin and related products. Its products provide natural sourced solutions for metabolic syndromes, such as blood glucose disorders, obesity, and hypertension. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was incorporated in 2010 and is headquartered in Richmond, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "EDEN.CN": {
        "short_name": "EdenEmpireInc",
        "long_name": "Eden Empire Inc.",
        "summary": "Eden Empire Inc. invests in and operates in the cannabis sector. It engages in the retail sale of cannabis in Canada and the United States. Eden Empire Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EDSA": {
        "short_name": "Edesa Biotech, Inc.",
        "long_name": "Edesa Biotech, Inc.",
        "summary": "Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 2/Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical cream containing non-steroidal anti-inflammatory compound that is in Phase 2B clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of sPLA2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, a monoclonal antibody candidate. It has a collaboration agreement with NovImmune SA to develop products containing toll-like receptor 4 and chemokine ligand 10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Markham"
    },
    "EDT.TO": {
        "short_name": "SPECTRAL MEDICAL INC",
        "long_name": "Spectral Medical Inc.",
        "summary": "Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EDTXF": {
        "short_name": "SPECTRAL MEDICAL INC",
        "long_name": "Spectral Medical Inc.",
        "summary": "Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EEVVF": {
        "short_name": "EVE & CO INCORPORATED",
        "long_name": "Eve & Co Incorporated",
        "summary": "Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sells dried cannabis, cannabis plants, and cannabis seeds in Canada. It offers cannabis for women under the EVE brand. The company is headquartered in Strathroy, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Strathroy"
    },
    "EIY2.F": {
        "short_name": "RELAY MEDICAL",
        "long_name": "Relay Medical Corp.",
        "summary": "Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company provides Fionet, a mobile testing and tracking platform, which combines handheld devices linked to online AI-powered cloud, automating frontline testing, and capturing test results for tracking; HemoPalm, a blood analyzer and single-use cartridge that provides enterprise solution for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an user experience -centric system design to improve management and identification of medications. It offers techno-commercial leadership and support services for the venture that pursue technology opportunities in the medicinal cannabis, agrotechnology, and other related industries. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EKG.V": {
        "short_name": "CARDIOCOMM SOLUTIONS, INC.",
        "long_name": "CardioComm Solutions, Inc.",
        "summary": "CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals, and call centers to access and manage patient information. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EKGGF": {
        "short_name": "CARDIOCOMM SOLUTIONS INC",
        "long_name": "CardioComm Solutions, Inc.",
        "summary": "CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals, and call centers to access and manage patient information. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ELIXF": {
        "short_name": "ELIXXER LTD",
        "long_name": "Elixxer Ltd.",
        "summary": "Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It focuses on invests in medical and specialty cannabis derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "ELM.V": {
        "short_name": "ELEMENT LIFESTYLE RETIREMENT IN",
        "long_name": "Element Lifestyle Retirement Inc.",
        "summary": "Element Lifestyle Retirement Inc. develops and operates senior retirement communities in British Columbia, Canada. The company provides development consulting services, such as property selection, assembly and acquisition, building and community design, municipal approval and land entitlement processes, financing, marketing, sales and leasing, and construction project management. It also offers long-term management services for the facilities, which include management of the administration, operation, and financing of retirement communities and physical facilities. The company was incorporated in 2007 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ELXR.V": {
        "short_name": "ELIXXER LTD",
        "long_name": "Elixxer Ltd.",
        "summary": "Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It focuses on invests in medical and specialty cannabis derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "EMH.CN": {
        "short_name": "Emerald Heal",
        "long_name": "Emerald Health Therapeutics, Inc.",
        "summary": "Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EMHTF": {
        "short_name": "EMERALD HEALTH THERAPEUTICS INC",
        "long_name": "Emerald Health Therapeutics, Inc.",
        "summary": "Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EMYSF": {
        "short_name": "EASY TECHNOLOGIES INC",
        "long_name": "Easy Technologies Inc.",
        "summary": "Easy Technologies Inc. develops an Internet based platform in the online gaming area. It develops HouseTrivia.com, a platform that holds various trivia competitions. The company was formerly known as EasyMed Technologies Inc. and changed its name to Easy Technologies Inc. in January 2016. Easy Technologies Inc. was founded in 2005 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ENBI.CN": {
        "short_name": "Entheon Biomed",
        "long_name": "Entheon Biomedical Corp.",
        "summary": "Entheon Biomedical Corp., a biotechnology research and drug development company, engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EPIC.CN": {
        "short_name": "LeviathanNat",
        "long_name": "Leviathan Natural Products Inc.",
        "summary": "Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of cannabis and hemp products in Canada, the United States, and Colombia. The company was formerly known as Leviathan Cannabis Group Inc. and changed its name to Leviathan Natural Products Inc. in July 2020. Leviathan Natural Products Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "EPIX": {
        "short_name": "ESSA Pharma Inc.",
        "long_name": "ESSA Pharma Inc.",
        "summary": "ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EPRX.TO": {
        "short_name": "EUPRAXIA PHARMACEUTICALS INC",
        "long_name": "Eupraxia Pharmaceuticals Inc.",
        "summary": "Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "EPWCF": {
        "short_name": "EMPOWER CLINICS INC",
        "long_name": "Empower Clinics Inc.",
        "summary": "Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through its clinics, with digital and telemedicine care, and medical diagnostics laboratories in North America. It offers preventative, diagnostic, and treatment services that focuses on patient experience. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ERV2.F": {
        "short_name": "MOLECULE HOLDINGS",
        "long_name": "Molecule Holdings Inc.",
        "summary": "Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages. The company is based in Lansdowne, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Lansdowne"
    },
    "EVAHF": {
        "short_name": "EGF THERAMED HEALTH CORP",
        "long_name": "EGF Theramed Health Corp.",
        "summary": "EGF Theramed Health Corp., a consumer technology company, develops technologies, products, and diagnostic tools for personalized medical care. It engages in the provision of biomedical online services for monitoring and treating common health problems; and extraction and purification of botanical extracts and creation of extract formulations, as well as development of medical monitoring device technologies. The company also provides TULIP medical health system device. It offers services in the medical areas of mental health problems, weight loss, skin care, and heart diseases. The company was formerly known as Theramed Health Corporation and changed its name to EGF Theramed Health Corp. in October 2019. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "EVE.V": {
        "short_name": "EVE AND CO INCORPORATED",
        "long_name": "Eve & Co Incorporated",
        "summary": "Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sells dried cannabis, cannabis plants, and cannabis seeds in Canada. It offers cannabis for women under the EVE brand. The company is headquartered in Strathroy, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Strathroy"
    },
    "EVRRF": {
        "short_name": "MOLECULE HOLDINGS INC",
        "long_name": "Molecule Holdings Inc.",
        "summary": "Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages. The company is based in Lansdowne, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Lansdowne"
    },
    "EWOOF": {
        "short_name": "EASTWOOD BIO-MED CDA INC",
        "long_name": "Eastwood Bio-Medical Canada Inc.",
        "summary": "Eastwood Bio-Medical Canada Inc. distributes natural health supplements under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin and related products. Its products provide natural sourced solutions for metabolic syndromes, such as blood glucose disorders, obesity, and hypertension. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was incorporated in 2010 and is headquartered in Richmond, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "EXE.TO": {
        "short_name": "EXTENDICARE INC",
        "long_name": "Extendicare Inc.",
        "summary": "Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a net of 121 LTC homes and retirement communities, including 69 owned and 52 contract services, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was founded in 1968 and is based in Markham, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Markham"
    },
    "EXETF": {
        "short_name": "EXTENDICARE INC CDA",
        "long_name": "Extendicare Inc.",
        "summary": "Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a net of 121 LTC homes and retirement communities, including 69 owned and 52 contract services, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was founded in 1968 and is based in Markham, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Markham"
    },
    "EXP.V": {
        "short_name": "EXPERION HOLDINGS LTD",
        "long_name": "Experion Holdings Ltd.",
        "summary": "Experion Holdings Ltd., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Viridium Pacific Group Ltd. and changed its name to Experion Holdings Ltd. in June 2019. Experion Holdings Ltd. is headquartered in Mission, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mission"
    },
    "EXPFF": {
        "short_name": "EXPERION HOLDINGS LTD",
        "long_name": "Experion Holdings Ltd.",
        "summary": "Experion Holdings Ltd., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Viridium Pacific Group Ltd. and changed its name to Experion Holdings Ltd. in June 2019. Experion Holdings Ltd. is headquartered in Mission, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mission"
    },
    "F11.F": {
        "short_name": "FLOWER ONE HOLDINGS INC",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "F11.MU": {
        "short_name": "FLOWER ONE HOLDINGS INC",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FAF.TO": {
        "short_name": "FIRE AND FLOWER HOLDINGS CORP",
        "long_name": "Fire & Flower Holdings Corp.",
        "summary": "Fire & Flower Holdings Corp., through its subsidiary, Fire & Flower Inc., operates as an independent retailer that offers cannabis products and accessories to the adult-use market in Alberta and Saskatchewan. It also provides brand licensing and consulting services to licensed cannabis retail stores in Ontario. In addition, the company engages in the wholesale of regulated cannabis products and accessories in Saskatchewan; and operates Hifyre digital retail and analytics of regulated cannabis e-commerce platform. As of February 1, 2020, it owned or had interests in approximately 45 cannabis retail store licenses. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FFLWF": {
        "short_name": "FIRE & FLOWER HOLDINGS CORP",
        "long_name": "Fire & Flower Holdings Corp.",
        "summary": "Fire & Flower Holdings Corp., through its subsidiary, Fire & Flower Inc., operates as an independent retailer that offers cannabis products and accessories to the adult-use market in Alberta and Saskatchewan. It also provides brand licensing and consulting services to licensed cannabis retail stores in Ontario. In addition, the company engages in the wholesale of regulated cannabis products and accessories in Saskatchewan; and operates Hifyre digital retail and analytics of regulated cannabis e-commerce platform. As of February 1, 2020, it owned or had interests in approximately 45 cannabis retail store licenses. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FIOR.CN": {
        "short_name": "FioreCannabis",
        "long_name": "Fiore Cannabis Ltd.",
        "summary": "Fiore Cannabis Ltd. engages in the cultivation and production of medical and recreational marijuana in Canada and the United States. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in November 2020. Fiore Cannabis Ltd. was incorporated in 2007 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "FIORF": {
        "short_name": "FIORE CANNABIS LTD",
        "long_name": "Fiore Cannabis Ltd.",
        "summary": "Fiore Cannabis Ltd. engages in the cultivation and production of medical and recreational marijuana in Canada and the United States. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in November 2020. Fiore Cannabis Ltd. was incorporated in 2007 and is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "FIRE.TO": {
        "short_name": "THE SUPREME CANNABIS COMPANY IN",
        "long_name": "The Supreme Cannabis Company, Inc.",
        "summary": "The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FLOOF": {
        "short_name": "FLOWER ONE HOLDINGS INC",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FLURF": {
        "short_name": "FLUROTECH LTD",
        "long_name": "FluroTech Ltd.",
        "summary": "FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech's specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "FLWPF": {
        "short_name": "THE FLOWR CORPORATION",
        "long_name": "The Flowr Corporation",
        "summary": "The Flowr Corporation cultivates, produces, and sells cannabis in Canada. It also has operations in Canada, Europe, and Australia. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FLWR.V": {
        "short_name": "THE FLOWR CORPORATION",
        "long_name": "The Flowr Corporation",
        "summary": "The Flowr Corporation cultivates, produces, and sells cannabis in Canada. It also has operations in Canada, Europe, and Australia. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FONE.CN": {
        "short_name": "FlowerOneHldg",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FTRP.CN": {
        "short_name": "FieldTripHealth",
        "long_name": "Field Trip Health Ltd.",
        "summary": "Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics. The company also operates Field Trip Health clinics for psychedelic therapies in North America. Its Technology division engages in building digital and technological tools to support psychedelic experiences and consciousness expansion. Field Trip Health Ltd. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FTRPF": {
        "short_name": "FIELD TRIP HEALTH LTD",
        "long_name": "Field Trip Health Ltd.",
        "summary": "Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics. The company also operates Field Trip Health clinics for psychedelic therapies in North America. Its Technology division engages in building digital and technological tools to support psychedelic experiences and consciousness expansion. Field Trip Health Ltd. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "FUAPF": {
        "short_name": "GLOBAL CANNABIS APPLICATIONS CO",
        "long_name": "Global Cannabis Applications Corp.",
        "summary": "Global Cannabis Applications Corp. designs, develops, markets, and acquires data technologies and applications for the medical cannabis industry. The company offers Citizen Green platform, a medical cannabis data solution. It uses various technologies, such as mobile applications, artificial intelligence, regulatory, smart databases, blockchain, and digital reward tokens to qualify candidates for clinical studies. The company was formerly known as Fundamental Applications Corp. Global Cannabis Applications Corp. was founded in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "FUEL.CN": {
        "short_name": "PlantFueLif",
        "long_name": "PlantFuel Life Inc.",
        "summary": "Sire Bioscience Inc., together with its subsidiaries, invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC,FUSIONS, PURPLEK, INFUSIONS, Voila, Karma, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "FUSN": {
        "short_name": "Fusion Pharmaceuticals Inc.",
        "long_name": "Fusion Pharmaceuticals Inc.",
        "summary": "Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is involved in the progressing of its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Hamilton"
    },
    "G5Z3.F": {
        "short_name": "NEOVASC INC.",
        "long_name": "Neovasc Inc.",
        "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "GAGE.CN": {
        "short_name": "GageGrowth",
        "long_name": "Gage Growth Corp.",
        "summary": "Gage Growth Corp. provides support services to licensed Gage-branded cannabis cultivators, processors, and provisioning centers, as well as to Cookies-branded provisioning centers. It services include management, consulting, HR, financing, intellectual property, licensing, and real estate support. The company was formerly known as Wolverine Partners Corp. and changed its name to Gage Growth Corp. in October 2020. Gage Growth Corp. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GAIA.CN": {
        "short_name": "GaiaGrowCorp",
        "long_name": "Gaia Grow Corp.",
        "summary": "Gaia Grow Corp., through its subsidiaries, focuses on the cultivation and sale of industrial hemp for medical uses in Canada. Its principal property is located in Lamont County, Alberta. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "GBHPF": {
        "short_name": "GLOBAL HEMP GROUP INC",
        "long_name": "Global Hemp Group Inc.",
        "summary": "Global Hemp Group Inc. focuses on the industrial hemp industry in Canada and the United States. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "GBNH": {
        "short_name": "Greenbrook TMS Inc.",
        "long_name": "Greenbrook TMS Inc.",
        "summary": "Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GENX.V": {
        "short_name": "GENIX PHARMACEUTICALS CORPORATI",
        "long_name": "Genix Pharmaceuticals Corporation",
        "summary": "Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral spray; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and powders. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "GG0.F": {
        "short_name": "GAIA GROW CORP.",
        "long_name": "Gaia Grow Corp.",
        "summary": "Gaia Grow Corp., through its subsidiaries, focuses on the cultivation and sale of industrial hemp for medical uses in Canada. Its principal property is located in Lamont County, Alberta. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "GGTTF": {
        "short_name": "GTEC HOLDINGS LTD",
        "long_name": "GTEC Holdings Ltd.",
        "summary": "GTEC Holdings Ltd., doing business as GTEC Cannabis Co, cultivates, markets, and distributes cannabis products in Canada. The company brand portfolio includes BLK MKT, Tenzo, Pristine, GreenTec, Cognoscente, and Treehugger. It sells its products through medical and recreational sales channels, as well as through its GreenTec medical website and various licensed partners. The company was founded in 2017 and is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "GHG.CN": {
        "short_name": "GlobalHemp Grp",
        "long_name": "Global Hemp Group Inc.",
        "summary": "Global Hemp Group Inc. focuses on the industrial hemp industry in Canada and the United States. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "GHG.F": {
        "short_name": "GLOBAL HEMP GROUP INC.",
        "long_name": "Global Hemp Group Inc.",
        "summary": "Global Hemp Group Inc. focuses on the industrial hemp industry in Canada and the United States. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "GLDFF": {
        "short_name": "CHALICE BRANDS LIMITED",
        "long_name": "Golden Leaf Holdings Ltd.",
        "summary": "Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products in the United States. The company provides distillate vaporizer cartridges, ethanol extract products, and fruit chew blast products. It offers its products under the Private Stash, Jackpot, Chalice, Golden, RXO, and Elysium Fields brands. The company also engages in the ownership, administration, and leasing of real estate and intellectual properties, and capital equipment, as well as industrial hemp processing activities. In addition, it operates a network of six dispensaries under the Chalice Farms brand; and one dispensary under the Left Coast Connections brand in Oregon, as well as operates as a toll processing and white label service consultant. Golden Leaf Holdings Ltd. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GLH.CN": {
        "short_name": "GoldenLeaf",
        "long_name": "Golden Leaf Holdings Ltd.",
        "summary": "Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products in the United States. The company provides distillate vaporizer cartridges, ethanol extract products, and fruit chew blast products. It offers its products under the Private Stash, Jackpot, Chalice, Golden, RXO, and Elysium Fields brands. The company also engages in the ownership, administration, and leasing of real estate and intellectual properties, and capital equipment, as well as industrial hemp processing activities. In addition, it operates a network of six dispensaries under the Chalice Farms brand; and one dispensary under the Left Coast Connections brand in Oregon, as well as operates as a toll processing and white label service consultant. Golden Leaf Holdings Ltd. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GLOW.CN": {
        "short_name": "GlowLifeTech",
        "long_name": "Glow Lifetech Corp.",
        "summary": "Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada. Glow Lifetech Corp. operates as a subsidiary of Relay Medical Corp.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GNOM.CN": {
        "short_name": "GnomestarCraft",
        "long_name": "Gnomestar Craft Inc.",
        "summary": "Gnomestar Craft Inc. operates as a licensed stage company for producing medical marijuana in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Delta"
    },
    "GNWSF": {
        "short_name": "STAGEZERO LIFE SCIENCES LTD",
        "long_name": "StageZero Life Sciences Ltd.",
        "summary": "StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond Hill"
    },
    "GRIN.CN": {
        "short_name": "GrownRogIntInc",
        "long_name": "Grown Rogue International Inc.",
        "summary": "Grown Rogue International Inc., through with its subsidiaries, engages in the cultivation, production, and wholesale of cannabis products in Canada and the United States. The company offers flower products, such as indicas, sativas, and hybrids; and edibles, vape cartridges, pre-rolls, or concentrates. It sells its products directly to dispensaries. The company is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GRUSF": {
        "short_name": "GROWN ROGUE INTERNATIONAL INC",
        "long_name": "Grown Rogue International Inc.",
        "summary": "Grown Rogue International Inc., through with its subsidiaries, engages in the cultivation, production, and wholesale of cannabis products in Canada and the United States. The company offers flower products, such as indicas, sativas, and hybrids; and edibles, vape cartridges, pre-rolls, or concentrates. It sells its products directly to dispensaries. The company is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GSD.V": {
        "short_name": "DEVONIAN HEALTH GROUP INC",
        "long_name": "Devonian Health Group Inc.",
        "summary": "Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses, as well as distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Qu\u00c3\u00a9bec, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Qu\u00c3\u00a9bec"
    },
    "GTEC.V": {
        "short_name": "GTEC HOLDINGS LTD",
        "long_name": "GTEC Holdings Ltd.",
        "summary": "GTEC Holdings Ltd., doing business as GTEC Cannabis Co, cultivates, markets, and distributes cannabis products in Canada. The company brand portfolio includes BLK MKT, Tenzo, Pristine, GreenTec, Cognoscente, and Treehugger. It sells its products through medical and recreational sales channels, as well as through its GreenTec medical website and various licensed partners. The company was founded in 2017 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "GTMS.TO": {
        "short_name": "GREENBROOK TMS INC",
        "long_name": "Greenbrook TMS Inc.",
        "summary": "Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "GTSIF": {
        "short_name": "LOBE SCIENCES LTD",
        "long_name": "Lobe Sciences Ltd.",
        "summary": "Lobe Sciences Ltd., a technology and services company, provides real estate, financial, management, intellectual property, and branding support for development of transformational medicine in the United States. The company intends to develop psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. It also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "GUD.TO": {
        "short_name": "KNIGHT THERAPEUTICS INC",
        "long_name": "Knight Therapeutics Inc.",
        "summary": "Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with intact uterus; IMVEXXY to treat postmenopausal moderate to severe dyspareunia; IBSRELA for the treatment of irritable bowel syndrome with constipation in adults; TRELSTAR to treat advanced prostate cancer and for pain associated with endometriosis; ILUVIEN for the treatment of vision loss due to diabetic macular oedema; and NERLYNX to treat early-stage breast cancer. The company also provides Burinex, for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome; PROBUPHINE, to treat opioid addiction; and MOVANTIK for the treatment of opioid-induced constipation. In addition, it offers Vidaza to treat myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven to treat advanced or metastatic breast cancer; Lenvima for differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma; Ladevina to treat multiple myeloma; Zyvalix for metastatic prostate cancer; Karfib to treat relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; AmBisome and Cresemba to treat fungal infection; and Impavido for leishmaniasis. Further, the company provides Ursofalk to treat biliary cirrhosis; Salofalk for ulcerative colitis; Fibridoner to treat idiopathic pulmonary fibrosis; Toliscrin for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "HALO.NE": {
        "short_name": "HALO COLLECTIVE INC.",
        "long_name": "Halo Collective Inc.",
        "summary": "Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. The company also offers edible products, including single piece chews and a syrup-based drink in California and, Oregon. In addition, it markets branded and private label products. The company sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. It serves licensed retailers and wholesalers. Halo Collective Inc. has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HAVLF": {
        "short_name": "HAVN LIFE SCIENCES INC",
        "long_name": "HAVN Life Sciences Inc.",
        "summary": "HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was founded in 2020 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HAVN.CN": {
        "short_name": "HAVNLifeSci",
        "long_name": "HAVN Life Sciences Inc.",
        "summary": "HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was founded in 2020 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HBP.F": {
        "short_name": "HELIX BIOPHARMA CORP.",
        "long_name": "Helix BioPharma Corp.",
        "summary": "Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Richmond Hill"
    },
    "HBP.TO": {
        "short_name": "HELIX BIOPHARM",
        "long_name": "Helix BioPharma Corp.",
        "summary": "Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Richmond Hill"
    },
    "HCANF": {
        "short_name": "HALO COLLECTIVE INC",
        "long_name": "Halo Collective Inc.",
        "summary": "Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. The company also offers edible products, including single piece chews and a syrup-based drink in California and, Oregon. In addition, it markets branded and private label products. The company sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. It serves licensed retailers and wholesalers. Halo Collective Inc. has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HDSLF": {
        "short_name": "HEALTHSPACE DATA SYSTEMS LTD",
        "long_name": "HealthSpace Data Systems Ltd.",
        "summary": "HealthSpace Data Systems Ltd. develops and sells information and communication management systems for health inspection departments of federal, provincial, state, and municipal governments in Canada and the United States. Its products include HSCloud product, a no-code data management platform for managing applications, licenses, permits, inspections, and virtually other data for operating state and local government agencies; and HSTouch for data collection, such as calendars, past inspections, regulatory codes, and violations, which works either connected to or disconnected from the internet to record observations is the field, as well as captures electronic signature, and insert photos and email inspection reports. The company also offers HealthSpace EnviroIntel EHS Manager, an internet-based client/server application used to fill out forms, request information, and view data, including real-time reports. HealthSpace Data Systems Ltd. was founded in 1998 and is headquartered in Chilliwack, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Chilliwack"
    },
    "HEM.V": {
        "short_name": "HEMOSTEMIX INC",
        "long_name": "Hemostemix Inc.",
        "summary": "Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions. It develops cell therapy products from the patient's own blood, a relatively non-invasive source of therapeutic cells. The company's lead product is ACP-01, an autologous cell therapy for the treatment of critical limb ischemia, peripheral arterial disease, angina, ischemic cardiomyopathy, dilated cardiomyopathy, and other conditions of ischemia that is in Phase II clinical trial in Canada and the United States. It also offers various types of synergetic cell populations, such as angiogenic cell precursors, myocardial cell precursors, neural cell precursors, and bone cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "HERTF": {
        "short_name": "HERITAGE CANNABIS HOLDINGS CORP",
        "long_name": "Heritage Cannabis Holdings Corp.",
        "summary": "Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States. It offers extraction services; and focuses on processing, manufacturing, and distributing medical cannabis products and cannabis oils. It provides integrative approach to cannabinoid therapy for healthcare consumers and healthcare practitioners. The company was formerly known as Umbral Energy Corp. and changed its name to Heritage Cannabis Holdings Corp. in January 2018. Heritage Cannabis Holdings Corp. was incorporated in 2007 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HEXO": {
        "short_name": "HEXO Corp.",
        "long_name": "HEXO Corp.",
        "summary": "HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "city": "Kanata"
    },
    "HEXO.TO": {
        "short_name": "HEXO CORP",
        "long_name": "HEXO Corp.",
        "summary": "HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kanata"
    },
    "HITI.V": {
        "short_name": "HIGH TIDE INC",
        "long_name": "High Tide Inc.",
        "summary": "High Tide Inc. operates as a vertically-integrated company in the cannabis market in Canada, the United States, and internationally. It engages in the design, manufacture, and distribution of smoking accessories and cannabis lifestyle products. It is also involved in the wholesale and retailing of cannabis products, as well as operates and franchises licensed retail cannabis stores. In addition, the company provides data analytics services, as well as operates Grasscity.com and CBDcity.com platforms. As of June 3, 2021, it operated 88 retail locations in Canada. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "HITIF": {
        "short_name": "HIGH TIDE INC",
        "long_name": "High Tide Inc.",
        "summary": "High Tide Inc. operates as a vertically-integrated company in the cannabis market in Canada, the United States, and internationally. It engages in the design, manufacture, and distribution of smoking accessories and cannabis lifestyle products. It is also involved in the wholesale and retailing of cannabis products, as well as operates and franchises licensed retail cannabis stores. In addition, the company provides data analytics services, as well as operates Grasscity.com and CBDcity.com platforms. As of April 26, 2021, it operated 85 retail locations in Canada. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "HLS.TO": {
        "short_name": "HLS THERAPEUTICS INC",
        "long_name": "HLS Therapeutics Inc.",
        "summary": "HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HLTRF": {
        "short_name": "HLS THERAPEUTICS INC",
        "long_name": "HLS Therapeutics Inc.",
        "summary": "HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HMTXF": {
        "short_name": "HEMOSTEMIX INC",
        "long_name": "Hemostemix Inc.",
        "summary": "Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions. It develops cell therapy products from the patient's own blood, a relatively non-invasive source of therapeutic cells. The company's lead product is ACP-01, an autologous cell therapy for the treatment of critical limb ischemia, peripheral arterial disease, angina, ischemic cardiomyopathy, dilated cardiomyopathy, and other conditions of ischemia that is in Phase II clinical trial in Canada and the United States. It also offers various types of synergetic cell populations, such as angiogenic cell precursors, myocardial cell precursors, neural cell precursors, and bone cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "HN2.F": {
        "short_name": "HINTERLAND METALS INC.",
        "long_name": "Novamind Inc.",
        "summary": "Hinterland Metals Inc. builds a network of clinics, retreats, and research sites to serve the regulated psychedelics industry in the United States. It operates in two segments, Cedar Psychiatry and Cedar Research. The company offers outpatient mental health services; and manages and hosts third party clinical trials and participates in institutional review board studies. It also provides ketamine-assisted psychotherapy and other therapies; retreat network services; and clinical research for psychedelic medicines. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HN3Q.F": {
        "short_name": "NOVA MENTIS LI. SC. CORP.",
        "long_name": "Nova Mentis Life Science Corp.",
        "summary": "Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HOB.F": {
        "short_name": "HOLLISTER BIOSCIENCES INC",
        "long_name": "Hollister Biosciences Inc.",
        "summary": "Hollister Biosciences Inc., together with its subsidiaries, manufactures and distributes recreational cannabis and cannabis products in the United States. It offers pre rolls, infused pre rolls, vape formulation, vape cart filling, tinctures, and capsules under HashBone, Purity Petibles, Mighty Med Vape, NanoPure, and Rebel Hemp Company brands, as well as contract manufacturing white label products for other companies. The company has a collaboration with Easyriders to create cannabis products. Hollister Biosciences Inc. based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HOLL.CN": {
        "short_name": "Hollister Bio",
        "long_name": "Hollister Biosciences Inc.",
        "summary": "Hollister Biosciences Inc., together with its subsidiaries, manufactures and distributes recreational cannabis and cannabis products in the United States. It offers pre rolls, infused pre rolls, vape formulation, vape cart filling, tinctures, and capsules under HashBone, Purity Petibles, Mighty Med Vape, NanoPure, and Rebel Hemp Company brands, as well as contract manufacturing white label products for other companies. The company has a collaboration with Easyriders to create cannabis products. Hollister Biosciences Inc. based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HRAL": {
        "short_name": "HEAR ATLAST HOLDINGS INC",
        "long_name": "HearAtLast Holdings Inc.",
        "summary": "HearAtLast Holdings, Inc. operates hearing clinics in North America. The company offers hearing assessments and hearing instruments. Its products comprise digital hearing aid instruments and assistive-listening devices, as well as accessories, such as hearing aid wax guards, chargers, cleaners, sound tubes, etc. As of March 31, 2010, HearAtLast Holdings, Inc. had 23 hearing aid clinics within the Wal-Mart structure. The company was formerly known as 226 Music Group, Inc. and changed its name to HearAtLast Holdings, Inc. in 2007. HearAtLast Holdings, Inc. was founded in 2004 and is headquartered in Georgetown, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Georgetown"
    },
    "HRVOF": {
        "short_name": "HARVEST ONE CANNABIS INC",
        "long_name": "Harvest One Cannabis Inc.",
        "summary": "Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medical and Nutraceutical, and Consumer. The Medical and Nutraceutical segment is involved in the processing, manufacturing, and distribution of cannabis-based food supplement products. The Consumer segment engages in the marketing, distribution, and product development of liquid sleep shots and sleep powder packets, as well as pain relief creams. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HS.CN": {
        "short_name": "HealthSpace",
        "long_name": "HealthSpace Data Systems Ltd.",
        "summary": "HealthSpace Data Systems Ltd. develops and sells information and communication management systems for health inspection departments of federal, provincial, state, and municipal governments in Canada and the United States. Its products include HSCloud product, a no-code data management platform for managing applications, licenses, permits, inspections, and virtually other data for operating state and local government agencies; and HSTouch for data collection, such as calendars, past inspections, regulatory codes, and violations, which works either connected to or disconnected from the internet to record observations is the field, as well as captures electronic signature, and insert photos and email inspection reports. The company also offers HealthSpace EnviroIntel EHS Manager, an internet-based client/server application used to fill out forms, request information, and view data, including real-time reports. HealthSpace Data Systems Ltd. was founded in 1998 and is headquartered in Chilliwack, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Chilliwack"
    },
    "HSCHF": {
        "short_name": "H-SOURCE HOLDINGS LTD",
        "long_name": "H-Source Holdings Ltd.",
        "summary": "H-Source Holdings Ltd., a technology company, operates in the healthcare industry. It offers a hospital-to-hospital transaction platform that provides a marketplace for members to buy, sell, and transfer excess inventory supplies and capital equipment with each other. The company's platform allows members to conduct transactions within integrated delivery networks and group purchasing organizations. H-Source Holdings Ltd. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HSQ.F": {
        "short_name": "H-SOURCE HLDGS CL.A O.N.",
        "long_name": "H-Source Holdings Ltd.",
        "summary": "H-Source Holdings Ltd., a technology company, operates in the healthcare industry. It offers a hospital-to-hospital transaction platform that provides a marketplace for members to buy, sell, and transfer excess inventory supplies and capital equipment with each other. The company's platform allows members to conduct transactions within integrated delivery networks and group purchasing organizations. H-Source Holdings Ltd. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HSTRF": {
        "short_name": "HOLLISTER BIOSCIENCES INC",
        "long_name": "Hollister Biosciences Inc.",
        "summary": "Hollister Biosciences Inc., together with its subsidiaries, manufactures and distributes recreational cannabis and cannabis products in the United States. It offers pre rolls, infused pre rolls, vape formulation, vape cart filling, tinctures, and capsules under HashBone, Purity Petibles, Mighty Med Vape, NanoPure, and Rebel Hemp Company brands, as well as contract manufacturing white label products for other companies. The company has a collaboration with Easyriders to create cannabis products. Hollister Biosciences Inc. based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "HUGE.CN": {
        "short_name": "FSDPharmaInc",
        "long_name": "FSD Pharma Inc.",
        "summary": "FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HUGE": {
        "short_name": "FSD Pharma Inc.",
        "long_name": "FSD Pharma Inc.",
        "summary": "FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "HVT.V": {
        "short_name": "HARVEST ONE CANNABIS INC",
        "long_name": "Harvest One Cannabis Inc.",
        "summary": "Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medical and Nutraceutical, and Consumer. The Medical and Nutraceutical segment is involved in the processing, manufacturing, and distribution of cannabis-based food supplement products. The Consumer segment engages in the marketing, distribution, and product development of liquid sleep shots and sleep powder packets, as well as pain relief creams. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada.",
        "currency": null,
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "I4AA.F": {
        "short_name": "INTELLIPHARMACEUTICS INTL",
        "long_name": "Intellipharmaceutics International Inc.",
        "summary": "Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; and Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression. It also provides Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Pristiq, a desvenlafaxine extended-release tablet to treat depression; and Regabatin XR and Lyrica, a pregabalin extended-release capsule for the management of neuropathic pain. In addition, the company offers Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, it is developing Oxycodone ER, an extended release tablet for relief of pain. The company has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "IBT.F": {
        "short_name": "IBEX TECHS INC.",
        "long_name": "IBEX Technologies Inc.",
        "summary": "IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; cartilage assays for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides services, such as filling and lyophilization for making disposable medical device components; and custom fermentation and micro dispensing of enzymes, as well as contract manufacturing. It serves manufacturers of medical devices, quality control labs, and academic research institutions. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "IBT.V": {
        "short_name": "IBEX TECHNOLOGIES INC.",
        "long_name": "IBEX Technologies Inc.",
        "summary": "IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; cartilage assays for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides services, such as filling and lyophilization for making disposable medical device components; and custom fermentation and micro dispensing of enzymes, as well as contract manufacturing. It serves manufacturers of medical devices, quality control labs, and academic research institutions. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "ICAN.CN": {
        "short_name": "IcanicBrCo",
        "long_name": "Icanic Brands Company Inc.",
        "summary": "Icanic Brands Company Inc. provides life enhancement products in Canada. The company owns license for X-Sprays, a brand of life enhancement products administered through an oral spray delivery system. It markets and sells dietary supplements for nonmedical use primarily cannabinoid and cannabis-infused sprays, as well as non-cannabis infused sprays. The company was formerly known as Integrated Cannabis Company, Inc. and changed its name to Icanic Brands Company Inc. in February 2020. Icanic Brands Company Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ICNAF": {
        "short_name": "ICANIC BRANDS COMPANY INC",
        "long_name": "Icanic Brands Company Inc.",
        "summary": "Icanic Brands Company Inc. provides life enhancement products in Canada. The company owns license for X-Sprays, a brand of life enhancement products administered through an oral spray delivery system. It markets and sells dietary supplements for nonmedical use primarily cannabinoid and cannabis-infused sprays, as well as non-cannabis infused sprays. The company was formerly known as Integrated Cannabis Company, Inc. and changed its name to Icanic Brands Company Inc. in February 2020. Icanic Brands Company Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ICO.V": {
        "short_name": "ICO THERAPEUTICS INC.",
        "long_name": "iCo Therapeutics Inc.",
        "summary": "iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "IDL.V": {
        "short_name": "IMAGING DYNAMICS COMPANY LTD",
        "long_name": "Imaging Dynamics Company Ltd.",
        "summary": "Imaging Dynamics Company Ltd., a medical technology company, provides digital radiography equipment worldwide. The company offers imaging detectors; and flat panel detectors under Aquarius8600 and VetnovaXion names. It also provides Magellan, a medical image processing software; and Sirius, a veterinary image processing software. In addition, the company provides 1600 Plus X-Series, a DR solution with a floor mounted U-arm multi-axis positioning device that includes X-ray tube, collimator, and generator; and veterinary DR systems. Further, it provides after sales services. It offers products through dealers, distributors, and original equipment manufacturer partners. The company was formerly known as Imaging Dynamics Corporation and changed its name to Imaging Dynamics Company Ltd. in October 2001. Imaging Dynamics Company Ltd. was founded in 1995 and is headquartered in Vaughan, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vaughan"
    },
    "IGX.V": {
        "short_name": "INTELGENX TECHNOLOGIES CORP.",
        "long_name": "IntelGenx Technologies Corp.",
        "summary": "IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "IGXT": {
        "short_name": "INTELGENX TECHNOLOGIES CORPORAT",
        "long_name": "IntelGenx Technologies Corp.",
        "summary": "IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "IKAP.F": {
        "short_name": "AURINIA PHARMACEUT.",
        "long_name": "Aurinia Pharmaceuticals Inc.",
        "summary": "Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "IKNK-U.CN": {
        "short_name": "IkanikFarms",
        "long_name": "Ikanik Farms Inc.",
        "summary": "Ikanik Farms Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator. The company is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "IME.CN": {
        "short_name": "ImaginMedical",
        "long_name": "Imagin Medical Inc.",
        "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "IMEXF": {
        "short_name": "IMAGIN MEDICAL INC",
        "long_name": "Imagin Medical Inc.",
        "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "IMV": {
        "short_name": "IMV Inc.",
        "long_name": "IMV Inc.",
        "summary": "IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Dartmouth"
    },
    "IMV.TO": {
        "short_name": "IMV INC",
        "long_name": "IMV Inc.",
        "summary": "IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Dartmouth"
    },
    "INM": {
        "short_name": "InMed Pharmaceuticals Inc.",
        "long_name": "InMed Pharmaceuticals Inc.",
        "summary": "InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "INNO.CN": {
        "short_name": "InnoCanPharma",
        "long_name": "InnoCan Pharma Corporation",
        "summary": "InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "INNPF": {
        "short_name": "INNOCAN PHARMA CORPORATION",
        "long_name": "InnoCan Pharma Corporation",
        "summary": "InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "IOT.V": {
        "short_name": "INNOVOTECH INC.",
        "long_name": "Innovotech Inc.",
        "summary": "Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company offers InnovoSIL, an antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. It also provides implant medical devices; antibiotic, antimicrobial, and biocide resistance; bacteriophage, cytotoxicity, and in vitro antimicrobial testing; and analytical services. Innovotech Inc. serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company was incorporated in 2001 is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "IP4.F": {
        "short_name": "INNOCAN PHARMA CORP.",
        "long_name": "InnoCan Pharma Corporation",
        "summary": "InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "IPA": {
        "short_name": "ImmunoPrecise Antibodies Ltd.",
        "long_name": "ImmunoPrecise Antibodies Ltd.",
        "summary": "ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "IPA.V": {
        "short_name": "IMMUNOPRECISE ANTIBODIES LTD",
        "long_name": "ImmunoPrecise Antibodies Ltd.",
        "summary": "ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "IPCI.TO": {
        "short_name": "INTELLIPHARMACEUTICS INTERNATIO",
        "long_name": "Intellipharmaceutics International Inc.",
        "summary": "Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; and Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression. It also provides Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Pristiq, a desvenlafaxine extended-release tablet to treat depression; and Regabatin XR and Lyrica, a pregabalin extended-release capsule for the management of neuropathic pain. In addition, the company offers Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, it is developing Oxycodone ER, an extended release tablet for relief of pain. The company has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "IPCIF": {
        "short_name": "INTELLIPHARMACEUTICS INTL INC",
        "long_name": "Intellipharmaceutics International Inc.",
        "summary": "Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; and Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression. It also provides Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Pristiq, a desvenlafaxine extended-release tablet to treat depression; and Regabatin XR and Lyrica, a pregabalin extended-release capsule for the management of neuropathic pain. In addition, the company offers Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, it is developing Oxycodone ER, an extended release tablet for relief of pain. The company has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "IPOT.CN": {
        "short_name": "IsracannBiosci",
        "long_name": "Isracann Biosciences Inc.",
        "summary": "Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "IQ7.F": {
        "short_name": "LEVIATHAN NATURAL PRODUCT",
        "long_name": "Leviathan Natural Products Inc.",
        "summary": "Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of cannabis and hemp products in Canada, the United States, and Colombia. The company was formerly known as Leviathan Cannabis Group Inc. and changed its name to Leviathan Natural Products Inc. in July 2020. Leviathan Natural Products Inc. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "ISCNF": {
        "short_name": "ISRACANN BIOSCIENCES INC",
        "long_name": "Isracann Biosciences Inc.",
        "summary": "Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ISOLF": {
        "short_name": "ISODIOL INTERNATIONAL INC",
        "long_name": "Isodiol International Inc.",
        "summary": "Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "IVITF": {
        "short_name": "INVICTUS MD STRATEGIES CORP",
        "long_name": "Invictus MD Strategies Corp.",
        "summary": "Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "IVQ.TO": {
        "short_name": "INVESQUE INC CAD",
        "long_name": "Invesque Inc.",
        "summary": "Invesque Inc. operates as a real estate investment company in Canada and the United States. Its portfolio of investments include independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2021, it owned a portfolio of 107 properties, including 72 assisted living and memory care facilities, 17 skilled nursing facilities, 13 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "IZO.CN": {
        "short_name": "IzotropicCorp",
        "long_name": "Izotropic Corporation",
        "summary": "Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Surrey"
    },
    "IZOZF": {
        "short_name": "IZOTROPIC CORPORATION",
        "long_name": "Izotropic Corporation",
        "summary": "Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Surrey"
    },
    "J.CN": {
        "short_name": "LotusVentures",
        "long_name": "Lotus Ventures Inc.",
        "summary": "Lotus Ventures Inc. cultivates and sells cannabis products for medical purpose. The company was incorporated in 2007 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "JAM1.F": {
        "short_name": "TETRA BIO-PHARMA INC.",
        "long_name": "Tetra Bio-Pharma Inc.",
        "summary": "Tetra Bio-Pharma Inc., a development stage biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. It develops ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; Reduvo for chemotherapy-induced nausea and vomiting; PLENITUDE to treat advanced uncontrolled cancer pain; REBORN for the treatment of breakthrough cancer pain and fibromyalgia; and SERENITY to treat cancer cachexia. The company also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Orl\u00c3\u00a9ans"
    },
    "JMPHF": {
        "short_name": "LEVELJUMP HEALTHCARE CORP",
        "long_name": "Leveljump Healthcare Corp.",
        "summary": "Leveljump Healthcare Corp. operates as a medical diagnostic imaging company. It provides teleradiology services to its client hospitals and imaging centers. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "JNH.V": {
        "short_name": "JACK NATHAN MEDICAL CORP",
        "long_name": "Jack Nathan Medical Corp.",
        "summary": "Jack Nathan Medical Corp., a healthcare company, operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand. It operates medical centres in 76 Walmart locations in Canada, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec, as well as 6 locations in Mexico. The company is headquartered in Georgetown, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Georgetown"
    },
    "JNHMF": {
        "short_name": "JACK NATHAN MEDICAL CORP",
        "long_name": "Jack Nathan Medical Corp.",
        "summary": "Jack Nathan Medical Corp., a healthcare company, operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand. It operates medical centres in 76 Walmart locations in Canada, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec, as well as 6 locations in Mexico. The company is headquartered in Georgetown, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Georgetown"
    },
    "JNX.F": {
        "short_name": "THERMA BRIGHT INC.",
        "long_name": "Therma Bright Inc.",
        "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "JUMP.V": {
        "short_name": "LEVELJUMP HEALTHCARE CORP",
        "long_name": "Leveljump Healthcare Corp.",
        "summary": "Leveljump Healthcare Corp. operates as a medical diagnostic imaging company. It provides teleradiology services to its client hospitals and imaging centers. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "JUVA.CN": {
        "short_name": "JuvaLifeInc.",
        "long_name": "Juva Life Inc.",
        "summary": "Juva Life Inc. engages in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "JUVAF": {
        "short_name": "JUVA LIFE INC",
        "long_name": "Juva Life Inc.",
        "summary": "Juva Life Inc. engages in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "JWCAF": {
        "short_name": "JAMES E WAGNER CULTIVATION CORP",
        "long_name": "James E. Wagner Cultivation Corporation",
        "summary": "James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kitchener"
    },
    "KDA.V": {
        "short_name": "KDA GROUP INC",
        "long_name": "KDA Group Inc.",
        "summary": "KDA Group Inc. offers solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates in three segments: Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Cannabis. It provides pharmacy staff replacement services, professional and continued medical training services, online and in-class training for pharmacists and pharmacy technical assistants, human resource and crisis management consulting services, private health services, pharmacy re-engineering services, and pharmaceutical training services. The company also offers software applications, such as Virtual Clinics, Virtual Pharmacy, and eCommerce for orders of medical cannabis products, as well as counselling and training services on medical cannabis products for doctors, pharmacists, and patients; and replacement and training services to dental personnel. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. was incorporated in 2008 and is headquartered in Thetford Mines, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Thetford Mines"
    },
    "KHRN.V": {
        "short_name": "KHIRON LIFE SCIENCES CORP",
        "long_name": "Khiron Life Sciences Corp.",
        "summary": "Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "KHRNF": {
        "short_name": "KHIRON LIFE SCIENCES CORP",
        "long_name": "Khiron Life Sciences Corp.",
        "summary": "Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "KNBIF": {
        "short_name": "KANE BIOTECH INC",
        "long_name": "Kane Biotech Inc.",
        "summary": "Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; medical device coatings under the Aledex name; and shampoos for dogs, cats, and horses under the Alosera name. It also offers anti-itch shampoo under the silkstem name; scalp detoxifiers, shampoos, and shampoo bars under the DermaKB Biofilm brand name; and wound care products under the Coactiv+ name. The company was incorporated in 2001 and is based in Winnipeg, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "KNE.V": {
        "short_name": "KANE BIOTECH INC",
        "long_name": "Kane Biotech Inc.",
        "summary": "Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; medical device coatings under the Aledex name; and shampoos for dogs, cats, and horses under the Alosera name. It also offers anti-itch shampoo under the silkstem name; scalp detoxifiers, shampoos, and shampoo bars under the DermaKB Biofilm brand name; and wound care products under the Coactiv+ name. The company was incorporated in 2001 and is based in Winnipeg, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "KO.V": {
        "short_name": "KIARO HOLDINGS CORP",
        "long_name": "Kiaro Holdings Corp.",
        "summary": "Kiaro Holdings Corp. owns and operates cannabis retail stores in Canada. It also sells through online. The company was founded in 2019 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "KTNNF": {
        "short_name": "PEAKBIRCH LOGIC INC",
        "long_name": "PeakBirch Logic Inc.",
        "summary": "PeakBirch Logic Inc. engages in the e-commerce sales and delivery of cannabis-related and cannabidiol (CBD) containing products. The company distributes vaporizers, CBD related accessories, and ancillary products for aromatherapy and other applications, as well as CBD tinctures, topicals, edibles, and other products. It sells its products through Namastevapes.com, Everyonedoesit.com, LiftedCBD.com, Leafscience.com, and Lifted.com portals. PeakBirch Logic Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "KYH2.F": {
        "short_name": "PEAKBIRCH LOGIC INC.",
        "long_name": "PeakBirch Logic Inc.",
        "summary": "PeakBirch Logic Inc. engages in the e-commerce sales and delivery of cannabis-related and cannabidiol (CBD) containing products. The company distributes vaporizers, CBD related accessories, and ancillary products for aromatherapy and other applications, as well as CBD tinctures, topicals, edibles, and other products. It sells its products through Namastevapes.com, Everyonedoesit.com, LiftedCBD.com, Leafscience.com, and Lifted.com portals. PeakBirch Logic Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "L003.F": {
        "short_name": "GLOB.HEALTH CLINICS  O.N.",
        "long_name": "Global Health Clinics Ltd.",
        "summary": "Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of medical marijuana. It also operates as a marketing technology company that utilizes a digital platform, which generates leads through storefront kiosks that operates in marijuana dispensaries in British Columbia; and offers sorting, recording, and verification of patient information. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "L0MA.F": {
        "short_name": "NEXTLEAF SOLUTIONS",
        "long_name": "Nextleaf Solutions Ltd.",
        "summary": "Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. It also extracts, distills, purifies, delivers, and wholesales CBD oils and THC cannabinoid ingredients; researches and develops cannabis infused products, vapes, ingestible concentrates, and specialty extracts; and provides extraction services. The company was founded in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LABS.TO": {
        "short_name": "MEDIPHARM LABS CORP",
        "long_name": "MediPharm Labs Corp.",
        "summary": "MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Barrie"
    },
    "LD62.F": {
        "short_name": "CORE ONE LABS INC.",
        "long_name": "Core One Labs Inc.",
        "summary": "Core One Labs Inc. operates as a biotechnology research and technology life sciences company in the United States and Canada. It focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. The company manufactures CannaStrips, which are cannabis-infused strips, as well as produces oils, distillates, and resins. It also offers consulting services for cultivation, extraction, and manufacturing, as well as financing, nursery, and cultivation services; and holds real estate properties and equipment. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LFCOF": {
        "short_name": "LIFT & CO CORP",
        "long_name": "Lift & Co. Corp.",
        "summary": "Lift & Co. Corp. operates as a cannabis-focused technology and media company in Canada. The company monetizes a platform of advertising solutions, events, and data insights to cannabis businesses and consumers for making better-informed decisions. It operates a product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; offers a cannabis retail training program; and connects businesses and consumers through its digital platform and industry leading events. The company categorizes its platform of products in the categories of consumer marketing, trade marketing, data insights, and event marketing. Lift & Co. Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "LKYSF": {
        "short_name": "NUMINUS WELLNESS INC",
        "long_name": "Numinus Wellness Inc.",
        "summary": "Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LMLLF": {
        "short_name": "PHARMADRUG INC",
        "long_name": "Pharmadrug Inc.",
        "summary": "Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "LMNL": {
        "short_name": "Liminal BioSciences Inc.",
        "long_name": "Liminal BioSciences Inc.",
        "summary": "Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high unmet medical needs. It operates through two segments, Small Molecule Therapeutics and Plasma-Derived Therapeutics. The Small Molecule Therapeutics segment's lead product candidate is fezagepras (PBI-4050), which is in Phase 1 for the treatment of idiopathic pulmonary fibrosis and respiratory diseases. The Plasma-Derived Therapeutics segment focused on the development of its plasma-derived product candidate Ryplazim, a purified glu-plasminogen derived from human plasma that acts as a plasminogen replacement therapy for patients deficient in plasminogen protein. The company operates in Canada, the United Kingdom, and the United States. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Laval"
    },
    "LOBE.CN": {
        "short_name": "LobeSciences",
        "long_name": "Lobe Sciences Ltd.",
        "summary": "Lobe Sciences Ltd., a technology and services company, provides real estate, financial, management, intellectual property, and branding support for development of transformational medicine in the United States. The company intends to develop psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. It also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LOVE.V": {
        "short_name": "CANNARA BIOTECH INC",
        "long_name": "Cannara Biotech Inc.",
        "summary": "Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "LOVFF": {
        "short_name": "CANNARA BIOTECH INC",
        "long_name": "Cannara Biotech Inc.",
        "summary": "Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "LR23.F": {
        "short_name": "NUMINUS WELLNESS INC.",
        "long_name": "Numinus Wellness Inc.",
        "summary": "Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LR23.MU": {
        "short_name": "NUMINUS WELLNESS INC.",
        "long_name": "Numinus Wellness Inc.",
        "summary": "Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LTIA.F": {
        "short_name": "APTOSE BIOSCIENCES NEW",
        "long_name": "Aptose Biosciences Inc.",
        "summary": "Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806 and CG-806, which are in Phase 1a/b clinical trial for the treatment of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, and certain non-Hodgkin's lymphomas, as well as relapsed/refractory acute myeloid leukemia. The company also has an agreement with OHM Oncology for the development, manufacture, and commercialization of APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "LTTSF": {
        "short_name": "LOTUS VENTURES INC",
        "long_name": "Lotus Ventures Inc.",
        "summary": "Lotus Ventures Inc. cultivates and sells cannabis products for medical purpose. The company was incorporated in 2007 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LUFF.CN": {
        "short_name": "LuffEnterprises",
        "long_name": "Luff Enterprises Ltd.",
        "summary": "Luff Enterprises Ltd., a CBD lifestyle company, manufactures and distributes hemp-based cannabinoid wellness products in the United States. The company focuses on formulations leveraging cannabinoids, such as CBG and CBN; and boosts them with superfood ingredients to empower people to realize the potential of everyday life. Its products include tinctures, gummies, topicals, and gel caps. The company was formerly known as Ascent Industries Corp. and changed its name to Luff Enterprises Ltd. in May 2020. Luff Enterprises Ltd. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LV9.F": {
        "short_name": "LOTUS VENTURES INC.",
        "long_name": "Lotus Ventures Inc.",
        "summary": "Lotus Ventures Inc. cultivates and sells cannabis products for medical purpose. The company was incorporated in 2007 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LVCNF": {
        "short_name": "LEVIATHAN NATURAL PRODUCTS INC",
        "long_name": "Leviathan Natural Products Inc.",
        "summary": "Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of cannabis and hemp products in Canada, the United States, and Colombia. The company was formerly known as Leviathan Cannabis Group Inc. and changed its name to Leviathan Natural Products Inc. in July 2020. Leviathan Natural Products Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "LVRLF": {
        "short_name": "CORDOVACANN CORP",
        "long_name": "CordovaCann Corp.",
        "summary": "CordovaCann Corp., a cannabis-focused consumer products company, primarily provides services and investment capital to the processing, production, and retail vertical markets of the cannabis industry. As of March 8, 2021, it operated six stores under the Star Buds cannabis retail store in Alberta, Ontario, and Manitoba. The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "LWSCF": {
        "short_name": "SIENNA SENIOR LIVING INC",
        "long_name": "Sienna Senior Living Inc.",
        "summary": "Sienna Senior Living Inc., through its subsidiaries, provides senior living and long-term care (LTC) services in Canada. It operates through Retirement and LTC segments. The company offers a range of seniors' living options, including independent supportive and assisted living, memory care, long-term care, and specialized programs and services, as well as provides management services. As of December 31, 2020, it owned and operated a total of 70 seniors' living residences comprising 27 retirement residences, 35 LTC residences, and eight seniors' living residences. The company was formerly known as Leisureworld Senior Care Corporation and changed its name to Sienna Senior Living Inc. in May 2015. Sienna Senior Living Inc. was founded in 1972 and is headquartered in Markham, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Markham"
    },
    "LXGTF": {
        "short_name": "LEXINGTON BIOSCIENCES INC",
        "long_name": "Registered Plan Private Investments Inc.",
        "summary": "Lexington Biosciences, Inc. does not have significant operations. Previously, it was engaged in the development and commercialization of non-invasive diagnostic products for cardiovascular health. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "LYNX.CN": {
        "short_name": "LynxGlDigitFin",
        "long_name": "Lynx Global Digital Finance Corporation",
        "summary": "CannaOne Technologies Inc., a software development and technology company, develops and markets online e-commerce marketplace solution for the cannabis industry in Canada. It provides BloomKit, a software suite that delivers an online toolkit for various applications for companies in the cannabis sector; and BWell, which uses BloomKit to facilitate the sale of premium CBD products on its online marketplace. The company also operates Primo, a review driven marketplace that show a dispensary directory, brand pages, visual product attributes, and multi-varied cannabis centric reviews. CannaOne Technologies Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MB31.F": {
        "short_name": "EXPERION HOLDINGS LTD",
        "long_name": "Experion Holdings Ltd.",
        "summary": "Experion Holdings Ltd., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Viridium Pacific Group Ltd. and changed its name to Experion Holdings Ltd. in June 2019. Experion Holdings Ltd. is headquartered in Mission, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mission"
    },
    "MBCN.TO": {
        "short_name": "MINDBEACON HOLDINGS INC",
        "long_name": "MindBeacon Holdings Inc.",
        "summary": "MindBeacon Holdings Inc. designs and develops a platform for mental healthcare that includes self-guided psychoeducational, wellness content, therapist-assisted asynchronous therapies, and real-time synchronous therapies. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MBI-H.V": {
        "short_name": "MED BIOGENE INC",
        "long_name": "Med BioGene Inc.",
        "summary": "Med BioGene Inc. does not have significant operations. Previously, it was engaged in the life science business with a focus on the development and commercialization of genomic-based clinical tests for non-small-cell lung cancer. The company focuses on the commercialization of technologies in various industrial sectors. Med BioGene Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MBX.TO": {
        "short_name": "MICROBIX J",
        "long_name": "Microbix Biosystems Inc.",
        "summary": "Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry. Its infectious disease antigens also used in controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, or for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. The company also offers viral transport media that stabilize the organisms in patient samples. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "MBXBF": {
        "short_name": "MICROBIX BIOSYSTEMS",
        "long_name": "Microbix Biosystems Inc.",
        "summary": "Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry. Its infectious disease antigens also used in controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, or for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. The company also offers viral transport media that stabilize the organisms in patient samples. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "MCUJF": {
        "short_name": "MEDICURE INC",
        "long_name": "Medicure Inc.",
        "summary": "Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "MCUR.CN": {
        "short_name": "MindCureHealth",
        "long_name": "Mind Cure Health Inc.",
        "summary": "Mind Cure Health Inc. engages in the development, manufacture, and distribution of a branded line of organic and functional mushroom powders. It also operates Mind Cure Health Center, which offers psychedelic-assisted mental health therapy to patients, as well as training to therapists. The company sells its products through online and retail stores in North America. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MCURF": {
        "short_name": "MIND CURE HEALTH INC",
        "long_name": "Mind Cure Health Inc.",
        "summary": "Mind Cure Health Inc. engages in the development, manufacture, and distribution of a branded line of organic and functional mushroom powders. It also operates Mind Cure Health Center, which offers psychedelic-assisted mental health therapy to patients, as well as training to therapists. The company sells its products through online and retail stores in North America. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MDFZF": {
        "short_name": "MEDIFOCUS INC",
        "long_name": "Medifocus Inc.",
        "summary": "Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MDIN": {
        "short_name": "MEDGEN INC",
        "long_name": "MedGen, Inc.",
        "summary": "As of June 25, 2020, 9430075 Canada Ltd. was acquired by MedGen, Inc. in a reverse merger transaction. 9430075 Canada Ltd. operates an online health and wellness platform that helps consumers find the vital health information and referrals they need; and health and wellness professional to navigate to clients directly. The company was incorporated in 2015 and is based in Winnipeg, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "MDLH": {
        "short_name": "MEDICAL INTERNATIONAL TECHNOLOG",
        "long_name": "Medical International Technology, Inc.",
        "summary": "Medical International Technology, Inc. produces, markets, and sells needle-free jet injector products for use in humans and animals. It offers Med-Jet model needle-free injection systems for medical, cosmetic dermatology, and mesotherapy applications, as well as for single and mass vaccination in humans; Agro-Jet and Avian-Jet needle-free injection systems for small farm animal, pets clinic use, and livestock vaccination; Avian-Jet needle-free injectors for poultry vaccination; and MINI-JET for day old chick vaccination. The company sells its products to doctors, dentists, nurses, veterinarians, farmers, and home users in approximately 30 countries, including the United States. Medical International Technology, Inc. is based in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "MDNA": {
        "short_name": "Medicenna Therapeutics Corp.",
        "long_name": "Medicenna Therapeutics Corp.",
        "summary": "Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and non-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat cancer immunotherapies; MDNA209, an IL-2 antagonist for autoimmune diseases; MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis; and MDNA132, an IL-13 agonist to treat solid tumors and IL 13Ralpha2 chimeric antigen receptor T cell. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MDNA.TO": {
        "short_name": "MEDICENNA THERAPEUTICS CORP",
        "long_name": "Medicenna Therapeutics Corp.",
        "summary": "Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and non-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat cancer immunotherapies; MDNA209, an IL-2 antagonist for autoimmune diseases; MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis; and MDNA132, an IL-13 agonist to treat solid tumors and IL 13Ralpha2 chimeric antigen receptor T cell. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MDP.V": {
        "short_name": "MEDEXUS PHARMACEUTICALS INC",
        "long_name": "Medexus Pharmaceuticals Inc.",
        "summary": "Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Verdun"
    },
    "MDRM": {
        "short_name": "MODERN MOBILITY AIDS INC",
        "long_name": "Modern Mobility Aids, Inc.",
        "summary": "Modern Mobility Aids, Inc. does not have significant operations. The company focuses on the production and distribution of medical marijuana in North America. Previously, it was engaged in the distribution of products for mobility challenged individuals. The company was formerly known as Galileo Life Sciences, Inc. and changed its name to Modern Mobility Aids, Inc. in October 2017. Modern Mobility Aids, Inc. was founded in 2007 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MDVL": {
        "short_name": "MedAvail Holdings, Inc.",
        "long_name": "MedAvail Holdings, Inc",
        "summary": "MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "MDX.V": {
        "short_name": "MEDX HEALTH CORP",
        "long_name": "MedX Health Corp",
        "summary": "MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "MEDIF": {
        "short_name": "MEDIPHARM LABS CORP",
        "long_name": "MediPharm Labs Corp.",
        "summary": "MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Barrie"
    },
    "MEDXF": {
        "short_name": "MEDEXUS PHARMACEUTICALS INC",
        "long_name": "Medexus Pharmaceuticals Inc.",
        "summary": "Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Verdun"
    },
    "MFCSF": {
        "short_name": "MEDICAL FACILITIES CORPORATION",
        "long_name": "Medical Facilities Corporation",
        "summary": "Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and an ambulatory surgery center in the United States. The company's specialty surgical hospitals provide surgical, imaging, diagnostic, and other pain management procedures; and other ancillary services, such as urgent care and occupational health. It also offers ambulatory surgery center, which performs scheduled outpatient surgical procedures. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MGW.NE": {
        "short_name": "MAPLE LEAF GREEN WORLD INC.",
        "long_name": "Maple Leaf Green World Inc.",
        "summary": "Maple Leaf Green World Inc., together with its subsidiaries, focuses on the cannabis and industry in North America. The company was formerly known as Maple Leaf Reforestation Inc. and changed its name to Maple Leaf Green World Inc. in October 2012. Maple Leaf Green World Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "MGWFF": {
        "short_name": "MAPLE LEAF GREEN WORLD INC",
        "long_name": "Maple Leaf Green World Inc.",
        "summary": "Maple Leaf Green World Inc., together with its subsidiaries, focuses on the cannabis and industry in North America. The company was formerly known as Maple Leaf Reforestation Inc. and changed its name to Maple Leaf Green World Inc. in October 2012. Maple Leaf Green World Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "MHIVF": {
        "short_name": "INVESQUE INC",
        "long_name": "Invesque Inc.",
        "summary": "Invesque Inc. operates as a real estate investment company in Canada and the United States. Its portfolio of investments include independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2021, it owned a portfolio of 107 properties, including 72 assisted living and memory care facilities, 17 skilled nursing facilities, 13 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MHN2.F": {
        "short_name": "RELIQ HEALTH TECHS",
        "long_name": "Reliq Health Technologies Inc.",
        "summary": "Reliq Health Technologies Inc., a healthcare technology company, engages in the development of mobile software solutions for community care market. It offers iUGO Health technology platform, a hardware and software solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Hamilton"
    },
    "MHTCF": {
        "short_name": "MAITRI HEALTH TECHNOLOGIES CORP",
        "long_name": "Maitri Health Technologies Corp.",
        "summary": "Maitri Health Technologies Corp. operates as a healthcare supply platform in Canada and internationally. The company offers personal protective equipment, and testing and technology solutions. Its products include face masks, face shields, anti-viral cleaning solutions, sanitizers, disinfectants, and PCR test kits. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MIR.V": {
        "short_name": "MEDMIRA INC",
        "long_name": "MedMira Inc.",
        "summary": "MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America, the Caribbean, Europe, and the Asia Pacific. The company's research is focused on specific areas of the diagnostics market, such as rapid, point-of-care, and in vitro sectors. It offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. The company also provides Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis; and REVEALCOVID-19, an antibody test. In addition, it offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "MIST": {
        "short_name": "Milestone Pharmaceuticals Inc.",
        "long_name": "Milestone Pharmaceuticals Inc.",
        "summary": "Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as in the Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate, and other cardiovascular indications. The company was incorporated in 2003 and is headquartered in Montr\u00c3\u00a9al, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "MJ.CN": {
        "short_name": "TrueLeaf",
        "long_name": "True Leaf Brands Inc.",
        "summary": "True Leaf Brands Inc. manufactures and distributes hemp-based nutrition for pets. It sells dog chews, dental sticks, and supplement oils under the True Hemp brand name in North America and Europe, as well as through online on Amazon. The company was formerly known as True Leaf Medicine International Ltd. and changed its name to True Leaf Brands Inc. in May 2019. True Leaf Brands Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vernon"
    },
    "MJAR.CN": {
        "short_name": "MJardinGroupInc",
        "long_name": "MJardin Group, Inc.",
        "summary": "MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility ramp-up, and access to intellectual property held by the company to licensed cannabis operators with cultivation and retail businesses. It owns, manages, or advises on a portfolio of 32 cannabis operations. The company was founded in 2014 and is headquartered in Ontario, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MJARF": {
        "short_name": "MJARDIN GROUP INC",
        "long_name": "MJardin Group, Inc.",
        "summary": "MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility ramp-up, and access to intellectual property held by the company to licensed cannabis operators with cultivation and retail businesses. It owns, manages, or advises on a portfolio of 32 cannabis operations. The company was founded in 2014 and is headquartered in Ontario, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MJRX.CN": {
        "short_name": "GlobalHealth",
        "long_name": "Global Health Clinics Ltd.",
        "summary": "Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of medical marijuana. It also operates as a marketing technology company that utilizes a digital platform, which generates leads through storefront kiosks that operates in marijuana dispensaries in British Columbia; and offers sorting, recording, and verification of patient information. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MLCL.CN": {
        "short_name": "MoleculeHldngs",
        "long_name": "Molecule Holdings Inc.",
        "summary": "Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages. The company is based in Lansdowne, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Lansdowne"
    },
    "MLZ.F": {
        "short_name": "MEDIPHARM LABS CORP.",
        "long_name": "MediPharm Labs Corp.",
        "summary": "MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Barrie"
    },
    "MMIRF": {
        "short_name": "MEDMIRA INC",
        "long_name": "MedMira Inc.",
        "summary": "MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America, the Caribbean, Europe, and the Asia Pacific. The company's research is focused on specific areas of the diagnostics market, such as rapid, point-of-care, and in vitro sectors. It offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. The company also provides Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis; and REVEALCOVID-19, an antibody test. In addition, it offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "MMJ.CN": {
        "short_name": "MaticaEnterpr",
        "long_name": "Matica Enterprises Inc.",
        "summary": "Matica Enterprises Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odours. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MMJFF": {
        "short_name": "MATICA ENTERPRISES INC",
        "long_name": "Matica Enterprises Inc.",
        "summary": "Matica Enterprises Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odours. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MNOW.V": {
        "short_name": "MEDNOW INC",
        "long_name": "Mednow Inc.",
        "summary": "Mednow Inc. develops a proprietary website and a web application for the sale and distribution of prescription medications. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MO2.F": {
        "short_name": "MEDCOLCANNA ORGANICS",
        "long_name": "Medcolcanna Organics Inc.",
        "summary": "Medcolcanna Organics Inc. operates as a medical cannabis company in Colombia and Switzerland. The company cultivates, produces, and distributes medicinal cannabis and cannabis derived products, including pharmaceutical, cosmetic, and bulk API products. Medcolcanna Organics Inc. is based in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "MOJO.CN": {
        "short_name": "MojaveBrands",
        "long_name": "Mojave Brands Inc.",
        "summary": "Mojave Brands Inc. does not have significant operations. Previously, it was engaged in the manufacturing, processing, and sale of cannabis extracts. The company was formerly known as Mojave Jane Brands Inc. and changed its name to Mojave Brands Inc. in March 2020. Mojave Brands Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MOTNF": {
        "short_name": "CLEAN POWER CAPITAL CORP",
        "long_name": "Clean Power Capital Corp.",
        "summary": "Clean Power Capital Corp. is a venture capital firm specializing in investments in early stage, buyouts. It prefers to invest in equity, bridge loans, secured loans, unsecured loans, convertible debentures, warrants and options, joint ventures, partnerships, royalties, streaming investments, net profit interests and other hybrid instruments. It focuses its investments in energy sector, oil and gas equipment and commercial aircraft sector. The firm prefers to invest in securities of private and publicly listed entities that are involved in a variety of industries including renewable energy includes hydrogen & fuel cell technologies, wind power, solar power and geothermal power. The firm invests bio-medical, pharmaceutical, and naturopathic sectors, which may include medical or recreational cannabis. The firm prefers to focus on investing in cannabis enterprises. The firm considers investments in North America. The firm does not invest in Canada and United States. The firm takes control position and majority stake in the companies. Clean Power Capital Corp. was founded in 1980 and is headquartered in Vancouver, Canada with additional offices in Hamilton, Bermuda and London, United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MOVE.NE": {
        "short_name": "CLEAN POWER CAPITAL CORP.",
        "long_name": "Clean Power Capital Corp.",
        "summary": "Clean Power Capital Corp. is a venture capital firm specializing in investments in early stage, buyouts. It prefers to invest in equity, bridge loans, secured loans, unsecured loans, convertible debentures, warrants and options, joint ventures, partnerships, royalties, streaming investments, net profit interests and other hybrid instruments. It focuses its investments in energy sector, oil and gas equipment and commercial aircraft sector. The firm prefers to invest in securities of private and publicly listed entities that are involved in a variety of industries including renewable energy includes hydrogen & fuel cell technologies, wind power, solar power and geothermal power. The firm invests bio-medical, pharmaceutical, and naturopathic sectors, which may include medical or recreational cannabis. The firm prefers to focus on investing in cannabis enterprises. The firm considers investments in North America. The firm does not invest in Canada and United States. The firm takes control position and majority stake in the companies. Clean Power Capital Corp. was founded in 1980 and is headquartered in Vancouver, Canada with additional offices in Hamilton, Bermuda and London, United Kingdom.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MPH.V": {
        "short_name": "MEDICURE INC",
        "long_name": "Medicure Inc.",
        "summary": "Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "MPXI.CN": {
        "short_name": "MPXIntlCorp",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MPXOF": {
        "short_name": "MPX INTERNATIONAL CORPORATION",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MRRCF": {
        "short_name": "WAYLAND GROUP CORP",
        "long_name": "Wayland Group Corp.",
        "summary": "Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "MRV.TO": {
        "short_name": "NUVO PHARMACEUTICALS INC",
        "long_name": "Nuvo Pharmaceuticals Inc.",
        "summary": "Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "MRVFF": {
        "short_name": "NUVO PHARMACEUTICALS INC",
        "long_name": "Nuvo Pharmaceuticals Inc.",
        "summary": "Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "MSET.CN": {
        "short_name": "MindsetPharma",
        "long_name": "Mindset Pharma Inc.",
        "summary": "Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MSSTF": {
        "short_name": "MINDSET PHARMA INC",
        "long_name": "Mindset Pharma Inc.",
        "summary": "Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "MTEC.CN": {
        "short_name": "MaitriHealthTec",
        "long_name": "Maitri Health Technologies Corp.",
        "summary": "Maitri Health Technologies Corp. operates as a healthcare supply platform in Canada and internationally. The company offers personal protective equipment, and testing and technology solutions. Its products include face masks, face shields, anti-viral cleaning solutions, sanitizers, disinfectants, and PCR test kits. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MVMD.CN": {
        "short_name": "MountainValley",
        "long_name": "Mountain Valley MD Holdings Inc.",
        "summary": "Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation of its Quicksome oral drug formulation and delivery technologies with the intention of licensing to pharmaceutical, vaccine, and nutraceutical third parties. Its Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that are consumed orally. The company applies its Quicksome technology to its work for the oral delivery of vaccines and pharmaceutical drugs, as well as the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and others. Mountain Valley MD Holdings Inc. is headquartered in Vaughan, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vaughan"
    },
    "MVMDF": {
        "short_name": "MOUNTAIN VALLEY MD HOLDINGS INC",
        "long_name": "Mountain Valley MD Holdings Inc.",
        "summary": "Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation of its Quicksome oral drug formulation and delivery technologies with the intention of licensing to pharmaceutical, vaccine, and nutraceutical third parties. Its Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that are consumed orally. The company applies its Quicksome technology to its work for the oral delivery of vaccines and pharmaceutical drugs, as well as the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and others. Mountain Valley MD Holdings Inc. is headquartered in Vaughan, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vaughan"
    },
    "MWG.F": {
        "short_name": "INMED PHARMACEUT.",
        "long_name": "InMed Pharmaceuticals Inc.",
        "summary": "InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MYCO.NE": {
        "short_name": "MYDECINE INNOVATIONS GROUP INC.",
        "long_name": "Mydecine Innovations Group Inc.",
        "summary": "Mydecine Innovations Group Inc. operates as a biopharma and life sciences company which focuses on research, development, acceptance, and commercialization of alternative nature-sourced medicine for treating mental health problems. Its mental health solutions focuses on clinical trials focusing on veterans; emergency medical services (EMS); first responders with a PTSD indication; and drug discovery and delivery mechanisms. The company develops digital health solutions, such as digital therapeutics and quantified mental health solutions. Additionally, it engages in the operation of real estate and farm properties in North America. Mydecine has partnership with Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MYCOF": {
        "short_name": "MYDECINE INNOVATIONS GROUP INC",
        "long_name": "Mydecine Innovations Group Inc.",
        "summary": "Mydecine Innovations Group Inc. operates as a biopharma and life sciences company which focuses on research, development, acceptance, and commercialization of alternative nature-sourced medicine for treating mental health problems. Its mental health solutions focuses on clinical trials focusing on veterans; emergency medical services (EMS); first responders with a PTSD indication; and drug discovery and delivery mechanisms. The company develops digital health solutions, such as digital therapeutics and quantified mental health solutions. Additionally, it engages in the operation of real estate and farm properties in North America. Mydecine has partnership with Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MYM.CN": {
        "short_name": "MYM Nutraceutic",
        "long_name": "MYM Nutraceuticals Inc.",
        "summary": "MYM Nutraceuticals Inc. cultivates, processes, and sells cannabis in Canada. The company was formerly known as My Marijuana Canada Inc. and changed its name to MYM Nutraceuticals Inc. in February 2016. MYM Nutraceuticals Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MYMMF": {
        "short_name": "MYM NUTRACEUTICALS INC",
        "long_name": "MYM Nutraceuticals Inc.",
        "summary": "MYM Nutraceuticals Inc. cultivates, processes, and sells cannabis in Canada. The company was formerly known as My Marijuana Canada Inc. and changed its name to MYM Nutraceuticals Inc. in February 2016. MYM Nutraceuticals Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "MYND.CN": {
        "short_name": "MYNDLifeScien",
        "long_name": "MYND Lifesciencs Inc.",
        "summary": "MYND Life Science Inc. operates as a life sciences-based neuro-pharmaceutical drug development company, advancing medicines that leverage psychedelic compounds. It conducts research at the Michael Smith Laboratories at the University of British Columbia under a part J exemption granted by Health Canada to conduct research and development on restricted and controlled substances. The company has 38 licenses that allow for research into 38 different analogues of Psilocybin thereby determining which one is effective in modulating the Human Mycogene and subsequent decrease in inflammatory and immune responses leading to a reduction in depressive symptoms. MYND Life Science Inc. was incorporated in 2020 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "NAB.CN": {
        "short_name": "NabisHldgs",
        "long_name": "Nabis Holdings Inc.",
        "summary": "Nabis Holdings Inc., formerly known as Innovative Properties Inc., is a principal investment firm specializing in cannabis sector investments. It seeks to invest in the United States. It prefers to take majority stake in its portfolio companies and also prefers sellers to take a significant portion of the consideration in the form of equity. Nabis Holdings Inc. was founded in 2002 and is based in Vancouver, Canada, with additional office in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NCNNF": {
        "short_name": "48NORTH CANNABIS CORP",
        "long_name": "48North Cannabis Corp.",
        "summary": "48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NDVA.V": {
        "short_name": "INDIVA LIMITED",
        "long_name": "Indiva Limited",
        "summary": "Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "NDVAF": {
        "short_name": "INDIVA LIMITED",
        "long_name": "Indiva Limited",
        "summary": "Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "NEON.CN": {
        "short_name": "NeonmindBio",
        "long_name": "NeonMind Biosciences Inc.",
        "summary": "NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin based products comprising mushroom-infused beverages and other mushroom-infused products to treat weight loss and management, depression, cardiovascular, obesity, diabetes, and heart diseases. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NEPT": {
        "short_name": "Neptune Wellness Solutions Inc.",
        "long_name": "Neptune Wellness Solutions Inc.",
        "summary": "Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Forest Remedies and, Ocean Remedies, Neptune Wellness, Mood Ring, and OCEANO3 brands. The company offers turnkey product development and supply chain solutions to businesses and government customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It also provides extraction and purification services from cannabis and hemp biomass; raw material sourcing, formulation, quality control, and quality assurance primarily for omega-3 and hemp-derived ingredients under various delivery forms, such as soft gels, capsules, and liquids; and formulation and manufacturing solutions for value added product forms comprising tinctures, sprays, topicals, vapor products, and edibles and beverages. The company has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Laval"
    },
    "NEPT.TO": {
        "short_name": "NEPTUNE WELLNESS SOLUTIONS INC",
        "long_name": "Neptune Wellness Solutions Inc.",
        "summary": "Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Forest Remedies and, Ocean Remedies, Neptune Wellness, Mood Ring, and OCEANO3 brands. The company offers turnkey product development and supply chain solutions to businesses and government customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It also provides extraction and purification services from cannabis and hemp biomass; raw material sourcing, formulation, quality control, and quality assurance primarily for omega-3 and hemp-derived ingredients under various delivery forms, such as soft gels, capsules, and liquids; and formulation and manufacturing solutions for value added product forms comprising tinctures, sprays, topicals, vapor products, and edibles and beverages. The company has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Laval"
    },
    "NEWU.V": {
        "short_name": "NEWTOPIA INC",
        "long_name": "Newtopia Inc.",
        "summary": "Newtopia Inc., a health technology company, operates a habit change platform. It offers a personalized habit change platform that focuses on metabolic risk reduction by developing and implementing personalized experiences based on social, behavioral, and genetic information. The company was incorporated in 2008 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NEWUF": {
        "short_name": "NEWTOPIA INC",
        "long_name": "Newtopia Inc.",
        "summary": "Newtopia Inc., a health technology company, operates a habit change platform. It offers a personalized habit change platform that focuses on metabolic risk reduction by developing and implementing personalized experiences based on social, behavioral, and genetic information. The company was incorporated in 2008 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NGEN.V": {
        "short_name": "NERVGEN PHARMA CORP",
        "long_name": "NervGen Pharma Corp.",
        "summary": "NervGen Pharma Corp., a biotech company, discovers and develops treatments for patients suffering from medical conditions related to nerve damage. Its lead product candidate is the NVG-291 that is in clinical studies for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. The company has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NGENF": {
        "short_name": "NERVGEN PHARMA CORP",
        "long_name": "NervGen Pharma Corp.",
        "summary": "NervGen Pharma Corp., a biotech company, discovers and develops treatments for patients suffering from medical conditions related to nerve damage. Its lead product candidate is the NVG-291 that is in clinical studies for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. The company has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NGQ1.F": {
        "short_name": "MEDICURE INC.",
        "long_name": "Medicure Inc.",
        "summary": "Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "NGW.CN": {
        "short_name": "NextGreenWave",
        "long_name": "Next Green Wave Holdings Inc.",
        "summary": "Next Green Wave Holdings Inc. cultivates and distributes medicinal and recreational cannabis in California. It is also involved in the processing, production, and packaging of dry flower, cannabis oils, and concentrates. The company offers its products under the Loki the Dog, Carey Hart, King Louie, Sketchy Tank, Junkyard, SD Cannabis, Thorn St. Brewing, Toy Machine Co, and Junkyard brands. The company was formerly known as Crossgate Capital Corporation and changed its name to Next Green Wave Holdings Inc. in August 2018. Next Green Wave Holdings Inc. was incorporated in 2011 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NHP.V": {
        "short_name": "LUMIERA HEALTH INC",
        "long_name": "Lumiera Health Inc.",
        "summary": "Lumiera Health Inc. develops and commercializes evidence-based botanical products for the healthcare, bio-agriculture, and organic markets in Canada. It is developing botanical based specialty fertilizers for enhancing plant growth and crop yield; botanical agents to prevent and treat fungal infections of plants; oral and topical botanical agents to manage unmet medical needs, such as fungal infections of nails and skin, women's health, dermatology, and sleep; natural bio stimulants, bio fertilizers, and bio pesticides; specialty fertilizers for use in household plants, lawns and golf courses, urban gardens, nurseries, commercial greenhouses, and indoor cannabis growers; and products for acne and wound healing. The company was formerly known as Mondias Natural Products Inc. and changed its name to Lumiera Health Inc. in November 2020. Lumiera Health Inc. is based in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Saint-Hubert"
    },
    "NHPHF": {
        "short_name": "LUMIERA HEALTH INC",
        "long_name": "Lumiera Health Inc.",
        "summary": "Lumiera Health Inc. develops and commercializes evidence-based botanical products for the healthcare, bio-agriculture, and organic markets in Canada. It is developing botanical based specialty fertilizers for enhancing plant growth and crop yield; botanical agents to prevent and treat fungal infections of plants; oral and topical botanical agents to manage unmet medical needs, such as fungal infections of nails and skin, women's health, dermatology, and sleep; natural bio stimulants, bio fertilizers, and bio pesticides; specialty fertilizers for use in household plants, lawns and golf courses, urban gardens, nurseries, commercial greenhouses, and indoor cannabis growers; and products for acne and wound healing. The company was formerly known as Mondias Natural Products Inc. and changed its name to Lumiera Health Inc. in November 2020. Lumiera Health Inc. is based in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Saint-Hubert"
    },
    "NLH.V": {
        "short_name": "NOVA LEAP HEALTH CORP",
        "long_name": "Nova Leap Health Corp.",
        "summary": "Nova Leap Health Corp. provides home and home health care services. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, daily living, light housekeeping, transportation, medication reminders, and medication administration by nursing staff. The company serves clients and families in the states of Arkansas, Vermont, New Hampshire, Massachusetts, Rhode Island, Oklahoma, and Ohio in the United States; and Nova Scotia, Canada. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "NLV.CN": {
        "short_name": "NewLeafVentInc",
        "long_name": "New Leaf Ventures Inc",
        "summary": "New Leaf Ventures Inc. focuses on the extraction, production, and processing of cannabis and related products. The company provides dried flower, oil concentrate, vapor, capsules, and wax under the D\u00c3\u0080M\u00c3\u0080 brand; and outdoor flower and non-connoisseur products under the WEED brand. It also licenses its brands, equipment, and facility to a Washington-based Tier 3 producer/processor focused on cultivating, processing, packaging, and distributing cannabis and cannabis related products. The company was incorporated in 2018 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NLVVF": {
        "short_name": "NEW LEAF VENTURES INC",
        "long_name": "New Leaf Ventures Inc",
        "summary": "New Leaf Ventures Inc. focuses on the extraction, production, and processing of cannabis and related products. The company provides dried flower, oil concentrate, vapor, capsules, and wax under the D\u00c3\u0080M\u00c3\u0080 brand; and outdoor flower and non-connoisseur products under the WEED brand. It also licenses its brands, equipment, and facility to a Washington-based Tier 3 producer/processor focused on cultivating, processing, packaging, and distributing cannabis and cannabis related products. The company was incorporated in 2018 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NM.CN": {
        "short_name": "Novamind Inc.",
        "long_name": "Novamind Inc.",
        "summary": "Hinterland Metals Inc. builds a network of clinics, retreats, and research sites to serve the regulated psychedelics industry in the United States. It operates in two segments, Cedar Psychiatry and Cedar Research. The company offers outpatient mental health services; and manages and hosts third party clinical trials and participates in institutional review board studies. It also provides ketamine-assisted psychotherapy and other therapies; retreat network services; and clinical research for psychedelic medicines. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NMDBF": {
        "short_name": "NEONMIND BIOSCIENCES INC",
        "long_name": "NeonMind Biosciences Inc.",
        "summary": "NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin based products comprising mushroom-infused beverages and other mushroom-infused products to treat weight loss and management, depression, cardiovascular, obesity, diabetes, and heart diseases. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NMLSF": {
        "short_name": "NOVA MENTIS LIFE SCIENCE CORP",
        "long_name": "Nova Mentis Life Science Corp.",
        "summary": "Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NMVA.F": {
        "short_name": "CAPTOR CAPITAL CORP.",
        "long_name": "Captor Capital Corp.",
        "summary": "Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NOBDF": {
        "short_name": "NORTH BUD FARMS INC",
        "long_name": "North Bud Farms Inc.",
        "summary": "North Bud Farms Inc., through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada. The company was incorporated in 2016 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NOVA.CN": {
        "short_name": "NovaMentisLife",
        "long_name": "Nova Mentis Life Science Corp.",
        "summary": "Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NOVC.V": {
        "short_name": "NOVA CANNABIS INC",
        "long_name": "Nova Cannabis Inc.",
        "summary": "Alcanna Cannabis Stores GP Inc. and Alcanna Cannabis Stores Limited Partnership represents the combined operations of Alcanna Cannabis Stores GP Inc. and Alcanna Cannabis Stores Limited Partnership. Alcanna Cannabis Stores Limited Partnership engages in retail of cannabis. Alcanna Cannabis Stores GP Inc. and Alcanna Cannabis Stores Limited Partnership is based in Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": null
    },
    "NPAU.F": {
        "short_name": "BETTERLIFE PHARMA INC.",
        "long_name": "BetterLife Pharma Inc.",
        "summary": "BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumours to treat various types of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was founded in 2002 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NPCUF": {
        "short_name": "ALLON THERAPEUTICS INC",
        "long_name": "Allon Therapeutics Inc.",
        "summary": "Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004. Allon Therapeutics Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NPTH.V": {
        "short_name": "NEUPATH HEALTH INC",
        "long_name": "NeuPath Health Inc.",
        "summary": "NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage chronic pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers. The company operates 12 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario. NeuPath Health Inc. is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "NRTH.V": {
        "short_name": "48NORTH CANNABIS CORP",
        "long_name": "48North Cannabis Corp.",
        "summary": "48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NRXCF": {
        "short_name": "NEUTRISCI INTL INC",
        "long_name": "NeutriSci International Inc.",
        "summary": "NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "NSHS.CN": {
        "short_name": "NanoSphereHlth",
        "long_name": "NanoSphere Health Sciences Inc.",
        "summary": "Nanosphere Health Sciences Inc., a nano-biotechnology company, focuses on providing next generation delivery of biologically active compounds in the United States. Its nanoencapsulation technology delivers nutritive elements and medicants through licensing arrangements. The company was incorporated in 2005 is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NSHSF": {
        "short_name": "NANOSPHERE HEALTH SCIENCES INC",
        "long_name": "NanoSphere Health Sciences Inc.",
        "summary": "Nanosphere Health Sciences Inc., a nano-biotechnology company, focuses on providing next generation delivery of biologically active compounds in the United States. Its nanoencapsulation technology delivers nutritive elements and medicants through licensing arrangements. The company was incorporated in 2005 is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NSP.V": {
        "short_name": "NATURALLY SPLENDID ENTERPRISES ",
        "long_name": "Naturally Splendid Enterprises Ltd.",
        "summary": "Naturally Splendid Enterprises Ltd., a biotechnology and consumer products company, develops, produces, commercializes, sells, and licenses plant-derived, bio-active ingredients, nutrient dense foods, and related products in Canada, Japan, South Korea, Thailand, and Western Europe. The company offers nutrition for athletes under the Natera Sport brand; food energy bars under the WOODS WILD BAR; healthy snack bars under the ELEVATE ME brand; hemp for health under the CHII brand; products for dogs under the PawsitiveFX brand; and hemp and plant-based natural health products under the Natera FX brand. It also provides hemp processing, manufacturing, private label, and CBD extraction services; and distributes lifestyle and healthy meal replacement products. The company sells food and ingredients to commercial processors and consumers through grocery stores, health and nutrition stores, and online. Naturally Splendid Enterprises Ltd. was incorporated in 2010 and is headquartered in Pitt Meadows, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Pitt Meadows"
    },
    "NSPDF": {
        "short_name": "NATURALLY SPLENDID ENTERPRISES ",
        "long_name": "Naturally Splendid Enterprises Ltd.",
        "summary": "Naturally Splendid Enterprises Ltd., a biotechnology and consumer products company, develops, produces, commercializes, sells, and licenses plant-derived, bio-active ingredients, nutrient dense foods, and related products in Canada, Japan, South Korea, Thailand, and Western Europe. The company offers nutrition for athletes under the Natera Sport brand; food energy bars under the WOODS WILD BAR; healthy snack bars under the ELEVATE ME brand; hemp for health under the CHII brand; products for dogs under the PawsitiveFX brand; and hemp and plant-based natural health products under the Natera FX brand. It also provides hemp processing, manufacturing, private label, and CBD extraction services; and distributes lifestyle and healthy meal replacement products. The company sells food and ingredients to commercial processors and consumers through grocery stores, health and nutrition stores, and online. Naturally Splendid Enterprises Ltd. was incorporated in 2010 and is headquartered in Pitt Meadows, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Pitt Meadows"
    },
    "NSVGF": {
        "short_name": "NASS VALLEY GATEWAY LTD.",
        "long_name": "Nass Valley Gateway Ltd.",
        "summary": "Nass Valley Gateway Ltd. operates as a healthcare company in the United States and internationally. It develops and sells hemp based cannabidiol (CBD) products without tetrahydrocannabinol content for internal use, including CBD infused skin, bath, and body care products. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NTU.F": {
        "short_name": "NEPTUNE WELLNESS SOL.",
        "long_name": "Neptune Wellness Solutions Inc.",
        "summary": "Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Forest Remedies and, Ocean Remedies, Neptune Wellness, Mood Ring, and OCEANO3 brands. The company offers turnkey product development and supply chain solutions to businesses and government customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It also provides extraction and purification services from cannabis and hemp biomass; raw material sourcing, formulation, quality control, and quality assurance primarily for omega-3 and hemp-derived ingredients under various delivery forms, such as soft gels, capsules, and liquids; and formulation and manufacturing solutions for value added product forms comprising tinctures, sprays, topicals, vapor products, and edibles and beverages. The company has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Laval"
    },
    "NU.V": {
        "short_name": "NEUTRISCI INTERNATIONAL INC",
        "long_name": "NeutriSci International Inc.",
        "summary": "NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "NUMI.V": {
        "short_name": "NUMINUS WELLNESS INC",
        "long_name": "Numinus Wellness Inc.",
        "summary": "Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NVCN": {
        "short_name": "Neovasc Inc.",
        "long_name": "Neovasc Inc.",
        "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "NVCN.TO": {
        "short_name": "NEOVASC INC",
        "long_name": "Neovasc Inc.",
        "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "NVG.CN": {
        "short_name": "NassValley",
        "long_name": "Nass Valley Gateway Ltd.",
        "summary": "Nass Valley Gateway Ltd. operates as a healthcare company in the United States and internationally. It develops and sells hemp based cannabidiol (CBD) products without tetrahydrocannabinol content for internal use, including CBD infused skin, bath, and body care products. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "NVLPF": {
        "short_name": "NOVA LEAP HEALTH CORP",
        "long_name": "Nova Leap Health Corp.",
        "summary": "Nova Leap Health Corp. provides home and home health care services. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, daily living, light housekeeping, transportation, medication reminders, and medication administration by nursing staff. The company serves clients and families in the states of Arkansas, Vermont, New Hampshire, Massachusetts, Rhode Island, Oklahoma, and Ohio in the United States; and Nova Scotia, Canada. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "NVMDF": {
        "short_name": "NOVAMIND INC",
        "long_name": "Novamind Inc.",
        "summary": "Hinterland Metals Inc. builds a network of clinics, retreats, and research sites to serve the regulated psychedelics industry in the United States. It operates in two segments, Cedar Psychiatry and Cedar Research. The company offers outpatient mental health services; and manages and hosts third party clinical trials and participates in institutional review board studies. It also provides ketamine-assisted psychotherapy and other therapies; retreat network services; and clinical research for psychedelic medicines. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NXG.V": {
        "short_name": "NEXGENRX INC.",
        "long_name": "NexgenRx Inc.",
        "summary": "NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was founded in 2003 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Healthcare Plans",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "NXGWF": {
        "short_name": "NEXT GREEN WAVE HOLDINGS INC",
        "long_name": "Next Green Wave Holdings Inc.",
        "summary": "Next Green Wave Holdings Inc. cultivates and distributes medicinal and recreational cannabis in California. It is also involved in the processing, production, and packaging of dry flower, cannabis oils, and concentrates. The company offers its products under the Loki the Dog, Carey Hart, King Louie, Sketchy Tank, Junkyard, SD Cannabis, Thorn St. Brewing, Toy Machine Co, and Junkyard brands. The company was formerly known as Crossgate Capital Corporation and changed its name to Next Green Wave Holdings Inc. in August 2018. Next Green Wave Holdings Inc. was incorporated in 2011 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "O1GA.F": {
        "short_name": "THE GREEN ORG.DUTCH.HLDGS",
        "long_name": "The Green Organic Dutchman Holdings Ltd.",
        "summary": "The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "OGI": {
        "short_name": "Organigram Holdings Inc.",
        "long_name": "OrganiGram Holdings Inc.",
        "summary": "Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Moncton"
    },
    "OGI.TO": {
        "short_name": "ORGANIGRAM HOLDINGS INC",
        "long_name": "OrganiGram Holdings Inc.",
        "summary": "Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Moncton"
    },
    "OILFF": {
        "short_name": "NEXTLEAF SOLUTIONS LTD",
        "long_name": "Nextleaf Solutions Ltd.",
        "summary": "Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. It also extracts, distills, purifies, delivers, and wholesales CBD oils and THC cannabinoid ingredients; researches and develops cannabis infused products, vapes, ingestible concentrates, and specialty extracts; and provides extraction services. The company was founded in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "OILS.CN": {
        "short_name": "NextleafSolns",
        "long_name": "Nextleaf Solutions Ltd.",
        "summary": "Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. It also extracts, distills, purifies, delivers, and wholesales CBD oils and THC cannabinoid ingredients; researches and develops cannabis infused products, vapes, ingestible concentrates, and specialty extracts; and provides extraction services. The company was founded in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ONC.TO": {
        "short_name": "ONCOLYTICS BIOTECH INC",
        "long_name": "Oncolytics Biotech Inc.",
        "summary": "Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "ONCY": {
        "short_name": "Oncolytics Biotech Inc.",
        "long_name": "Oncolytics Biotech Inc.",
        "summary": "Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "ONYN.F": {
        "short_name": "ONCOLYTICS BIOTECH",
        "long_name": "Oncolytics Biotech Inc.",
        "summary": "Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "OPS.TO": {
        "short_name": "OPSENS INC",
        "long_name": "Opsens Inc.",
        "summary": "Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a direct sales force to distributors in the United States, Japan, Canada, and internationally. The company is headquartered in Qu\u00c3\u00a9bec, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Qu\u00c3\u00a9bec"
    },
    "OPSSF": {
        "short_name": "OPSENS INC",
        "long_name": "Opsens Inc.",
        "summary": "Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a direct sales force to distributors in the United States, Japan, Canada, and internationally. The company is headquartered in Qu\u00c3\u00a9bec, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Qu\u00c3\u00a9bec"
    },
    "ORO.F": {
        "short_name": "CHOOM HOLDINGS INC.",
        "long_name": "Choom Holdings Inc.",
        "summary": "Choom Holdings Inc., through its subsidiaries, engages in the retail of cannabis. As of June 30, 2020, the company operates two medical and two coaching clinics under the name Concord Medical Centre; and 13 retail stores. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ORTH.CN": {
        "short_name": "OrthoRegenTech",
        "long_name": "Ortho Regenerative Technologies Inc.",
        "summary": "Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair. It also develops Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kirkland"
    },
    "ORTIF": {
        "short_name": "ORTHO REGENERATIVE TECHNOLOGIES",
        "long_name": "Ortho Regenerative Technologies Inc.",
        "summary": "Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair. It also develops Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kirkland"
    },
    "OUGA.F": {
        "short_name": "CARDIOCOMM SOLUTIONS NEW",
        "long_name": "CardioComm Solutions, Inc.",
        "summary": "CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals, and call centers to access and manage patient information. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "OVAT.CN": {
        "short_name": "OvationScience",
        "long_name": "Ovation Science Inc.",
        "summary": "Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "OVATF": {
        "short_name": "OVATION SCIENCE INC",
        "long_name": "Ovation Science Inc.",
        "summary": "Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "OXIHF": {
        "short_name": "OXFORD INVESTMENTS HOLDINGS INC",
        "long_name": "Oxford Investments Holdings Inc.",
        "summary": "Oxford Investments Holdings Inc., together with its subsidiaries, engages in the business of direct-banking and payment-card solutions. The company offers \u00c2\u0091FocusKard' suite of products that consists of an online-access account represented by a stored-value card, which is a substitute for cash, gift certificates, and check payments. Its stored-value card's applications include payroll, gift-card, travel, insurance, membership, student, and incentive/promotional products. The company was formerly known as Oxford Software Developers Inc. and changed its name to Oxford Investments Holdings Inc. in December 2003. Oxford Investments Holdings Inc. was founded in 2000 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "P6P2.F": {
        "short_name": "REPLICEL LIFE SCIENCES",
        "long_name": "RepliCel Life Sciences Inc.",
        "summary": "RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that has completed Phase I clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase II clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "P731.F": {
        "short_name": "MEDEXUS PHARMACEUTIC.",
        "long_name": "Medexus Pharmaceuticals Inc.",
        "summary": "Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Verdun"
    },
    "PACR.CN": {
        "short_name": "PacRootsCann",
        "long_name": "Pac Roots Cannabis Corp.",
        "summary": "Pac Roots Cannabis Corp. cultivates and sells marijuana for medicinal purposes. The company was incorporated in 2012 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PAS.V": {
        "short_name": "PASCAL BIOSCIENCES INC",
        "long_name": "Pascal Biosciences Inc.",
        "summary": "Pascal Biosciences Inc., a biotechnology company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy for cancer treatment. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PAXH": {
        "short_name": "PREAXIA HEALTH CARE PAYMENT SYS",
        "long_name": "PreAxia Health Care Payment Systems Inc.",
        "summary": "PreAxia Health Care Payment Systems Inc. focuses on the development, distribution, marketing, and sale of health care payment processing services and products. It is developing an online access system creating a health spending account that allows card payments and processing services to third-party administrators, insurance companies, and others; and software systems for the issuing of health payment cards and financial transaction processing services. The company was founded in 2008 and is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "PBIC.CN": {
        "short_name": "Plant-BasedInve",
        "long_name": "Plant-Based Investment Corp.",
        "summary": "Plant-Based Investment Corp. is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PCLO.V": {
        "short_name": "PHARMACIELO LTD",
        "long_name": "PharmaCielo Ltd.",
        "summary": "PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PCLOF": {
        "short_name": "PHARMACIELO LTD",
        "long_name": "PharmaCielo Ltd.",
        "summary": "PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. PharmaCielo Ltd. has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PDTTF": {
        "short_name": "PREFERRED DENTAL TECHNOLOGIES I",
        "long_name": "Preferred Dental Technologies Inc.",
        "summary": "Preferred Dental Technologies Inc. develops and commercializes various technologies in the dental implant industry. It offers EAS components for custom dental abutments for dental implants. The company is headquartered in Winnipeg, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "PEMTF": {
        "short_name": "THOUGHTFUL BRANDS INC",
        "long_name": "Thoughtful Brands Inc.",
        "summary": "Mota Ventures Corp., together with its subsidiaries, operates in the cannabidiol (CBD) e-commerce business. It provides CBD hemp-oil formulations and cosmetics. The company offers its products under the Nature's Exclusive, First Class, and Sativida brands in the United States and Europe. Mota Ventures Corp. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PGTMF": {
        "short_name": "LUFF ENTERPRISES LTD",
        "long_name": "Luff Enterprises Ltd.",
        "summary": "Luff Enterprises Ltd., a CBD lifestyle company, manufactures and distributes hemp-based cannabinoid wellness products in the United States. The company focuses on formulations leveraging cannabinoids, such as CBG and CBN; and boosts them with superfood ingredients to empower people to realize the potential of everyday life. Its products include tinctures, gummies, topicals, and gel caps. The company was formerly known as Ascent Industries Corp. and changed its name to Luff Enterprises Ltd. in May 2020. Luff Enterprises Ltd. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PHA.V": {
        "short_name": "PREMIER HEALTH OF AMERICA INC",
        "long_name": "Premier Health of America Inc.",
        "summary": "Premier Health of America Inc., a specialized healthcare services company, provides staffing and outsourced service solutions for healthcare needs in Canada. It also offers health consulting, nursing, and health-care services in remote communities, as well as medical transport services. The company offers its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company is headquartered in Blainville, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Blainville"
    },
    "PHBI": {
        "short_name": "PHARMAGREEN BIOTECH INC",
        "long_name": "Pharmagreen Biotech Inc.",
        "summary": "Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company is headquartered in Coquitlam, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Coquitlam"
    },
    "PHE.F": {
        "short_name": "CIPHER PHARMACEUTICALS",
        "long_name": "Cipher Pharmaceuticals Inc.",
        "summary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Oakville"
    },
    "PHRM.CN": {
        "short_name": "PharmaTher",
        "long_name": "PharmaTher Holdings Ltd.",
        "summary": "Newscope Capital Corporation, through its subsidiary, PharmaTher Inc., a specialty life sciences company, focuses on the research and development of psychedelic pharmaceuticals to treat neuropsychiatric, neurological, and neuromuscular diseases. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PHRRF": {
        "short_name": "PHARMATHER HOLDINGS LTD",
        "long_name": "PharmaTher Holdings Ltd.",
        "summary": "Newscope Capital Corporation, through its subsidiary, PharmaTher Inc., a specialty life sciences company, focuses on the research and development of psychedelic pharmaceuticals to treat neuropsychiatric, neurological, and neuromuscular diseases. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PILL.CN": {
        "short_name": "CanntabTheraLtd",
        "long_name": "Canntab Therapeutics Limited",
        "summary": "Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Markham"
    },
    "PINK.V": {
        "short_name": "PERIMETER MEDICAL IMAGING AI IN",
        "long_name": "Perimeter Medical Imaging AI, Inc.",
        "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PJ2N.F": {
        "short_name": "LIMINAL BIOSCIENCES",
        "long_name": "Liminal BioSciences Inc.",
        "summary": "Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high unmet medical needs. It operates through two segments, Small Molecule Therapeutics and Plasma-Derived Therapeutics. The Small Molecule Therapeutics segment's lead product candidate is fezagepras (PBI-4050), which is in Phase 1 for the treatment of idiopathic pulmonary fibrosis and respiratory diseases. The Plasma-Derived Therapeutics segment focused on the development of its plasma-derived product candidate Ryplazim, a purified glu-plasminogen derived from human plasma that acts as a plasminogen replacement therapy for patients deficient in plasminogen protein. The company operates in Canada, the United Kingdom, and the United States. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Laval"
    },
    "PKB.CN": {
        "short_name": "PeakbirchLogic",
        "long_name": "PeakBirch Logic Inc.",
        "summary": "PeakBirch Logic Inc. engages in the e-commerce sales and delivery of cannabis-related and cannabidiol (CBD) containing products. The company distributes vaporizers, CBD related accessories, and ancillary products for aromatherapy and other applications, as well as CBD tinctures, topicals, edibles, and other products. It sells its products through Namastevapes.com, Everyonedoesit.com, LiftedCBD.com, Leafscience.com, and Lifted.com portals. PeakBirch Logic Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PLNT.CN": {
        "short_name": "BetterPlantSci",
        "long_name": "Better Plant Sciences Inc.",
        "summary": "Better Plant Sciences Inc., through its subsidiaries, develops, markets, and sells of plant-based products for health and wellness. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils. It also develop and acquire intellectual property for plant-based products. The company offers plant-based skin care products under Urban Juve brand name; cannabis wellness products under Wright & Well and Jack n Jane brands; botanicals, fruit extracts, and spices under the UJ Beverages brand. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PLPRF": {
        "short_name": "PLUS PRODUCTS INC",
        "long_name": "Plus Products Inc.",
        "summary": "Plus Products Inc. develops, manufactures, and sells cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company sells products under the PLUS brand to dispensaries and delivery service customers. Plus Products Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PLUS.CN": {
        "short_name": "PlusProdnc",
        "long_name": "Plus Products Inc.",
        "summary": "Plus Products Inc. develops, manufactures, and sells cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company sells products under the PLUS brand to dispensaries and delivery service customers. Plus Products Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PMED.CN": {
        "short_name": "PredictmedixInc",
        "long_name": "Predictmedix Inc.",
        "summary": "Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for healthcare screenings and impairment detection. The company's AI products use facial, thermal, video, and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease, or mental illness. It also focuses on developing AI based screening, such as COVID19 solutions for the healthcare industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PMEDF": {
        "short_name": "PREDICTMEDIX INC",
        "long_name": "Predictmedix Inc.",
        "summary": "Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for healthcare screenings and impairment detection. The company's AI products use facial, thermal, video, and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease, or mental illness. It also focuses on developing AI based screening, such as COVID19 solutions for the healthcare industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PMM1.F": {
        "short_name": "CAREBOOK TECHNOLOGIES",
        "long_name": "Carebook Technologies Inc.",
        "summary": "Carebook Technologies Inc., digital health company, develops digital health solutions. The company provides COVID-19 application and pharmacy engagement platform. It also offers virtual care and COVID-19 vital signs screening for pharmacies, insurance providers, individuals, governments, and businesses. The company is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "PMN.TO": {
        "short_name": "PROMIS NEUROSCIENCES INC",
        "long_name": "ProMIS Neurosciences, Inc.",
        "summary": "ProMIS Neurosciences, Inc., a development stage biotech company, discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform\u00c2\u0097ProMIS and Collective Coordinates to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb); PMN350, a mAb targeting on toxic amyloid beta oligomers (A\u00c3\u009fO); and PMN330, a monoclonal antibody targeting toxic prion-like forms of A\u00c3\u009fO for AD. The company is also developing therapeutics targeting the neurotoxic form of the tau protein in AD; and superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in PD and Lewy body dementia. The company has a collaboration with BC Neuroimmunology to develop and commercialize proprietary diagnostic assays; and BC Neuroimmunology to develop and offer blood-based diagnostic tests for Alzheimer's diseases. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "POLXF": {
        "short_name": "POLYDEX PHARMACEUTICALS INC",
        "long_name": "Polydex Pharmaceuticals Limited",
        "summary": "Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry. In addition, the company develops Ushercell, a high molecular weight cellulose sulphate for topical vaginal use primarily in the prevention and transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies; and Usherdex 4, a low molecular weight dextran product to treat cystic fibrosis, a genetic disease. Further, it supplies ferric hydroxide and hydrogenated dextran solutions. Polydex Pharmaceuticals Limited sells its products through independent distributors and wholesalers, as well as directly to companies. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited in March 1984. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "POT.CN": {
        "short_name": "PotentVentu",
        "long_name": "Potent Ventures Inc.",
        "summary": "Potent Ventures Inc. sells branded cannabis packaging. It offers its products through Wknd! and Orchard Heights brand name. The company was formerly known as Weekend Unlimited Industries Inc. and changed its name to Potent Ventures Inc. in April 2021. Potent Ventures Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PRCNF": {
        "short_name": "PURE GLOBAL CANNABIS INC",
        "long_name": "Pure Global Cannabis Inc.",
        "summary": "Pure Global Cannabis Inc. produces cannabis products for the medical and adult-use markets in Canada. The company provides cannabis products, such as dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topicals, sublingual strip/spray, transdermal patch, and edibles and beverages, as well as wellness products. It offers its products under the PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company brands. The company serves medical, pharmaceutical, wellness, health and beauty, natural health, food and beverage, and recreational legal markets. Pure Global Cannabis Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PREV.CN": {
        "short_name": "PreveCeuticalMe",
        "long_name": "PreveCeutical Medical Inc.",
        "summary": "PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products in the United States and Canada. It has research and development programs, including dual gene therapy for curative and prevention therapies for type 2 diabetes and obesity; a soluble gel drug delivery program, which provide relief from pain, inflammation, seizures, and neurological disorders; Nature Identical peptide therapeutic applications; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. It also provides medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PROF": {
        "short_name": "Profound Medical Corp.",
        "long_name": "Profound Medical Corp.",
        "summary": "Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "PRVCF": {
        "short_name": "PREVECEUTICAL MEDICAL INC",
        "long_name": "PreveCeutical Medical Inc.",
        "summary": "PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products in the United States and Canada. It has research and development programs, including dual gene therapy for curative and prevention therapies for type 2 diabetes and obesity; a soluble gel drug delivery program, which provide relief from pain, inflammation, seizures, and neurological disorders; Nature Identical peptide therapeutic applications; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. It also provides medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PRXTF": {
        "short_name": "PURE EXTRACTS TECHNOLOGIES CORP",
        "long_name": "Pure Extracts Technologies Corp.",
        "summary": "Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Pemberton"
    },
    "PSH.DE": {
        "short_name": "SERNOVA CORP.",
        "long_name": "Sernova Corp.",
        "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "GER",
        "market": "de_market",
        "country": "Canada",
        "city": "London"
    },
    "PSH.F": {
        "short_name": "SERNOVA CORP.",
        "long_name": "Sernova Corp.",
        "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "London"
    },
    "PSYG.CN": {
        "short_name": "PsyenceGroup",
        "long_name": "Psyence Group Inc.",
        "summary": "Psyence Group Inc. engages in the commercial psilocybin cultivation and production activities. Its natural psilocybin is used for the long-term treatment of psychological trauma and its mental health consequences. The company is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "PU31.F": {
        "short_name": "AGRAFLORA ORGAN. INTL",
        "long_name": "AgraFlora Organics International Inc.",
        "summary": "AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "PULL.CN": {
        "short_name": "PureExtractTech",
        "long_name": "Pure Extracts Technologies Corp.",
        "summary": "Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Pemberton"
    },
    "PUX.F": {
        "short_name": "PURE EXTRACTS TECHN. CORP",
        "long_name": "Pure Extracts Technologies Corp.",
        "summary": "Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Pemberton"
    },
    "PVTTF": {
        "short_name": "PIVOTAL THERAPEUTI",
        "long_name": "Pivotal Therapeutics Inc.",
        "summary": "Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Woodbridge"
    },
    "PWR.CN": {
        "short_name": "CaptivaVerde",
        "long_name": "Captiva Verde Wellness Corp.",
        "summary": "Captiva Verde Wellness Corp. operates as a health and wellness company. The company's assets include sustainable real estate communities in California; outdoor organic cannabis cultivation in Canada; premium infused products and consumer retail partnerships across North America; and medical cannabis license product distribution in Mexico. It primarily invests in assets that contain green residential communities, disruptive manufacturing facilities, organic food production, and pharmaceutical products. The company was formerly known as Captiva Verde Land Corp. and changed its name to Captiva Verde Wellness Corp. in May 2021. Captiva Verde Wellness Corp. was incorporated in 2015 and is based in Coquitlam, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Coquitlam"
    },
    "PYNKF": {
        "short_name": "PERIMETER MEDICAL IMAGING AI IN",
        "long_name": "Perimeter Medical Imaging AI, Inc.",
        "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "QPT.V": {
        "short_name": "QUEST PHARMATECH INC.",
        "long_name": "Quest PharmaTech Inc.",
        "summary": "Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. The company focuses on combinatorial immunotherapeutic approaches to cancer by using monoclonal antibodies of the immunoglobulin G or E subclass in combination with chemotherapy/immune-adjuvant. Its lead product candidate is Oregovomab, a monoclonal antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications; and develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "QTNA.F": {
        "short_name": "TITAN MEDICAL INC.",
        "long_name": "Titan Medical Inc.",
        "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "R5WP.F": {
        "short_name": "TRILLIUM THERAPEUTICS",
        "long_name": "Trillium Therapeutics Inc.",
        "summary": "Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "R7E1.F": {
        "short_name": "CYBIN INC.",
        "long_name": "Cybin Inc.",
        "summary": "Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "RAMM.CN": {
        "short_name": "RammPharma",
        "long_name": "RAMM Pharma Corp.",
        "summary": "RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products. The company offers Epifract\u00c3\u00a1n, a cannabinoid pharmaceutical drug for the treatment of various medical conditions and pathologies; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. It also offers cosmetic products, such as cannabipiel nite, cannabipiel body lotion, cannabipiel hair conditioners, cannabipiel liquid soaps, cannabipiel tite, cannabipiel cleaning emulsions, cannabipiel shampoos, cannabipiel lite, and cannbipiel facial tonics. In addition, the company also engages in the agricultural business. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. The company was incorporated in 1987 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "RAMMF": {
        "short_name": "RAMM PHARMA CORP",
        "long_name": "RAMM Pharma Corp.",
        "summary": "RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products. The company offers Epifract\u00c3\u00a1n, a cannabinoid pharmaceutical drug for the treatment of various medical conditions and pathologies; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. It also offers cosmetic products, such as cannabipiel nite, cannabipiel body lotion, cannabipiel hair conditioners, cannabipiel liquid soaps, cannabipiel tite, cannabipiel cleaning emulsions, cannabipiel shampoos, cannabipiel lite, and cannbipiel facial tonics. In addition, the company also engages in the agricultural business. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. The company was incorporated in 1987 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "RD8.F": {
        "short_name": "RADIENT TECHNOLOGIES",
        "long_name": "Radient Technologies Inc.",
        "summary": "Radient Technologies Inc. processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was founded in 2001 and is headquartered in Edmonton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "RDDTF": {
        "short_name": "RADIENT TECHNOLOGIES INC",
        "long_name": "Radient Technologies Inc.",
        "summary": "Radient Technologies Inc. processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was founded in 2001 and is headquartered in Edmonton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "RDTCF": {
        "short_name": "RAPID DOSE THERAPEUTICS CORP",
        "long_name": "Rapid Dose Therapeutics Corp.",
        "summary": "Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. It also offers PharmaStrip delivery system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Burlington"
    },
    "REL.F": {
        "short_name": "SUGARBUD CRAFT GROWERS",
        "long_name": "SugarBud Craft Growers Corp.",
        "summary": "SugarBud Craft Growers Corp. engages in the acquisition, development, production, and distribution of cannabis products in Canada. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Alberta.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "RELA.CN": {
        "short_name": "RelayMedCorp",
        "long_name": "Relay Medical Corp.",
        "summary": "Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company provides Fionet, a mobile testing and tracking platform, which combines handheld devices linked to online AI-powered cloud, automating frontline testing, and capturing test results for tracking; HemoPalm, a blood analyzer and single-use cartridge that provides enterprise solution for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an user experience -centric system design to improve management and identification of medications. It offers techno-commercial leadership and support services for the venture that pursue technology opportunities in the medicinal cannabis, agrotechnology, and other related industries. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "REPCF": {
        "short_name": "REPLICEL LIFE SCIENCES INC",
        "long_name": "RepliCel Life Sciences Inc.",
        "summary": "RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that has completed Phase I clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase II clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "RFS.F": {
        "short_name": "RESVERLOGIX CORP",
        "long_name": "Resverlogix Corp.",
        "summary": "Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "RHT.V": {
        "short_name": "RELIQ HEALTH TECHNOLOGIES INC",
        "long_name": "Reliq Health Technologies Inc.",
        "summary": "Reliq Health Technologies Inc., a healthcare technology company, engages in the development of mobile software solutions for community care market. It offers iUGO Health technology platform, a hardware and software solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Hamilton"
    },
    "RIV.TO": {
        "short_name": "RIV CAPITAL INC",
        "long_name": "RIV Capital Inc.",
        "summary": "RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "RLLVF": {
        "short_name": "RELEVIUM TECHNOLOGIES INC",
        "long_name": "Relevium Technologies Inc.",
        "summary": "Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "RLV.V": {
        "short_name": "RELEVIUM TECHNOLOGIES INC",
        "long_name": "Relevium Technologies Inc.",
        "summary": "Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "ROMJ.V": {
        "short_name": "RUBICON ORGANICS INC",
        "long_name": "Rubicon Organics Inc.",
        "summary": "Rubicon Organics Inc. produces and sells organic cannabis in Canada. The company processes organic cannabis at its federally licensed 125,000 square foot facility in Delta, British Columbia and sells under its wholly owned and other licensed brands. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ROMJF": {
        "short_name": "RUBICON ORGANICS INC",
        "long_name": "Rubicon Organics Inc.",
        "summary": "Rubicon Organics Inc. produces and sells organic cannabis in Canada. The company processes organic cannabis at its federally licensed 125,000 square foot facility in Delta, British Columbia and sells under its wholly owned and other licensed brands. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "RP.V": {
        "short_name": "REPLICEL LIFE SCIENCES INC",
        "long_name": "RepliCel Life Sciences Inc.",
        "summary": "RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that has completed Phase I clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase II clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "RPTX": {
        "short_name": "Repare Therapeutics Inc.",
        "long_name": "Repare Therapeutics Inc.",
        "summary": "Repare Therapeutics Inc., a precision oncology company, discovers and develops novel therapeutics by using its synthetic lethality approach in Canada. The company use its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing CCNE1-SL inhibitor, a proprietary drug discovery program for tumors with amplification of CCNE1; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montr\u00c3\u00a9al, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "RQHTF": {
        "short_name": "RELIQ HEALTH TECHNOLOGIES INC",
        "long_name": "Reliq Health Technologies Inc.",
        "summary": "Reliq Health Technologies Inc., a healthcare technology company, engages in the development of mobile software solutions for community care market. It offers iUGO Health technology platform, a hardware and software solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Hamilton"
    },
    "RTI.V": {
        "short_name": "RADIENT TECHNOLOGIES INC",
        "long_name": "Radient Technologies Inc.",
        "summary": "Radient Technologies Inc. processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was founded in 2001 and is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Edmonton"
    },
    "RVV.CN": {
        "short_name": "ReviveThera",
        "long_name": "Revive Therapeutics Ltd.",
        "summary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform, as well as a research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "RVVQF": {
        "short_name": "RAVENQUEST BIOMED INC",
        "long_name": "RavenQuest BioMed Inc.",
        "summary": "RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "RVVTF": {
        "short_name": "REVIVE THERAPEUTICS LTD",
        "long_name": "Revive Therapeutics Ltd.",
        "summary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform, as well as a research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "RVX.TO": {
        "short_name": "RESVERLOGIX CORP.",
        "long_name": "Resverlogix Corp.",
        "summary": "Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "RVXCF": {
        "short_name": "RESVERLOGIX CORP",
        "long_name": "Resverlogix Corp.",
        "summary": "Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "RWB.CN": {
        "short_name": "RedWhite&Bloom",
        "long_name": "Red White & Bloom Brands Inc.",
        "summary": "Red White & Bloom Brands Inc. engages in the cultivation and retail of cannabis products primarily in Michigan, Illinois, Massachusetts, California, and Florida. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "RWBYF": {
        "short_name": "RED WHITE & BLOOM BRANDS INC",
        "long_name": "Red White & Bloom Brands Inc.",
        "summary": "Red White & Bloom Brands Inc. engages in the cultivation and retail of cannabis products primarily in Michigan, Illinois, Massachusetts, California, and Florida. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "RX.V": {
        "short_name": "BIOSYENT INC.",
        "long_name": "BioSyent Inc.",
        "summary": "BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis;  ; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository for the healing of the anus and rectum; and Cysview, an adjunct to white-light cystoscopy for the detection and management of non-muscle invasive papillary bladder cancer. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "RYMDF": {
        "short_name": "RELAY MEDICAL CORP",
        "long_name": "Relay Medical Corp.",
        "summary": "Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company provides Fionet, a mobile testing and tracking platform, which combines handheld devices linked to online AI-powered cloud, automating frontline testing, and capturing test results for tracking; HemoPalm, a blood analyzer and single-use cartridge that provides enterprise solution for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an user experience -centric system design to improve management and identification of medications. It offers techno-commercial leadership and support services for the venture that pursue technology opportunities in the medicinal cannabis, agrotechnology, and other related industries. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SARSF": {
        "short_name": "CANADA HOUSE WELLNESS GROUP INC",
        "long_name": "Canada House Wellness Group Inc.",
        "summary": "Canada House Wellness Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics; and a licensed dispensary. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company is headquartered in Pickering, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Pickering"
    },
    "SBFM": {
        "short_name": "SUNSHINE BIOPHARMA INC",
        "long_name": "Sunshine Biopharma, Inc.",
        "summary": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also provides generic prescription drugs for the treatment of breast cancer, prostate cancer, and benign prostatic hyperplasia; and Essential 9, a dietary supplement tablet. Sunshine Biopharma, Inc. has a license agreement with the University of Georgia to advance the development of two anti-coronavirus compounds in parallel with its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. was founded in 2006 and is headquartered in Pointe-Claire, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Pointe-Claire"
    },
    "SBM.V": {
        "short_name": "SIRONA BIOCHEM CORP.",
        "long_name": "Sirona Biochem Corp.",
        "summary": "Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. It develops programs in the areas of diabetes, anti-inflammatories, and anti-infectives for therapeutics; and anti-aging and depigmenting agents in cosmeceuticals. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SBUDF": {
        "short_name": "SUGARBUD CRAFT GROWERS CORP",
        "long_name": "SugarBud Craft Growers Corp.",
        "summary": "SugarBud Craft Growers Corp. engages in the acquisition, development, production, and distribution of cannabis products in Canada. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Alberta.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "SCNNF": {
        "short_name": "SATIVA WELLNESS GROUP INC",
        "long_name": "Sativa Wellness Group Inc.",
        "summary": "Sativa Wellness Group Inc. operates as a CBD wellness company. The company engages in the cultivation and extraction of cannabinoids. It also sells CBD products to wholesale and online retail markets, as well as white label CBD products for third party brands. The company is based in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "SCRN.CN": {
        "short_name": "ScreenProSec",
        "long_name": "ScreenPro Security Inc.",
        "summary": "ScreenPro Security Ltd. provides Covid-19 testing solutions to governments and corporations. The company was incorporated in 2020 and is headquartered in British Columbia, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SD4.F": {
        "short_name": "SPECTRAL MEDICAL",
        "long_name": "Spectral Medical Inc.",
        "summary": "Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SE.CN": {
        "short_name": "SweetEarthHldng",
        "long_name": "Sweet Earth Holdings Corporation",
        "summary": "Sweet Earth Holdings Corporation cultivates, processes, and sells hemp Cannabidiol (CBD) products. The company offers cosmetics products, including hemp hydrating oat and honey facial cleanser, balancing jasmine body oil, hydration cream, salve, lip balm, hydrating cleanser, hand sanitizer, balancing body oil, organic body scrub, rejuvenating salt soak, and muscle recovery rub. It also provides CBD dog treats comprising beef and cheddar potato; turkey and sweet potato; peanut butter crunch; sweet potato cranberry; pumpkin flax; apple carrot oat; and antioxidant blueberry fax. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SEHCF": {
        "short_name": "SWEET EARTH HOLDINGS CORPORATIO",
        "long_name": "Sweet Earth Holdings Corporation",
        "summary": "Sweet Earth Holdings Corporation cultivates, processes, and sells hemp Cannabidiol (CBD) products. The company offers cosmetics products, including hemp hydrating oat and honey facial cleanser, balancing jasmine body oil, hydration cream, salve, lip balm, hydrating cleanser, hand sanitizer, balancing body oil, organic body scrub, rejuvenating salt soak, and muscle recovery rub. It also provides CBD dog treats comprising beef and cheddar potato; turkey and sweet potato; peanut butter crunch; sweet potato cranberry; pumpkin flax; apple carrot oat; and antioxidant blueberry fax. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SEOVF": {
        "short_name": "SERNOVA CORPORATION",
        "long_name": "Sernova Corp.",
        "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "London"
    },
    "SHG.V": {
        "short_name": "SKYLIGHT HEALTH GROUP INC",
        "long_name": "Skylight Health Group Inc.",
        "summary": "Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network that comprises of physical practices, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "SHGFF": {
        "short_name": "SKYLIGHT HEALTH GROUP INC",
        "long_name": "Skylight Health Group Inc.",
        "summary": "Skylight Health Group Inc., a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. The Company operates a US multi-state primary care health network that comprises of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. It also owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. In addition, the Company offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "SIA.TO": {
        "short_name": "SIENNA SENIOR LIVING INC",
        "long_name": "Sienna Senior Living Inc.",
        "summary": "Sienna Senior Living Inc., through its subsidiaries, provides senior living and long-term care (LTC) services in Canada. It operates through Retirement and LTC segments. The company offers a range of seniors' living options, including independent supportive and assisted living, memory care, long-term care, and specialized programs and services, as well as provides management services. As of December 31, 2020, it owned and operated a total of 70 seniors' living residences comprising 27 retirement residences, 35 LTC residences, and eight seniors' living residences. The company was formerly known as Leisureworld Senior Care Corporation and changed its name to Sienna Senior Living Inc. in May 2015. Sienna Senior Living Inc. was founded in 1972 and is headquartered in Markham, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Markham"
    },
    "SKLV": {
        "short_name": "SKYE LIFE VENTURES LTD",
        "long_name": "SKYE Life Ventures Ltd.",
        "summary": "SuperDate Networks Inc. develops dating software application. It matches users through common interests and activities. SuperDate Networks Inc. was founded in 2012 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SLGWF": {
        "short_name": "SLANG WORLDWIDE INC",
        "long_name": "SLANG Worldwide Inc.",
        "summary": "SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. It owns, licenses, and/or markets 11 brands which serve flower, inhalable concentrates, and ingestibles, including edibles and pressed pills. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SLNG.CN": {
        "short_name": "SLANGWorldwide",
        "long_name": "SLANG Worldwide Inc.",
        "summary": "SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. It owns, licenses, and/or markets 11 brands which serve flower, inhalable concentrates, and ingestibles, including edibles and pressed pills. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SNANF": {
        "short_name": "SONA NANOTECH INC",
        "long_name": "Sona Nanotech Inc.",
        "summary": "Sona Nanotech Inc., nanotechnology life sciences company, manufactures gold nanorod products for diagnostic tests. Its products portfolio comprises Gemini 650NM, Gemini 700NM, Gemini 725NM, Gemini 750NM, Gemini 800NM, Gemini 850NM, Gemini 900NM, Gemini 950NM, and Gemini 1050NM. The company also provides Sona Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens from individuals, who are suspected of COVID-19. In addition, it offers Gemini and Omni gold nanorods for in-vitro and in-vivo applications, such as lateral flow diagnostics and cell imaging. The company has collaboration agreements with Soma Bioscience Ltd. to produce diagnostic tests using lateral flow assay technology; and Expedeon Ltd to develop multiplex point-of-care and lateral flow assay diagnostic tests. Sona Nanotech Inc. is based in Halifax, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "SNDL": {
        "short_name": "Sundial Growers Inc.",
        "long_name": "Sundial Growers Inc.",
        "summary": "Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "SNNVF": {
        "short_name": "SUNNIVA INC",
        "long_name": "Sunniva Inc.",
        "summary": "Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SOL.CN": {
        "short_name": "SOLGlobal",
        "long_name": "SOL Global Investments Corp.",
        "summary": "SOL Global Investments Corp. is a principal investment firm with a focus on the biopharmaceutical and cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SOLCF": {
        "short_name": "SOL GLOBAL INVESTMENTS CORP",
        "long_name": "SOL Global Investments Corp.",
        "summary": "SOL Global Investments Corp. is a principal investment firm with a focus on the biopharmaceutical and cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SONA.CN": {
        "short_name": "SonaNanoInc",
        "long_name": "Sona Nanotech Inc.",
        "summary": "Sona Nanotech Inc., nanotechnology life sciences company, manufactures gold nanorod products for diagnostic tests. Its products portfolio comprises Gemini 650NM, Gemini 700NM, Gemini 725NM, Gemini 750NM, Gemini 800NM, Gemini 850NM, Gemini 900NM, Gemini 950NM, and Gemini 1050NM. The company also provides Sona Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens from individuals, who are suspected of COVID-19. In addition, it offers Gemini and Omni gold nanorods for in-vitro and in-vivo applications, such as lateral flow diagnostics and cell imaging. The company has collaboration agreements with Soma Bioscience Ltd. to produce diagnostic tests using lateral flow assay technology; and Expedeon Ltd to develop multiplex point-of-care and lateral flow assay diagnostic tests. Sona Nanotech Inc. is based in Halifax, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Halifax"
    },
    "SP4P.F": {
        "short_name": "ACHIEVE LIFE SCIE. DL-001",
        "long_name": "Achieve Life Sciences, Inc.",
        "summary": "Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SPBBF": {
        "short_name": "SPEAKEASY CANNABIS CLUB LTD",
        "long_name": "Speakeasy Cannabis Club Ltd.",
        "summary": "Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Rock Creek"
    },
    "SPDR.V": {
        "short_name": "SPYDER CANNABIS INC",
        "long_name": "Spyder Cannabis Inc.",
        "summary": "Spyder Cannabis Inc. engages in the retail of various cannabis products in Canada and the United States. The company offers electronic cigarettes, cannabis supplies, e-juices, and accessories. It sells its products through a chain of five vape stores in Woodbridge, Scarborough, Pickering, Niagara Falls, and Burlington, Ontario, as well as through online. In addition, the company engages in the development of hemp-based products. Spyder Cannabis Inc. was founded in 2014 and is headquartered in Woodbridge, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Woodbridge"
    },
    "SPLIF": {
        "short_name": "NUTRITIONAL HIGH INTERNATIONAL ",
        "long_name": "Nutritional High International Inc.",
        "summary": "Nutritional High International Inc. manufactures and processes hemp and marijuana-infused cannabis oils, extracts, and edible products for medical and adult recreation use in the United States and Canada. It offers cannabis-based vaping, concentrate, and infused edible products, such as oil vape cartridges, syringes, dab jars, and mints, as well as cannabis infused chocolates under the FL\u00c3\u008f brand name. The company also distributes other branded cannabis products. Nutritional High International Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SPR.CN": {
        "short_name": "SproutlyCdaInc",
        "long_name": "Sproutly Canada Inc.",
        "summary": "Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumable markets in Canada. It offers its products under the Caliber brand name. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SPRWF": {
        "short_name": "SUPREME CANNABIS CO INC",
        "long_name": "The Supreme Cannabis Company, Inc.",
        "summary": "The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SQD.V": {
        "short_name": "SQI DIAGNOSTICS INC.",
        "long_name": "SQI Diagnostics Inc.",
        "summary": "SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company provides advanced diagnostics targeting organ transplant, autoimmune disease, and serological testing. It also offers TOR-dx, a lung panel test, which enables surgeon to assess the health of donor's lung; and COVID-19 at-home antibody test kit, and the RALI-Dx and RALI-fast point-of care tests to triage COVID-19 patients for respiratory distress. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SQIDF": {
        "short_name": "SQI DIAGNOSTICS INC",
        "long_name": "SQI Diagnostics Inc.",
        "summary": "SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company provides advanced diagnostics targeting organ transplant, autoimmune disease, and serological testing. It also offers TOR-dx, a lung panel test, which enables surgeon to assess the health of donor's lung; and COVID-19 at-home antibody test kit, and the RALI-Dx and RALI-fast point-of care tests to triage COVID-19 patients for respiratory distress. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "SRBCF": {
        "short_name": "SIRONA BIOCHEM CORPORATION",
        "long_name": "Sirona Biochem Corp.",
        "summary": "Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. It develops programs in the areas of diabetes, anti-inflammatories, and anti-infectives for therapeutics; and anti-aging and depigmenting agents in cosmeceuticals. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SRUTF": {
        "short_name": "SPROUTLY CANADA INC",
        "long_name": "Sproutly Canada Inc.",
        "summary": "Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumable markets in Canada. It offers its products under the Caliber brand name. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "SUGR.V": {
        "short_name": "SUGARBUD CRAFT GROWERS CORP",
        "long_name": "SugarBud Craft Growers Corp.",
        "summary": "SugarBud Craft Growers Corp. engages in the acquisition, development, production, and distribution of cannabis products in Canada. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Alberta.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "SVA.V": {
        "short_name": "SERNOVA CORP.",
        "long_name": "Sernova Corp.",
        "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "London"
    },
    "SWEL.CN": {
        "short_name": "SativaWellness",
        "long_name": "Sativa Wellness Group Inc.",
        "summary": "Sativa Wellness Group Inc. operates as a CBD wellness company. The company engages in the cultivation and extraction of cannabinoids. It also sells CBD products to wholesale and online retail markets, as well as white label CBD products for third party brands. The company is based in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "North Vancouver"
    },
    "SZLS.TO": {
        "short_name": "STAGEZERO LIFE SCIENCES LTD",
        "long_name": "StageZero Life Sciences Ltd.",
        "summary": "StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Richmond Hill"
    },
    "T8RP.F": {
        "short_name": "INDIVA LTD",
        "long_name": "Indiva Limited",
        "summary": "Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "TBD.F": {
        "short_name": "EMERALD HEALTH THER.",
        "long_name": "Emerald Health Therapeutics, Inc.",
        "summary": "Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TBF1.F": {
        "short_name": "CANNTAB THERAPEUTICS LTD.",
        "long_name": "Canntab Therapeutics Limited",
        "summary": "Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Markham"
    },
    "TBI.CN": {
        "short_name": "ThoughtfulBran",
        "long_name": "Thoughtful Brands Inc.",
        "summary": "Mota Ventures Corp., together with its subsidiaries, operates in the cannabidiol (CBD) e-commerce business. It provides CBD hemp-oil formulations and cosmetics. The company offers its products under the Nature's Exclusive, First Class, and Sativida brands in the United States and Europe. Mota Ventures Corp. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TBP.TO": {
        "short_name": "TETRA BIO PHARMA INC",
        "long_name": "Tetra Bio-Pharma Inc.",
        "summary": "Tetra Bio-Pharma Inc., a development stage biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. It develops ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; Reduvo for chemotherapy-induced nausea and vomiting; PLENITUDE to treat advanced uncontrolled cancer pain; REBORN for the treatment of breakthrough cancer pain and fibromyalgia; and SERENITY to treat cancer cachexia. The company also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Orl\u00c3\u00a9ans"
    },
    "TBPMF": {
        "short_name": "TETRA BIO PHARMA INC",
        "long_name": "Tetra Bio-Pharma Inc.",
        "summary": "Tetra Bio-Pharma Inc., a development stage biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. It develops ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; Reduvo for chemotherapy-induced nausea and vomiting; PLENITUDE to treat advanced uncontrolled cancer pain; REBORN for the treatment of breakthrough cancer pain and fibromyalgia; and SERENITY to treat cancer cachexia. The company also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Orl\u00c3\u00a9ans"
    },
    "TCAN.CN": {
        "short_name": "TranscannaHldgs",
        "long_name": "TransCanna Holdings Inc.",
        "summary": "TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TCNAF": {
        "short_name": "TRANSCANNA HOLDINGS INC",
        "long_name": "TransCanna Holdings Inc.",
        "summary": "TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TDSGF": {
        "short_name": "TELO GENOMICS CORP",
        "long_name": "Telo Genomics Corp.",
        "summary": "Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TED.F": {
        "short_name": "TERRASCEND CORP.",
        "long_name": "TerrAscend Corp.",
        "summary": "TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TELO.V": {
        "short_name": "TELO GENOMICS CORP",
        "long_name": "Telo Genomics Corp.",
        "summary": "Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TEQ.CN": {
        "short_name": "Terranueva",
        "long_name": "Terranueva Corporation",
        "summary": "Terranueva Corporation intends to produce cannabis for medical and recreational purposes. The company was incorporated in 2017 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Laval"
    },
    "TER.CN": {
        "short_name": "TerrAscendCorp",
        "long_name": "TerrAscend Corp.",
        "summary": "TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TEST.V": {
        "short_name": "FLUROTECH LTD",
        "long_name": "FluroTech Ltd.",
        "summary": "FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech's specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "TEVNF": {
        "short_name": "TEVANO SYSTEMS HOLDINGS INC",
        "long_name": "Tevano Systems Holdings Inc.",
        "summary": "Tevano Systems Holdings Inc. develops and sells electronics products to businesses and consumers. It offers Health Shield, an AI-driven electronic device that provides instant body temperature scanning and notifies users if they need to wear a face mask. The company was formerly known as RBI Ventures Ltd. and changed its name to Tevano System Holdings Inc. in March 2021. Tevano System Holdings Inc. was incorporated in 2000 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TEVO.CN": {
        "short_name": "TevanoSysHdg",
        "long_name": "Tevano Systems Holdings Inc.",
        "summary": "Tevano Systems Holdings Inc. develops and sells electronics products to businesses and consumers. It offers Health Shield, an AI-driven electronic device that provides instant body temperature scanning and notifies users if they need to wear a face mask. The company was formerly known as RBI Ventures Ltd. and changed its name to Tevano System Holdings Inc. in March 2021. Tevano System Holdings Inc. was incorporated in 2000 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TFHD.F": {
        "short_name": "THC BIOMED INTL",
        "long_name": "THC Biomed Intl Ltd.",
        "summary": "THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "TGIF.CN": {
        "short_name": "1933IndInc",
        "long_name": "1933 Industries Inc.",
        "summary": "1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in AMA and Infused MFG segments. The company operates in the medical and recreational cannabis sectors. It also provides cannabidiol infused products, such as tinctures, lotions, creams, vape pens, cartridges, lip balms, tetrahydrocannabinol concentrates, hemp-seed oils, and capsules under Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands; and cannabis flowers and concentrates. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. was incorporated in 2008 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TGIFF": {
        "short_name": "1933 INDUSTRIES INC",
        "long_name": "1933 Industries Inc.",
        "summary": "1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in AMA and Infused MFG segments. The company operates in the medical and recreational cannabis sectors. It also provides cannabidiol infused products, such as tinctures, lotions, creams, vape pens, cartridges, lip balms, tetrahydrocannabinol concentrates, hemp-seed oils, and capsules under Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands; and cannabis flowers and concentrates. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. was incorporated in 2008 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TGOD.TO": {
        "short_name": "THE GREEN ORGANIC DUTCHMAN HOLD",
        "long_name": "The Green Organic Dutchman Holdings Ltd.",
        "summary": "The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TGODF": {
        "short_name": "GREEN ORGANIC DUTCHMAN HLDGS LT",
        "long_name": "The Green Organic Dutchman Holdings Ltd.",
        "summary": "The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TH.TO": {
        "short_name": "THERATECHNOLOGIES",
        "long_name": "Theratechnologies Inc.",
        "summary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "TH8.F": {
        "short_name": "TRANSCANNA HOLDINGS INC.",
        "long_name": "TransCanna Holdings Inc.",
        "summary": "TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "THC.CN": {
        "short_name": "THCBiomed Intl",
        "long_name": "THC Biomed Intl Ltd.",
        "summary": "THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "THNK.V": {
        "short_name": "THINK RESEARCH CORPORATION",
        "long_name": "Think Research Corporation",
        "summary": "Think Research Corp., an investment holding company, develops and provides clinical software and services for the health care industry. The company's products portfolio includes order sets that structures clinical pathway at the point of care; Progress Notes, which helps frontline clinical teams to align their documentation in a standardized digital note shared across all team members; eReferrals that allows physicians to find and refer specialists directly from EMR systems; VirtualCare, which allows clinicians and allied health professionals to replace in-person appointments with virtual visits; and eforms, a real-time analytics to track resident volumes, signature adherence, and compliance, as well as decision support tools for seniors living in long-term care and retirement homes. It serves in Canada, the United States, Latin America, Europe, Australia, and the Middle East. Think Research Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "THRBF": {
        "short_name": "THERMA BRIGHT INC",
        "long_name": "Therma Bright Inc.",
        "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "THRM.V": {
        "short_name": "THERMA BRIGHT INC",
        "long_name": "Therma Bright Inc.",
        "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "THTX": {
        "short_name": "Theratechnologies Inc.",
        "long_name": "Theratechnologies Inc.",
        "summary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "TLAA.F": {
        "short_name": "TRUE LEAF BRANDS INC.",
        "long_name": "True Leaf Brands Inc.",
        "summary": "True Leaf Brands Inc. manufactures and distributes hemp-based nutrition for pets. It sells dog chews, dental sticks, and supplement oils under the True Hemp brand name in North America and Europe, as well as through online on Amazon. The company was formerly known as True Leaf Medicine International Ltd. and changed its name to True Leaf Brands Inc. in May 2019. True Leaf Brands Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vernon"
    },
    "TLT.V": {
        "short_name": "THERALASE TECHNOLOGIES INC.",
        "long_name": "Theralase Technologies Inc.",
        "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TLTFF": {
        "short_name": "THERALASE TECHNOLOGIES INC",
        "long_name": "Theralase Technologies Inc.",
        "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TMD.TO": {
        "short_name": "TITAN MEDICAL INC",
        "long_name": "Titan Medical Inc.",
        "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TMDI": {
        "short_name": "Titan Medical Inc.",
        "long_name": "Titan Medical Inc.",
        "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TMED.CN": {
        "short_name": "EGFThera",
        "long_name": "EGF Theramed Health Corp.",
        "summary": "EGF Theramed Health Corp., a consumer technology company, develops technologies, products, and diagnostic tools for personalized medical care. It engages in the provision of biomedical online services for monitoring and treating common health problems; and extraction and purification of botanical extracts and creation of extract formulations, as well as development of medical monitoring device technologies. The company also provides TULIP medical health system device. It offers services in the medical areas of mental health problems, weight loss, skin care, and heart diseases. The company was formerly known as Theramed Health Corporation and changed its name to EGF Theramed Health Corp. in October 2019. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TOKI.CN": {
        "short_name": "TreeofKnowledge",
        "long_name": "Tree of Knowledge International Corp.",
        "summary": "Tree of Knowledge International Corp. produces and sells hemp-based cannabidiol (CBD) products. The company offers industrial hemp-derived CBD oil, airless metered pens, capsules, drops, balms, creams, and tinctures. It also operates multidisciplinary specialty pain clinics, which focuses on the treatment of chronic pain, including controlled assessment, authorization, and monitoring of medical cannabis therapy; and develops products for therapeutic purposes, and wellness and natural health product alternatives. In addition, the company distributes and sells hemp-based cannabidiol products. It has a research agreement with the Ryerson University for medical cannabis research and new medical grade products development. The company has operations in the United States, Canada, Europe, and Brazil. Tree of Knowledge International Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TOKIF": {
        "short_name": "TREE OF KNOWLEDGE INTERNATIONAL",
        "long_name": "Tree of Knowledge International Corp.",
        "summary": "Tree of Knowledge International Corp. produces and sells hemp-based cannabidiol (CBD) products. The company offers industrial hemp-derived CBD oil, airless metered pens, capsules, drops, balms, creams, and tinctures. It also operates multidisciplinary specialty pain clinics, which focuses on the treatment of chronic pain, including controlled assessment, authorization, and monitoring of medical cannabis therapy; and develops products for therapeutic purposes, and wellness and natural health product alternatives. In addition, the company distributes and sells hemp-based cannabidiol products. It has a research agreement with the Ryerson University for medical cannabis research and new medical grade products development. The company has operations in the United States, Canada, Europe, and Brazil. Tree of Knowledge International Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TPPRF": {
        "short_name": "TOP STRIKE RES CORP",
        "long_name": "Top Strike Resources Corp.",
        "summary": "Top Strike Resources Corp., doing business as Vencanna Ventures Inc., operates as a merchant capital firm. It provides capital for early-stage global cannabis initiatives, including state compliant opportunities in the United States. The company was formerly known as Colossal Resources Corp. and changed its name to Top Strike Resources Corp. in December 2012. Top Strike Resources Corp. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "TQ8.F": {
        "short_name": "THERATECHNOLOGIES INC.",
        "long_name": "Theratechnologies Inc.",
        "summary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Montreal"
    },
    "TQB.F": {
        "short_name": "IMMUNOPRECISE ANTIBOD.",
        "long_name": "ImmunoPrecise Antibodies Ltd.",
        "summary": "ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "TRCNF": {
        "short_name": "TRANSNATIONAL CANNABIS LTD",
        "long_name": "TRANSNATIONAL CANNABIS LTD",
        "summary": "TRANSNATIONAL CANNABIS LTD, through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and transport cannabis and derivative products; and engages in procuring and distributing medical cannabis products and cannabis derivatives. The company has strategic partnerships with Green Tree International Inc., Auxly Cananbis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. The company was formerly known as ICC International Cannabis Corp. and changed its name to TRANSNATIONAL CANNABIS LTD in February 2020. TRANSNATIONAL CANNABIS LTD was incorporated in 2006 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "TRIL": {
        "short_name": "Trillium Therapeutics Inc.",
        "long_name": "Trillium Therapeutics Inc.",
        "summary": "Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TRIL.TO": {
        "short_name": "TRILLIUM THERAPEUTICS INC",
        "long_name": "Trillium Therapeutics Inc.",
        "summary": "Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TRIP.CN": {
        "short_name": "RedLightHolland",
        "long_name": "Red Light Holland Corp.",
        "summary": "Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the legal recreational market in the Netherlands. It sells its products under the iMicrodose brand name through smart shops operators and an advanced e-commerce platform, iMicrodose.nl. The company was incorporated in 1982 and is based in Toronto, Ontario.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TRLFF": {
        "short_name": "TRUE LEAF BRANDS INC",
        "long_name": "True Leaf Brands Inc.",
        "summary": "True Leaf Brands Inc. manufactures and distributes hemp-based nutrition for pets. It sells dog chews, dental sticks, and supplement oils under the True Hemp brand name in North America and Europe, as well as through online on Amazon. The company was formerly known as True Leaf Medicine International Ltd. and changed its name to True Leaf Brands Inc. in May 2019. True Leaf Brands Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vernon"
    },
    "TRSSF": {
        "short_name": "TERRASCEND CORP",
        "long_name": "TerrAscend Corp.",
        "summary": "TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Mississauga"
    },
    "TRUE.CN": {
        "short_name": "Treatment.com",
        "long_name": "Treatment.Com International Inc.",
        "summary": "Treatment.Com International Inc. operates as a mobile health, telemedicine, and artificial intelligence (AI) company in Canada. The company offers MERLIN, a probabilistic medical reasoning engine to provide medical advice such that individuals can make decisions about available treatments for their health care problems; and GLM, a collaborative repository where care providers, researchers, and developers exchange and publish medical knowledge. It also provides CareBOT, an AI prompting agent mobile application platform for use by consumers; and ClinBOT, an enterprise clinic application for use as diagnostic tool for medical professionals. Treatment.Com International Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "West Vancouver"
    },
    "TRUFF": {
        "short_name": "RED LIGHT HOLLAND CORP",
        "long_name": "Red Light Holland Corp.",
        "summary": "Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the legal recreational market in the Netherlands. It sells its products under the iMicrodose brand name through smart shops operators and an advanced e-commerce platform, iMicrodose.nl. The company was incorporated in 1982 and is based in Toronto, Ontario.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "TRYP.CN": {
        "short_name": "TrypTherapeutic",
        "long_name": "Tryp Therapeutics Inc.",
        "summary": "Tryp Therapeutics Inc., a clinical stage pharmaceutical company, focuses on developing compounds with known activity and/or safety profiles for the treatment of rare or orphan diseases and other diseases. The company's lead development program is psilocybin-for-neuropsychiatry (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 for fibromyalgia, hyperphagia in prader-willi syndrome, and other therapies; and TRP-1001, an oral formulation of razoxane evaluating for the treatment of soft tissue sarcoma. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was founded in 2019 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "TRYPF": {
        "short_name": "TRYP THERAPEUTICS INC",
        "long_name": "Tryp Therapeutics Inc.",
        "summary": "Tryp Therapeutics Inc., a clinical stage pharmaceutical company, focuses on developing compounds with known activity and/or safety profiles for the treatment of rare or orphan diseases and other diseases. The company's lead development program is psilocybin-for-neuropsychiatry (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 for fibromyalgia, hyperphagia in prader-willi syndrome, and other therapies; and TRP-1001, an oral formulation of razoxane evaluating for the treatment of soft tissue sarcoma. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was founded in 2019 and is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kelowna"
    },
    "TTX.F": {
        "short_name": "THERALASE TECHNOLOGIE.INC",
        "long_name": "Theralase Technologies Inc.",
        "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "V5D1.F": {
        "short_name": "DELTA 9 CANNABIS",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "V5D1.SG": {
        "short_name": "Delta 9 Cannabis Inc. Registere",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "VEGGF": {
        "short_name": "BETTER PLANT SCIENCES INC",
        "long_name": "Better Plant Sciences Inc.",
        "summary": "Better Plant Sciences Inc., through its subsidiaries, develops, markets, and sells of plant-based products for health and wellness. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils. It also develop and acquire intellectual property for plant-based products. The company offers plant-based skin care products under Urban Juve brand name; cannabis wellness products under Wright & Well and Jack n Jane brands; botanicals, fruit extracts, and spices under the UJ Beverages brand. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VEGN.CN": {
        "short_name": "Plant&Co.Brands",
        "long_name": "Plant & Co. Brands Ltd.",
        "summary": "Plant & Co. Brands Ltd. focuses on operating data-driven digital CBD marketplace. It operates as a vertically integrated enterprise focused on the health and wellness sector. Plant & Co. Brands has collaboration with the University of Manitoba to develop an all-natural hemp-based food line. The company was formerly known as Eurolife Brands Inc. and changed its name to Plant & Co. Brands Ltd. in December 2020. Plant & Co. Brands Ltd. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VENI.CN": {
        "short_name": "Top Strike",
        "long_name": "Top Strike Resources Corp.",
        "summary": "Top Strike Resources Corp., doing business as Vencanna Ventures Inc., operates as a merchant capital firm. It provides capital for early-stage global cannabis initiatives, including state compliant opportunities in the United States. The company was formerly known as Colossal Resources Corp. and changed its name to Top Strike Resources Corp. in December 2012. Top Strike Resources Corp. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "VERO": {
        "short_name": "Venus Concept Inc.",
        "long_name": "Venus Concept Inc.",
        "summary": "Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and treatment of ingrown hair; and Venus Fiore that is used for the treatment of vaginal canal, labia skin tightening, and mons pubis. The company also offers Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin; Venus Freeze Plus, a noninvasive device used in dermatologic and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides; Venus Bliss, a device is used for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance. In addition, it provides NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system; and ARTAS and ARTAS iX, a robotic systems to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "NGM",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VEXT.CN": {
        "short_name": "VextSciInc",
        "long_name": "Vext Science, Inc.",
        "summary": "Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VEXTF": {
        "short_name": "VEXT SCIENCE INC",
        "long_name": "Vext Science, Inc.",
        "summary": "Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VGANF": {
        "short_name": "PLANT & CO. BRANDS LTD",
        "long_name": "Plant & Co. Brands Ltd.",
        "summary": "Plant & Co. Brands Ltd. focuses on operating data-driven digital CBD marketplace. It operates as a vertically integrated enterprise focused on the health and wellness sector. Plant & Co. Brands has collaboration with the University of Manitoba to develop an all-natural hemp-based food line. The company was formerly known as Eurolife Brands Inc. and changed its name to Plant & Co. Brands Ltd. in December 2020. Plant & Co. Brands Ltd. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VGL.V": {
        "short_name": "VIGIL HEALTH SOLUTIONS INC.",
        "long_name": "Vigil Health Solutions Inc.",
        "summary": "Vigil Health Solutions Inc. develops, markets, and distributes hardware and software solutions for care plans and monitoring the aged in Canada and the United States. The company offers The Vigil Integrated Care Management System, a non-invasive monitoring system for residents with dementia. It also offers vigil memory care systems; nurse care systems; vitality care systems; and cloud applications, as well as specialty monitoring and notification devices. The company serves customers, such as independent living, assisted living, skilled nursing facilities, and continuing care retirement communities or life plan communities. Vigil Health Solutions Inc. is headquartered in Victoria, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Victoria"
    },
    "VHI.V": {
        "short_name": "VITALHUB CORP",
        "long_name": "Vitalhub Corp.",
        "summary": "Vitalhub Corp., together with its subsidiaries, develops technology solutions for health and human service providers in the hospital, regional health authority, mental health, long term care, home health, and community and social service sectors in Canada, the United Kingdom, and the United States. Its solutions include electronic healthcare record, case management, care coordination, patient flow and operational visibility, and DOCit mobile apps. Vitalhub Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VHIBF": {
        "short_name": "VITALHUB CORP",
        "long_name": "Vitalhub Corp.",
        "summary": "Vitalhub Corp., together with its subsidiaries, develops technology solutions for health and human service providers in the hospital, regional health authority, mental health, long term care, home health, and community and social service sectors in Canada, the United Kingdom, and the United States. Its solutions include electronic healthcare record, case management, care coordination, patient flow and operational visibility, and DOCit mobile apps. Vitalhub Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VIN.CN": {
        "short_name": "VinergyCapital",
        "long_name": "Vinergy Capital Inc.",
        "summary": "Vinergy Capital Inc. does not have significant operations. Previously, it was engaged in the development of cannabis products. The company was formerly known as Vinergy Cannabis Capital Inc. and changed its name to Vinergy Capital Inc. in March 2021. Vinergy Capital Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VISN.V": {
        "short_name": "BINOVI TECHNOLOGIES CORP",
        "long_name": "Binovi Technologies Corp.",
        "summary": "Binovi Technologies Corp. develops and commercializes visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. Its products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VIV.V": {
        "short_name": "AVIVAGEN INC",
        "long_name": "Avivagen Inc.",
        "summary": "Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "VIVO.TO": {
        "short_name": "VIVO CANNABIS INC",
        "long_name": "VIVO Cannabis Inc.",
        "summary": "VIVO Cannabis Inc. cultivates, produces, and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. The company offers dried cannabis flower products, pre-rolls and cannabis oils, and other cannabis-derived products; and cannabis-infused chocolates, vapes, kief, live rosin, bubble hash, brick hash, and shatter and wax solvent extracts under the Canna Farms, Beacon Medical, Fireside, Fireside-X, Lumina, and Canadian Bud Collection brands. The company also operates a network of medical cannabis clinics under the Harvest Medicine name. It serves customers through direct and retail sale; and HMED Connect telemedicine platform, an online medical cannabis platform. The company is headquartered in Napanee, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Napanee"
    },
    "VIVXF": {
        "short_name": "AVIVAGEN INC",
        "long_name": "Avivagen Inc.",
        "summary": "Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "VLNCF": {
        "short_name": "THE VALENS COMPANY INC",
        "long_name": "The Valens Company Inc.",
        "summary": "The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VLNS.TO": {
        "short_name": "THE VALENS COMPANYINC",
        "long_name": "The Valens Company Inc.",
        "summary": "The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VM.V": {
        "short_name": "VOYAGEUR PHARMACEUTICALS LTD",
        "long_name": "Voyageur Pharmaceuticals Ltd.",
        "summary": "Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the industrial barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is based in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "VNNYF": {
        "short_name": "VINERGY CAPITAL INC",
        "long_name": "Vinergy Capital Inc.",
        "summary": "Vinergy Capital Inc. does not have significant operations. Previously, it was engaged in the development of cannabis products. The company was formerly known as Vinergy Cannabis Capital Inc. and changed its name to Vinergy Capital Inc. in March 2021. Vinergy Capital Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VP2.F": {
        "short_name": "VALEO PHARMA INC.CL.A",
        "long_name": "Valeo Pharma Inc.",
        "summary": "Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and hospital products. Its products portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson's disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for the percutaneous anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation. The company also provides Ethacrynate Sodium, a loop diuretic used to treat high blood pressure and the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Yondelis, a novel marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product pipeline includes Piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for anti-fungal, antibiotic, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Kirkland"
    },
    "VPH.CN": {
        "short_name": "ValeoPharma",
        "long_name": "Valeo Pharma Inc.",
        "summary": "Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and hospital products. Its products portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson's disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for the percutaneous anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation. The company also provides Ethacrynate Sodium, a loop diuretic used to treat high blood pressure and the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Yondelis, a novel marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product pipeline includes Piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for anti-fungal, antibiotic, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Kirkland"
    },
    "VPHIF": {
        "short_name": "VALEO PHARMA INC",
        "long_name": "Valeo Pharma Inc.",
        "summary": "Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and hospital products. Its products portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson's disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for the percutaneous anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation. The company also provides Ethacrynate Sodium, a loop diuretic used to treat high blood pressure and the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Yondelis, a novel marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product pipeline includes Piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for anti-fungal, antibiotic, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Kirkland"
    },
    "VPT.V": {
        "short_name": "VENTRIPOINT DIAGNOSTICS LTD",
        "long_name": "VentriPoint Diagnostics Ltd.",
        "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VPTDF": {
        "short_name": "VENTRIPOINT DIAGNOSTICS LTD",
        "long_name": "VentriPoint Diagnostics Ltd.",
        "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VRSEF": {
        "short_name": "VERISANTE TECHNOLOGY INC",
        "long_name": "Verisante Technology Inc.",
        "summary": "Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "VRSYF": {
        "short_name": "VMS REHAB SYSTEMS",
        "long_name": "VMS Rehab Systems, Inc.",
        "summary": "VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses. It develops and tests generic tadalafil products. The company also sells orthopedic wedge seat cushions for relieving the discomfort and/or pain caused by other lower body medical issues, including pilonidal disease, piles disease, and hemorrhoids to home healthcare retail networks in Canada. VMS Rehab Systems, Inc. was founded in 1998 and is based in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Ottawa"
    },
    "VV5.F": {
        "short_name": "VEXT SCIENCE INC.",
        "long_name": "Vext Science, Inc.",
        "summary": "Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "VVCIF": {
        "short_name": "VIVO CANNABIS INC",
        "long_name": "VIVO Cannabis Inc.",
        "summary": "VIVO Cannabis Inc. cultivates, produces, and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. The company offers dried cannabis flower products, pre-rolls and cannabis oils, and other cannabis-derived products; and cannabis-infused chocolates, vapes, kief, live rosin, bubble hash, brick hash, and shatter and wax solvent extracts under the Canna Farms, Beacon Medical, Fireside, Fireside-X, Lumina, and Canadian Bud Collection brands. The company also operates a network of medical cannabis clinics under the Harvest Medicine name. It serves customers through direct and retail sale; and HMED Connect telemedicine platform, an online medical cannabis platform. The company is headquartered in Napanee, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Napanee"
    },
    "VXL.V": {
        "short_name": "VAXIL BIO LTD",
        "long_name": "Vaxil Bio Ltd.",
        "summary": "Vaxil Bio Ltd., an immunotherapy biotech company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VXLLF": {
        "short_name": "VAXIL BIO LTD (CA)",
        "long_name": "Vaxil Bio Ltd.",
        "summary": "Vaxil Bio Ltd., an immunotherapy biotech company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "VYYRF": {
        "short_name": "VOYAGEUR PHARMACEUTICALS LTD",
        "long_name": "Voyageur Pharmaceuticals Ltd.",
        "summary": "Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the industrial barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "W7V.F": {
        "short_name": "WELL HEALTH TECHS",
        "long_name": "WELL Health Technologies Corp.",
        "summary": "WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities in Canada and the United States. The company also provides digital electronic medical records (EMR) software services; and telehealth services. As of March 29, 2021, it operated 27 medical clinics; and provided digital EMR software and services to approximately 2,200 medical clinics across Canada. It also engages in developing digital health applications. The company was formerly known as Wellness Lifestyles Inc. and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. was incorporated in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "WAVE.V": {
        "short_name": "WAVERLEY PHARMA INC",
        "long_name": "Waverley Pharma Inc.",
        "summary": "Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the European Union and North America. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising Capecitabine, Erlotinib, and Temozolomide. Its products under development include injectable generic chemotherapy drugs, such as WAV-101 for the treatment of non-small cell lung cancer and pleural mesothelioma; and WAV-102 to treat multiple myeloma and mantle cell lymphoma. The company has a collaboration with the University of Manitoba for the development of a synthetic library of chloroquine analogs to treat COVID-19. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Winnipeg"
    },
    "WBIO.CN": {
        "short_name": "WPDPharma",
        "long_name": "WPD Pharmaceuticals Inc.",
        "summary": "WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "WDDMF": {
        "short_name": "WEEDMD INC",
        "long_name": "WeedMD Inc.",
        "summary": "WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Aylmer"
    },
    "WEED.TO": {
        "short_name": "CANOPY GROWTH CORPORATION",
        "long_name": "Canopy Growth Corporation",
        "summary": "Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Smiths Falls"
    },
    "WELL.TO": {
        "short_name": "WELL HEALTH TECHNOLOGIES CORP",
        "long_name": "WELL Health Technologies Corp.",
        "summary": "WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities in Canada and the United States. The company also provides digital electronic medical records (EMR) software services; and telehealth services. As of March 29, 2021, it operated 27 medical clinics; and provided digital EMR software and services to approximately 2,200 medical clinics across Canada. It also engages in developing digital health applications. The company was formerly known as Wellness Lifestyles Inc. and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. was incorporated in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "WKULF": {
        "short_name": "POTENT VENTURES INC",
        "long_name": "Potent Ventures Inc.",
        "summary": "Potent Ventures Inc. sells branded cannabis packaging. It offers its products through Wknd! and Orchard Heights brand name. The company was formerly known as Weekend Unlimited Industries Inc. and changed its name to Potent Ventures Inc. in April 2021. Potent Ventures Inc. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "WLDFF": {
        "short_name": "WILDFLOWER BRANDS INC",
        "long_name": "Wildflower Brands Inc.",
        "summary": "Wildflower Brands Inc. develops, designs, and sells branded products in the cannabis in Washington and California. It offers a line of hemp derived CBD+ wellness products, including CBD based topicals, soaps, tinctures, capsules, and vaporizers. The company also provides bundle box kit. The company offers its products online and through retailers. The company was formerly known as Wildflower Marijuana Inc. and changed its name to Wildflower Brands Inc. in April 2018. Wildflower Brands Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "WLLW.TO": {
        "short_name": "WILLOW BIOSCIENCES INC",
        "long_name": "Willow Biosciences Inc.",
        "summary": "Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "WLNS.CN": {
        "short_name": "DiscoverWell",
        "long_name": "Discover Wellness Solutions Inc.",
        "summary": "Discover Wellness Solutions Inc., a development stage company, cultivates, produces, processes, and sells cannabis in various forms. The company was formerly known as RMMI Corp. and changed its name to Discover Wellness Solutions Inc. in January 2021. Discover Wellness Solutions Inc. was incorporated in 2018 and is based in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "WLNSF": {
        "short_name": "DISCOVER WELLNESS SOLUTIONS INC",
        "long_name": "Discover Wellness Solutions Inc.",
        "summary": "Discover Wellness Solutions Inc., a development stage company, cultivates, produces, processes, and sells cannabis in various forms. The company was formerly known as RMMI Corp. and changed its name to Discover Wellness Solutions Inc. in January 2021. Discover Wellness Solutions Inc. was incorporated in 2018 and is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "WLYYF": {
        "short_name": "WELL HEALTH TECHNOLOGIES CORP",
        "long_name": "WELL Health Technologies Corp.",
        "summary": "WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities in Canada and the United States. The company also provides digital electronic medical records (EMR) software services; and telehealth services. As of March 29, 2021, it operated 27 medical clinics; and provided digital EMR software and services to approximately 2,200 medical clinics across Canada. It also engages in developing digital health applications. The company was formerly known as Wellness Lifestyles Inc. and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. was incorporated in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "WMD.V": {
        "short_name": "WEEDMD INC",
        "long_name": "WeedMD Inc.",
        "summary": "WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Aylmer"
    },
    "WUHN": {
        "short_name": "WUHAN GENERAL GROUP CHINA INC",
        "long_name": "Wuhan General Group (China), Inc.",
        "summary": "Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Pointe-Claire"
    },
    "XCX.CN": {
        "short_name": "AMPAlterMedPro",
        "long_name": "AMP Alternative Medical Products Inc.",
        "summary": "AMP Alternative Medical Products Inc., through its subsidiaries, operates in the medical cannabis industry. It imports and sells EU-GMP medical cannabis for patients in Germany. The company was formerly known as AMP German Cannabis Group Inc. and changed its name to AMP Alternative Medical Products Inc. in February 2021. AMP Alternative Medical Products Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "XENE": {
        "short_name": "Xenon Pharmaceuticals Inc.",
        "long_name": "Xenon Pharmaceuticals Inc.",
        "summary": "Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NGM",
        "market": "us_market",
        "country": "Canada",
        "city": "Burnaby"
    },
    "XLY.TO": {
        "short_name": "AUXLY CANNABIS GROUP INC",
        "long_name": "Auxly Cannabis Group Inc.",
        "summary": "Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "XP0.F": {
        "short_name": "XENON PHARMACEUTICALS",
        "long_name": "Xenon Pharmaceuticals Inc.",
        "summary": "Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Burnaby"
    },
    "XPHY.CN": {
        "short_name": "XPhytoThera",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "XPHYF": {
        "short_name": "XPHYTO THERAPEUTICS CORP",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "XRTXF": {
        "short_name": "XORTX THERAPEUTICS INC",
        "long_name": "XORTX Therapeutics Inc.",
        "summary": "XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "XRX.CN": {
        "short_name": "XORTXTherap",
        "long_name": "XORTX Therapeutics Inc.",
        "summary": "XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "XSQ.F": {
        "short_name": "SQI DIAGNOSTICS INC.",
        "long_name": "SQI Diagnostics Inc.",
        "summary": "SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company provides advanced diagnostics targeting organ transplant, autoimmune disease, and serological testing. It also offers TOR-dx, a lung panel test, which enables surgeon to assess the health of donor's lung; and COVID-19 at-home antibody test kit, and the RALI-Dx and RALI-fast point-of care tests to triage COVID-19 patients for respiratory distress. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Toronto"
    },
    "XTRX.CN": {
        "short_name": "PhytoExtraction",
        "long_name": "Phyto Extractions Inc.",
        "summary": "Adastra Labs Holdings Ltd. operates as a cannabis extraction and processing solutions company. It also offers third party analytical testing services, such as white labelling, contract processing, and cannabis testing. The company is based in Langley, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "city": "Langley"
    },
    "YG3.F": {
        "short_name": "BETTER PLANT SCIENCES INC",
        "long_name": "Better Plant Sciences Inc.",
        "summary": "Better Plant Sciences Inc., through its subsidiaries, develops, markets, and sells of plant-based products for health and wellness. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils. It also develop and acquire intellectual property for plant-based products. The company offers plant-based skin care products under Urban Juve brand name; cannabis wellness products under Wright & Well and Jack n Jane brands; botanicals, fruit extracts, and spices under the UJ Beverages brand. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "YSSCD": {
        "short_name": "NOVA CANNABIS INC",
        "long_name": "Nova Cannabis Inc.",
        "summary": "Alcanna Cannabis Stores GP Inc. and Alcanna Cannabis Stores Limited Partnership represents the combined operations of Alcanna Cannabis Stores GP Inc. and Alcanna Cannabis Stores Limited Partnership. Alcanna Cannabis Stores Limited Partnership engages in retail of cannabis. Alcanna Cannabis Stores GP Inc. and Alcanna Cannabis Stores Limited Partnership is based in Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Pharmaceutical Retailers",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": null
    },
    "ZBISF": {
        "short_name": "ZENABIS GLOBAL INC",
        "long_name": "Zenabis Global Inc.",
        "summary": "Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-\u00c3\u00bcp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ZENA.TO": {
        "short_name": "ZENABIS GLOBAL INC",
        "long_name": "Zenabis Global Inc.",
        "summary": "Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-\u00c3\u00bcp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ZENI-P.V": {
        "short_name": "ZENITH CAPITAL CORPORATION",
        "long_name": "Zenith Capital Corporation",
        "summary": "Zenith Capital Corporation does not have significant operations. It intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. The company was founded in 2019 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ZHCLF": {
        "short_name": "ZENITH CAPITAL CORPORATION",
        "long_name": "Zenith Capital Corp.",
        "summary": "Zenith Capital Corp., a biotechnology investment company, develops bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. Its lead compound ZEN-3694 which is in phase II clinical trials for the treatment of metastatic castration resistant prostate cancer and in a phase 1b/2 clinical trial for triple negative breast cancer. The company was incorporated in 2013 and is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Calgary"
    },
    "ZMSPF": {
        "short_name": "ZECOTEK PHOTONICS INC",
        "long_name": "Zecotek Photonics Inc.",
        "summary": "Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets in Canada. The company operates through three divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Its imaging systems include lutetium fine silicate scintillation crystals; solid-state micro-pixel avalanche photo diode photo detectors and transistors; and integrated detector modules. The company also develops glasses-free 3D displays; and 3D auto-stereoscopic displays, and 3D printers and related technologies. The company was formerly known as Zecotek Medical Systems Inc. and changed its name to Zecotek Photonics Inc. in November 2007. Zecotek Photonics Inc. was incorporated in 1983 and is headquartered in Richmond, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "city": "Richmond"
    },
    "ZSB.F": {
        "short_name": "SIRONA BIOCHEM CORP.",
        "long_name": "Sirona Biochem Corp.",
        "summary": "Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. It develops programs in the areas of diabetes, anti-inflammatories, and anti-infectives for therapeutics; and anti-aging and depigmenting agents in cosmeceuticals. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "city": "Vancouver"
    },
    "ZYME": {
        "short_name": "Zymeworks Inc.",
        "long_name": "Zymeworks Inc.",
        "summary": "Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "city": "Vancouver"
    }
}